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SUMMARY 
 
In my first project, I analyzed the role of the amiloride-sensitive epithelial sodium channel 
(ENaC) in the skin during wound healing. ENaC is present in the skin and a function in 
keratinocyte differentiation and barrier formation has been demonstrated. Previous findings 
suggested, that ENaC might be implicated in keratinocyte migration, although its role in 
wound healing was not analyzed yet. Using skin-specific (K14-Cre) conditional αENaC 
knockout and overexpressing mice, I determined the wound closure kinetic and performed 
morphometric measurements. The time course of wound repair was not significantly different 
in knockouts or transgenics when compared to control mice and the morphology of the 
closing wound was not altered. 
In my second project, I studied the glucocorticoid-induced leucine zipper (GILZ, Tsc22d3). 
GILZ is widely expressed and an important role has been predicted in immunity, adipogenesis 
and renal sodium handling. Mice were generated that constitutively lack all the functional 
domains of the Gilz gene. In these mice, the expression of GILZ mRNA transcripts and 
protein were completely abolished in all tissues tested. Surprisingly, knockout mice survived. 
To test whether GILZ mimicks glucocorticoid action, we studied its implication in T- and B-
cell development and in a model of sepsis. We measured cytokine secretion in different 
inflammatory models, like in peritoneal and bone marrow-derived macrophages, in 
splenocytes and a model of sepsis. In all our experiments, cytokine secretion from GILZ-
deficient cells was not different from controls. From 6 months onwards, knockout mice 
contained significantly less body fat and were lighter. Following sodium and water 
deprivation experiments, water and salt homeostasis was preserved. Sterility of knockout 
males was associated with a severe testis dysplasia, smaller seminiferous tubules, the number 
of Sertoli and germ cell was reduced while increased apoptosis, but not cell proliferation, was 
evidenced. The interstitial Leydig cell population was augmented, and higher plasma FSH and 
testosterone levels were found. Interestingly, the expression of the target gene Pparγ2 was 
diminished in the testis and in the liver, but not in the skin, kidney or fat. Tsc22d1 mRNA 
transcript level was found to be upregulated in testis, but not in the kidney or fat tissue. In 
most tissue, excepted the testis, GILZ-deficient mice reveal functional redundancy amongst 
members of the Tsc22d family or genes involved in the same regulatory pathways. In 
summary, contrarily to the published in vitro data, GILZ does not play a crucial role attributed 
in immunology or inflammation, but we identified a novel function in spermatogenesis. 
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RESUME 
 
Dans mon premier projet, j’ai analysé le rôle du canal épithélial sodique sensible à l’amiloride 
(ENaC) dans la cicatrisation de la peau. ENaC est présent dans la peau et il a une fonction 
dans la différenciation des kératinocytes et dans la formation de la barrière. Des études 
suggèrent qu’ENaC pourrait être impliqué dans la migration des kératinocytes, cependant, son 
rôle dans la cicatrisation n’a pas encore été étudié. A l’aide de souris qui surexpriment ou qui 
sont knockout pour αENaC, spécifiquement dans la peau (K14-Cre), j’ai analysé le temps de 
clôture de la cicatrice et j’ai aussi étudié la morphologie de la plaie guérissant. Chez les souris 
qui surexpriment ou chez les knockouts, la vitesse de fermeture et la morphologie de la 
cicatrice étaient identiques aux souris contrôles. 
Dans mon second projet, j’ai étudié le glucocorticoid-induced leucine zipper (GILZ, 
Tsc22d3). GILZ est largement exprimé et un rôle important a été prédit dans l’immunité, 
l’adipogénèse et le transport sodique rénal. Des souris ont été générées dont les domaines 
fonctionnels du gène Gilz sont éliminés. L’expression de GILZ en ARNm et protéine a été 
complètement abolie dans tous les tissus testés. Étonnamment, ces souris knockout survivent. 
Afin de tester si GILZ imite les effets des glucocorticoïdes, nous avons étudié son implication 
dans le développement des cellules T et B ainsi qu’un modèle de septicémie. Nous avons 
mesuré la sécrétion de cytokines à partir de différents modèles d’inflammation tels que des 
macrophages péritonéaux ou de moelle, de splénocytes ou encore d’un modèle de septicémie. 
Dans toutes nos expériences, la sécrétion de cytokines de cellules GILZ-déficientes était 
semblable. Dès 6 mois, les knockouts contenaient significativement moins de graisses et 
étaient plus légères. Suite à une privation sodique et aqueuse, l’homéostasie du sel et de l’eau 
était préservée. Les mâles knockouts présentaient une stérilité accompagnée d’une dysplasie 
testiculaire sévère, de tubules séminifères étaient plus petits et contenaient un nombre réduit 
de cellules de Sertoli et de cellules germinales. L’apoptose était augmentée dans ces cellules 
mais pas la prolifération cellulaire. Le nombre de cellules de Leydig était aussi plus élevé, 
ainsi que la FSH et la testostérone. L’expression du gène cible Pparγ2 était diminuée dans le 
testicule et le foie, mais pas dans la peau, le rein ou le tissu adipeux. L’ARNm de Tsc22d1 
était plus exprimé dans le testicule, mais pas dans le rein ou le tissu adipeux. Dans la plupart 
des tissus, sauf le testicule, les souris knockouts révélaient une redondance fonctionnelle des 
autres membres de la famille Tsc22d ou de gènes impliqués dans les mêmes voies de 
régulation. En résumé, contrairement aux données in vitro, GILZ ne joue pas un rôle essentiel 
en immunologie, mais nous avons identifié une nouvelle fonction dans la spermatogénèse. 
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INTRODUCTION 
The epithelial sodium channel (ENaC) 
Gene structure and function 
The epithelial sodium channel (ENaC) belongs to the ENaC/Degenerin gene family (figure 1). 
In the beginning of the 1990’s, the sequence of the ENaC α subunit was identified from 
epithelial cells of rat distal colon and identified by functional expression in Xenopus laevis 
oocytes (Canessa et al., 1993), quickly followed by the two other β and γ subunits (Canessa et 
al., 1994). At the same period, genetic screening of Caenorhabditis elegans mutants presenting 
defective mechanosensation allowed to identify degenerin genes (Chalfie and Wolinsky, 1990). 
Later, it has been determined that gain-of-function of these two degenerin ion channel genes 
results in toxicity for the nematode by causing degeneration of several neurons and rendering 
mutants incapable of mechanosensation. Neuronal degenerins from human and rat brain were 
cloned and described as amiloride-sensitive cation channels for which phylogenic analysis 
indicated that they were equally divergent from all other members of the ENaC/Degenerin 
family. These channels are activated by rapid extracellular acidification (Waldmann et al., 
1997), so they are called acid-sensing ion channel (ASIC). In the snail Helix aspersa, it has 
been found that the FMRFamide-gated sodium channel (FaNaC) could be blocked by 
amiloride. Despite the low sequence homology with ENaC subunits and degenerins, FaNaC 
displays the same overall structural organization (Lingueglia et al., 1995). Sequence alignment 
studies between all members of ENaC/Deg family led to a potential phylogenetic tree proposed 
in figure 1. Related sequences are organized into subfamilies. Figure 2 shows the conservation 
of several domains between the main subfamilies (Kellenberger and Schild, 2002; Golubovic et 
al., 2007). 
The highly amiloride-sensitive epithelial sodium channel (Scnn1, sodium channel non-voltage-
gated) is composed of 3 homologous subunits α, β and γ. The α subunit is required for channel 
activity, whereas β and γ are necessary for maximal channel activity (Canessa et al., 1994; 
Rossier et al., 2002). Each subunit consists of two transmembrane helices, a large extracellular 
loop and short cytoplasmic amino- and carboxy-termini. ENaC is thought to be composed of 
2α, 1β and 1γ subunits (figure 3A) and showed to be functional by construction of a 
concatemeric cDNA (Firsov et al., 1998; Kosari et al., 1998; Anantharam and Palmer, 2007). A 
stoichiometry of 8 to 9 subunits has also been proposed (Snyder et al., 1998; Eskandari et al., 
1999).  
  3 
 
Figure 1: Quartet-puzzling consensus tree for the DEG/ENaC data set. The tree has been constructed by maximum likelihood analysis 
with the program TREE-PUZZLE; branch lengths are proportional to the evolutionary distance. Support values below 90% are 
indicated. The small schematics illustrate the topology and domain organization of different branches of the DEG/ENaC gene family. 
The ASIC branch is shown also at higher magnification. Abbreviations of species names are as follows: c, chicken (Gallus gallus); f, 
toadfish (Opsanus tau); h, human (Homo sapiens); Ha, Helix aspersa; Ht, Helisoma trivolvis; Hy, H. magnipapillata; l, lamprey 
(Lampetra fluviatilis); Ls, Limnea stagnalis;m, mouse (Mus musculus); r, rat (Rattus norvegicus); sh, shark (Squalus acanthias); z, 
zebrafish (Danio rerio). Other proteins are from Drosophila melanogaster or C. elegans (Golubovic et al., 2007). 
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Figure 2: Linear representation of the primary structure shows the conserved regions found in each of the main subfamilies. The 
length of the domains in the diagram reflects their relative size in the protein. M1, M2, transmembrane segments; HG, conserved His-
Gly motif within a conserved NH2-terminal domain; pM1, post-M1, conserved domain directly downstream of M1; CRD, cysteine-rich 
domain; pre-M2, hydrophobic domain directly preceding M2; ERD, extracellular regulatory domain unique to C. elegans degenerins; 
NTD, neurotoxin domain; PY, PPPxY domain of α , β , and γENaC (Kellenberger and Schild, 2002). 
 
New insights about the molecular organization have been recently given with the low pH 
crystal structure of a chicken ASIC1 in a desensitized state, suggesting a homotrimeric 
structure for this proton-sensing ion channel (Jasti et al., 2007; Gonzales et al., 2009). Since 
ASICs belong to the ENaC/DEG family, ENaC has been proposed to a trimer composed of 1α, 
1β and 1γ subunits. However, it is worth to mention that the homotrimeric organization of 
ASIC1 was determined by crystallography on the truncated protein expressed in SF9 insect 
cells. This is a cell line having very low cholesterol content and different phospholipid profile 
compared with mammalian cell lines. Furthermore, only the functionality of the GFP-tagged 
construct of ASIC, used for the transfection, has been tested. The construct, as it was 
crystallized, has never been assessed. Thus, the number of subunits composing the functional 
ENaC is still under debate. 
 
Figure 3: ENaC structure. A, Model of the tetrameric assembly of an ENaC channel around the central pore. Functional analyses have 
shown that α , β and γENaC subunits participate in the formation of the pore and establish the stoechiometry of the channel 
(Kellenberger and Schild, 2002). B, Homology models of α  (green), β  (red) and γ  (yellow) ENaC subunits based on the crystal 
structure of ASIC channel. These homologous subunits show a large extracellular domain that represents more than half of the mass 
of the protein. The two transmembrane domains (TM1 and TM2) consist of α helices, and the TM2 is involved in lining the pore. The 
crystal obtained for ASIC1a did not allow the resolution of the structure of the amino and the carboxy termini, and therefore are 
absent as well in the present homology models of α, β and γ subunits (Schild, 2010). 
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ENaC is constitutively active and localized at the apical membrane of tight epithelia. Single 
ENaC recordings in the cortical collecting tubule show slow kinetics with open and closed 
times in the range of seconds at room temperature (Palmer and Frindt, 1986). ENaC activity 
can be pharmacologically inhibited by amiloride and triamterene that bind extracellularly to a 
common site on the TM2 segment (Kellenberger et al., 2003).  
 
Figure 4: Structure of the nephron (Boron and Boulpaep, 2004) 
 
In the kidney (figure 4), ENaC is expressed in the aldosterone-sensitive distal nephron 
(ASDN), a region that includes successively, the late portion of the distal convoluted tubule 
(DCT2), the connecting tubule (CNT) and the collecting duct (CD) (Loffing et al., 2001). In 
spite of their different embryonic origin (mesenchymal for DCT and CNT, ureteric bud for CD) 
(Vainio and Lin, 2002), all three nephron segments express ENaC, the mineralocorticoid 
receptor (MR) and the 11-β hydroxysteroid dehydrogenase type-2, the enzyme that confers to 
the MR receptor a functional mineralocorticoid specificity (Edwards et al., 1988; Funder et al., 
1988). The subcellular location and the level of expression of ENaC subunits change drastically 
upon the elevation of plasma aldosterone levels in response to sodium diet (Masilamani et al., 
1999; Loffing et al., 2000). In rodents under standard Na+ diet associated with moderate plasma 
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aldosterone levels, ENaC subunits are detectable by immunohistochemistry in the cytosol of 
principal cells, with a discrete labelling of the apical membrane of the late DCT and the CNT. 
Under low Na+ diet leading to high plasma levels of aldosterone in these animals, ENaC 
subunits are localized in the apical membrane of principal cells of the CD, with a more 
prominent expression in the early ASDN compared with the late ASDN. ENaC in the apical 
membrane of principal cells is the major entry for Na+ from the tubule lumen into the cell. Na+ 
enters the cell across the apical membrane following a favourable electrochemical gradient 
(Palmer and Andersen, 2008). The vectorial transport of Na+ across the epithelial cell is 
ensured by the Na+/K+-ATPase located at the basolateral membrane that pumps the sodium 
ions out of the cell toward the blood.  
Regulation of ENaC 
Open probability of ENaC 
ENaC is a non-voltage-gated sodium channel. Its activity is strongly regulated by sodium itself 
via two distinct phenomena: self-inhibition and feedback inhibition. Self-inhibition reduces 
ENaC activity by an increase in extracellular sodium concentration (Chraibi and Horisberger, 
2002). The feedback inhibition displays slower kinetics compared to the self inhibition due to 
the increase of intracellular sodium concentration. (Kellenberger et al., 2002; Anantharam et 
al., 2006). Beside sodium, some molecules have been shown to inactivate the channel at low 
concentrations, like amiloride, which is the most classical blocker for ENaC activity. Actually, 
the inhibition of ENaC by amiloride was described in the frog skin and bladder 15 years before 
the cloning of the channel (Fuchs et al., 1977; Diamond, 1978; Palmer, 1984) Another blocker 
of ENaC is benzamil, which has a Ki about ten times lower than amiloride (0.01µM), but with a 
lower specificity to ENaC (Kellenberger et al., 2003). 
Protease activation of ENaC 
ENaC was found to be stimulated by soluble proteases such as trypsin, kallikrein or thrombin 
(Vallet et al., 1997; Chraibi et al., 1998; Harris et al., 2007). Serine proteases increase ENaC 
activity at the cell surface. The channel activating protease 1 (CAP1), the ortholog of human 
prostasin (Prss8), was the first to be cloned and characterized (Vallet et al., 1997; Vuagniaux et 
al., 2000). CAP2 (TMPRSS4), CAP3 (matriptase) and elastase were thereafter discovered and 
described as further activators of ENaC (Vuagniaux et al., 2002).  
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Figure 5: Linear models for ENaC subunit cleavage. Each subunit has common features, including two transmembrane domains (M1 
and M2) with short N and C termini, a large extracellular loop with 5–12 N-glycosylation sites, and multiple cysteines that participate 
in disulfides bridges critical for folding, trafficking, and/or activity. Known and suspected sites of ENaC cleavage are indicated. 
Molecular masses (kDa) of nonglycosylated fragments consistent with cleavage at the indicated sites, and that have been detected by N-
terminal (asterisks) or C-terminal antibodies (double asterisks), are indicated. (Top) In the α subunit model, within the first cysteine 
disulfide bridge (C158-C332) two furin cleavage sites (F) are identified (yellow boxes). Putative trypsin (T), chymotrypsin (CT), 
elastase (E), or SPs within the second cysteine disulfide bridge (C458-C472) are indicated (green box). These sites may generate a 65–
70-kDa fragment as detected by an N-terminal antibody and as observed in oocytes, kidney, and lung. (Middle) In the β subunit model, 
furin cleavage sites (F) are absent. Putative trypsin (T), chymotrypsin (CT), elastase (E), or CAP-induced cleavage sites are postulated 
to be protected by heavy glycosylation (ten potential N-glycosylation sites) and/or by the absence of conformational changes induced by 
furin. (Bottom) In the γ subunit model, only one furin cleavage site (F) is observed within the first cysteine disulfide bridge (C100-
C284) (yellow). A CAP-1/prostasin cleavage site (light blue box) and elastase cleavage sites (pink box) are indicated. Putative trypsin 
(T), chymotrypsin (CT), elastase (E), or SPs within the second cysteine disulfide bridge (C410-C424) are indicated, but there are no 
experimental data confirming that they exist in vivo or in vitro (Rossier and Stutts, 2009). 
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As illustrated in figure 5, it has been speculated that ENaC activation by proteases results from 
the release of an inhibitory peptide from the α and γ subunits (Hamm et al., 2010). Cleavage by 
furin of the α subunit leading to activation of ENaC was first reported (Carattino et al., 2006). 
A cleavage site by furin was also proposed for the γ subunit (Hughey et al., 2004; Bruns et al., 
2007). However, more recent studies indicated that mutation of the furin site in the αENaC 
subunit did not alter the channel activation (Diakov et al., 2008). Moreover, Harris et al., 
showed from oocyte experiments, that furin-mediated cleavage is not required for participation 
of α and γ in heteromers (Harris et al., 2008). These proteolytic processes occur within the 
trans-Golgi network, but both cleaved and uncleaved channels are expressed at the cell 
membrane (figure 6).  
 
Figure 6: Schematic representation of the proteolytic regulation of ENaC. (A) The colocalization model emphasizes the presence of 
consensus recognition and cleavage sequences for furin and furin-like convertases in α and γ ENaC. Convertase(s) and substrate 
(ENaC) are expected to cotraffic along the same trans-Golgi path, potentially allowing partially proteolized ENaC heteromers to be 
delivered to the cell surface. At the cell surface, channel-activating serine proteases (SPs) become activated and, if appropriately 
colocalized, can complete proteolytic activation. Alternatively, certain soluble serine proteases present in the extracellular milieu can 
activate near-silent ENaC under the influence of soluble serine protease inhibitors (serpins). (B) The sequential model elaborates on 
the colocalization implicit in proteases directly cleaving ENaC to include the further possibility that a protease or proteases may be 
essential for activating ENaC but may act indirectly by participating in a protease cascade. As depicted, ENaC may be partially 
processed by convertases and then fully activated by a protease that requires activation by other membrane-bound or soluble 
proteases. (Rossier and Stutts, 2009). 
 
This allows a more precise regulation of the activity of the channel by soluble and membrane-
associated serine proteases (Rossier and Stutts, 2009). Furthermore, several in vivo studies 
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support the importance of the proteolytic cleavage of ENaC. The γENaC and probably also the 
αENaC subunits are present in the apical membrane mainly in proteolytically cleaved forms, 
particularly under conditions of high aldosterone. This was shown directly for γENaC and 
inferred for αENaC on the basis of the absence of the full-length form of the subunit. Previous 
work showed that the overall amounts of the cleaved forms correlated with the physiological 
activity of the channels (Masilamani et al., 1999; Frindt et al., 2001; Ergonul et al., 2006). 
Regulation of ENaC activity 
To keep the extracellular volume constant, the kidney has to balance precisely the urinary 
excretion of electrolytes and water with daily salt and fluid intake. This regulation is tightly 
controlled by aldosterone and vasopressin. The action of these hormones is located in the distal 
nephron and on the collecting tubules of the kidney. These cells express ENaC, the 
mineralocorticoid receptor (MR), aquaporin 2 (AQP2) and the vasopressin receptor (V2R). The 
correct function of these channels and receptors is crucial to sustain hormonally balanced 
sodium and water homeostasis (figure 7). 
Aldosterone, a mineralocorticoid hormone, principally increases the open probability (Po) and 
the number of active ENaC channels at the surface (Loffing et al., 2000). Aldosterone induces 
the phosphatidylinositide 3′-kinase (PI3K)-dependent kinase SGK1 (serum- and 
glucocorticoid-regulated kinase 1), a Ser/Thr kinase that elevates ENaC level and activity at the 
cell surface in heterologous expression systems (Alvarez de la Rosa et al., 1999; Chen et al., 
1999; Naray-Fejes-Toth et al., 1999). Subsequently, SGK1 was found to phosphorylate Nedd4-
2, leading to a decreased interaction and ubiquitylation of ENaC subunits, finally resulting in 
an increased ENaC activity at the cell surface (Debonneville et al., 2001). Other aldosterone-
induced transcripts have been identified, in particular the deubiquitylating enzyme Usp2-45, 
which also increases ENaC activity at the cell surface in vitro (Fakitsas et al., 2007). These 
observations suggest that the regulation of ENaC activity by aldosterone is mediated at least in 
part by inhibition of Nedd4-2-dependent ubiquitylation of ENaC, that ultimately tends to 
increase the number of active channel at the cell surface (Verrey et al., 2008). 
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Figure 7: Model for the early transcriptional action of aldosterone on ENaC function. The ubiquitin ligase Nedd4-2 that tonically 
inhibits ENaC surface expression is highlighted in red, and red dashed arrows indicate pathways downregulating ENaC that are 
antagonized by aldosterone. Blue boxes represent the regulatory proteins implicated in the early aldosterone action that are rapidly 
induced via activated MR. The blue lines terminated by a dash indicate at what level these regulatory proteins interfere with ENaC 
inhibition (Verrey et al., 2008). 
 
Additionally, vasopressin also increases ENaC activity in the ASDN. Binding of vasopressin to 
the V2R, stimulates the release of cAMP, which in turn increases the density of ENaC channel 
at the cell surface (Canessa and Schafer, 1992; Auberson et al., 2003). In vitro studies indicate 
that PKA, much like SGK1, also phosphorylates Nedd4-2, providing a cellular mechanism for 
the positive regulation of ENaC by vasopressin (Snyder et al., 2004). PKA and SGK1 
phosphorylate the same residues of Nedd4-2. Thus, the converging phosphorylation of Nedd4-2 
by these two kinases does not explain the additive effects of vasopressin and aldosterone on 
ENaC-mediated Na+ absorption in the ASDN (Bugaj et al., 2009); therefore, other mechanisms 
are most likely involved in the regulation of ENaC by PKA. 
The regulation of Nedd4-2 remains poorly understood. As shown in figure 8, the 
phosphorylation of Nedd4-2 by SGK1 and PKA stabilizes the interaction of Nedd4-2 with 14-
3-3 scaffolding proteins, preventing the Nedd4-2 dependent ubiquitylation of ENaC (Bhalla et 
al., 2005). Interestingly, 2 isoforms of the 14-3-3 proteins are induced by aldosterone, as 
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SGK1. Another 14-3-3 binding protein has recently been identified that controls the trafficking 
of ENaC from an intracellular compartment to the cell surface: this binding partner, AS160, is a 
Rab GTPase-activating protein (Rab-GAP) known to play a role in GLUT4 transport to the 
plasma membrane in response to insulin (Liang et al., 2010). In CCD cells, AS160 
phosphorylation, possibly by SGK1, allows ENaC trafficking to the cell surface, providing a 
mechanism for endocytosed ENaC to recycle to the cell surface (Liang et al., 2010). 
 
 
Figure 8: Phosphorylation regulates Nedd4-2 activity. A, To reduce the rate of epithelial Na+ transport, Nedd4-2 binds to ENaC PY 
motifs and catalyzes its ubiquitination. This induces ENaC endocytosis and lysosomal targeting, resulting in fewer channels at the cell 
surface. B, To increase Na+ transport, Nedd4-2 is phosphorylated by kinases, including PKA, SGK, and IKKβ. Phosphorylation 
induces binding of 14-3-3 dimers, which prevents Nedd4-2 from binding to ENaC. As a result, increased ENaC abundance at the 
surface enhances epithelial Na+ absorption (Snyder, 2009). 
 
In parallel to the SGK1/Nedd4-2 pathway that stabilizes ENaC at the cell surface, a signaling 
cascade involving the Raf-1-MAPK/ERK kinases acts to inhibit the cell surface expression of 
ENaC by stimulating the interaction between Nedd4-2 and ENaC (Nicod et al., 2002; Falin and 
Cotton, 2007). These studies essentially performed in vitro on heterologous expression systems 
or in cortical collecting duct cell lines, identify Nedd4-2 as a critical convergence point for the 
regulation of ENaC at the cell surface. Interestingly, the activation of ERK could be inhibited 
by another aldosterone-induced protein in a cortical collecting cell line, the glucocorticoid-
induced leucine zipper protein (GILZ) (Soundararajan et al., 2010).  
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Figure 9: The ENaC-regulatory complex. In the “basal/no-hormone” state, ENaC is associated with and inhibited by an ENaC 
regulatory complex (ERC), which contains Nedd4-2, as well as Raf-1, MEK, and ERK. ERK phosphorylates the channel (small yellow 
circles), which in turn stimulates recruitment of Nedd4-2, and hence channel ubuiquitination (orange trapezoids). ENaC 
internalization, endocytic trafficking, and lysosome-mediated degradation are thus augmented. Aldosterone coordinately induces the 
expression of SGK1 and GILZ1. GILZ1 in turn: a) recruits SGK1 to the ERC, b) increases interaction of SGK1 with its substrates 
Nedd4-2 and Raf-1, c) augments SGK1 inhibition of Nedd4-2 and Raf-1 within the ERC, which results in the recruitment of inhibitory 
14-3-3 proteins, and d) synergizes with SGK1 to selectively stimulate its ENaC specific functions. The net effect is “dual disinhibition” 
of ENaC (by SGK1 and GILZ1) resulting in increased channel surface expression and activity. Blue arrows represent Na+ movement 
through the channel, while black arrows represent proteins recruited to the complex. Top ellipse shows ENaC in the “inhibited” state, 
in which endocytosis and degradation are favored, while bottom ellipse shows the activated or “disinhibited” state, favoring 
accumulation at the plasma membrane (Soundararajan et al., 2010). 
 
The Pearce group recently showed that GILZ1 physically interacts with Nedd4-2 and with 
SGK1. There is a synergistic effect with SGK1 in the inhibition of Raf-1 and Nedd4-2 
(Soundararajan et al., 2009). GILZ1 physically interacts with and inhibits Raf-1 (Ayroldi et al., 
2002; Ayroldi et al., 2007), leading to ENaC activation. All of these factors are associated with 
ENaC within an ENaC-regulatory complex (ERC), the composition of which is controlled by 
GILZ1 (figure 9). In the absence of aldosterone with low levels of GILZ1 and SGK1, the 
complex is likely comprised of Nedd4-2 and Raf-1, along with other components of the Raf-
MEK-ERK signalling pathway that are known to be tightly associated with Raf-1. In the 
presence of aldosterone, GILZ1 recruits SGK1 into the complex. Together they cooperatively 
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inhibit Nedd4-2 and Raf-1, and synergistically stimulate ENaC surface expression and activity 
(Soundararajan et al., 2009). 
ENaC and human pathophysiology 
Liddle's syndrome is an autosomal dominant form of salt-sensitive hypertension with early 
onset of elevated blood pressure during adolescence; this hypertension is usually associated 
with hypokalemia, metabolic alkalosis, low plasma aldosterone, and suppressed plasma renin 
activity (Botero-Velez et al., 1994). The elevated blood pressure in Liddle’s syndrome can be 
normalized by salt restriction and amiloride treatment. The mutation identified in the index 
case, is a 45 amino acid deletion in the cytosolic C-terminus of the β ENaC subunit. Despite the 
fact that Liddle's syndrome is a very rare condition, subsequent genetic analysis of other 
Liddle's syndrome families revealed corresponding deletion mutations in the C-terminus of the 
γ ENaC subunit, but none in the α subunit (Shimkets et al., 1994). Furthermore, missense 
mutations causing Liddle's syndrome identified the target amino acid sequence in the β and γ 
C-termini that involves the conserved proline-rich motif, the canonical PPXY motif  (Hansson 
et al., 1995b; Hansson et al., 1995a; Snyder et al., 1995; Firsov et al., 1996; Schild et al., 1996). 
Experiments using ENaC channels expressed from synthetic RNA and carrying the mutations 
associated with Liddle's syndrome exhibit an increased channel activity in Xenopus oocytes and 
in a cortical collecting duct cell line (Schild et al., 1995; Auberson et al., 2003). This gain of 
function of the mutated channels results from both, an increased number of active channels at 
the cell surface, and a higher probability for the channel to remain open (Firsov et al., 1996). 
The PPXY motifs of β and γENaC bind the ubiquitin ligase Nedd4-2 that is responsible for the 
ubiquitylation of the active channel complex at the cell surface, and the subsequent targeting of 
the channel for endocytosis and lysosomal degradation. In Liddle's syndrome patients, deletion 
or missense mutations of PPXY motifs in the β or γENaC subunits impair the ability of Nedd4-
2 to bind and thus ubiquitylate the channel, leading to the accumulation of active ENaC 
channels at the cell surface (Abriel et al., 1999). 
Pseudohypoaldosteronism type 1 (PHA1) is characterized in the first week of life by severe 
dehydration, hyponatremia, metabolic acidosis and hyperkalemia (Chang et al., 1996). There 
are two clinically distinct forms of (PHA1), an autosomal recessive form affecting multiple 
organs (systemic form), including the kidneys, colon, salivary glands, skin and sweat ducts (but 
not the inner ear) and an autosomal dominant form restricted to the kidney (Belot et al., 2008). 
Patients with a systemic form of PHA1 exhibit mutations in α, β and γ ENaC subunits. 
Mutations in the α, β or γ ENaC genes include nonsense, frameshift or missense mutations 
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leading to channel loss of function, and the clinical severity of the syndrome correlates with the 
extent to which ENaC activity is reduced. The autosomal dominant form of PHA1 is caused by 
mutations of the mineralocorticoid receptors (Geller et al., 1998). Thus, both Liddle's and 
PHA1 syndromes clearly indicate the critical role of ENaC in the ASDN for the maintenance of 
sodium balance. 
ENaC mouse models 
Several transgenic mouse models have been developed to study in vivo the physiological and 
pathophysiological roles of ENaC in the maintenance of sodium balance and in the control of 
blood pressure. The phenotypes observed in these mice demonstrate that each subunit is 
essential for survival and for regulation of sodium transport (Bonny and Hummler, 2000). 
Inactivation of the for Scnn1a gene led to death due to lung clearance defect within 48h after 
birth (Hummler et al., 1996). Mice with mutations in the Scnn1b and Scnn1g genes die from 
dehydration and hyperkalaemia during the first week of life (Barker et al., 1998; McDonald et 
al., 1999).  
To obtain new insights into the pathophysiology of salt-sensitive hypertension, a mouse model 
of Liddle's syndrome has been developed, with the deletion of the C-terminal end of the βENaC 
subunit mimicking the human mutation of the index case (Pradervand et al., 1999). Under 
normal salt diet, these mice develop normally with a blood pressure similar to their wild type 
counterparts of identical genetic background. However, under high salt diet the Liddle mice 
develop high blood pressure, hypokalemia, metabolic alkalosis, low plasma aldosterone, 
recapitulating clinical features in Liddle's syndrome patients. 
The mouse model of Liddle's syndrome with the mutation in the PPXY motif of β ENaC, 
together with the Nedd4-2 knockout and SGK1 knockout mouse models thereby allow a 
genetic dissection of the aldosterone-signaling pathway. The Nedd4-2 knockout mice had a 
slightly elevated blood pressure under normal salt diet that was exacerbated under high salt 
diet. In these knockout mice, plasma aldosterone level was low (tendency) under normal salt 
diet and significantly under low salt diet. (Shi et al., 2008). The SGK1 knockout mice were 
viable and did not display any major phenotype under normal salt diet. Low salt diet induced a 
significantly higher natriuresis in the knockout mice when compared to controls (Wulff et al., 
2002; Fejes-Toth et al., 2008). These Nedd4-2 and SGK1 knockout mouse models show that 
these genes are not absolutely required for aldosterone-mediated control of ENaC. 
Since constitutive deficiency of a gene/protein may lead to embryonic or early perinatal 
lethality, conditional knockouts have been developed to study a gene deletion in a given cell 
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type or in a timely controlled manner. The development of site-specific recombinases and 
recognition sites from bacteriophages (Cre/loxP-mediated recombination) or yeast (Flp/frt-
mediated recombination) was a prerequisite for this technique. These strategies have already 
helped to understand the physiological role of proteins implicated in salt and water balance in 
the ASDN (Rubera et al., 2003; Rubera et al., 2009; Christensen et al., 2010a; Christensen et 
al., 2010b).  
The skin and ENaC 
Skin structure and function 
The skin is a complex organ. It is also the largest of the human body (about 4-5 kg). During 
mammalian embryogenesis the epidermis develops from the surface ectoderm, which initially 
consists of a multipotent single-layer epithelium. Once these epithelial cells receive the 
appropriate developmental signals, they become committed to stratify, initiate a massive 
expansion program, and finally result in terminal differentiation to produce the 
morphologically distinct layers of the epidermis. The end result is the formation of an 
impervious cornified envelope via a highly specialized form of programmed cell death, termed 
“cornification” (Candi et al., 2005), which is distinct in many ways from the classic apoptotic 
pathways (Mack et al., 2005).  
To prevent water loss, the skin provides a relatively dry and impermeable barrier. The 
regulation of water release from the organism into the atmosphere is defined as trans epidermal 
water loss (TEWL), which is the constitutive steady-state water loss from the skin, excluding 
sweat gland activity (Rogiers, 2001). Another important skin function is somatosensation. The 
skin contains a variety of nerve endings that reacts to heat and cold, touch, pressure, vibration 
and tissue injury (Bressler and Bressler, 1989; Willis, 2007). The skin is involved in heat 
regulation since it contains a blood supply, far greater than its requirements, which allows 
precise control of energy loss by radiation, convection and conduction. Dilated blood vessels 
increase perfusion and heat loss, while constricted vessels greatly reduce cutaneous blood flow 
and conserve heat (Rowell, 1974). The skin exhibit pigmentation, or melanin, provided by 
melanocytes that adsorb some of the potentially dangerous sunlight ultraviolet (UV) radiations 
(Brenner and Hearing, 2008). The skin can act as a storage for lipids (Schmitz and Muller, 
1991) and water (Verdier-Sevrain and Bonte, 2007), as well as a means of synthesis of vitamin 
D by the action of UV (Poduje et al., 2008). A continual self-renewal of cells occurs to 
compensate the loss of damaged tissue.  
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The skin is composed of three parts: the epidermis which provides waterproofing and serves as 
a barrier to infection; the dermis which serves as a location for skin appendages, like hair 
follicles, and the hypodermis which is a subcutaneous adipose layer (figure 10A). Hair follicles 
consist of an external epithelial envelope (outer root sheath) that is continuous with the 
epidermis, ensheaths the shaft and its thin internal envelope (inner root sheath) and embedded 
in it there is a distinct group of specialized dermal cells, the papilla. This core is surrounded by 
mesenchymal tissue, the dermal sheath (Paus and Cotsarelis, 1999). The hair follicle displays a 
remarkable ability for self regeneration, undergoing a regular succession of growth (anagen) 
and regression (catagen) phases associated with replacement of the old hair shaft by a new one 
(Hardy, 1992). Epidermis ("epi" coming from the greek meaning "over" or "upon") is the 
outermost layer of the skin. It forms the protective wrap over the surface of the body, and it is 
made up of stratified squamous epithelium (Blanpain and Fuchs, 2009). The dermis is the layer 
of skin beneath the epidermis consisting of connective tissue and it cushions the body from 
stress and strain (figure 10B). 
 
 
Figure 10: The skin. A, Structure of the human skin (MacNeil, 2007). B, Epidermis and the different layers forming this pluristratified 
epithelium (Fuchs, 2008). 
 
The epidermis is tightly connected to the dermis by a basement membrane. It also harbours 
many mechanoreceptor nerve endings that provide the sense of touch and heat (Boulais and 
Misery, 2008). It contains the hair follicles, sweat glands, sebaceous glands, apocrine glands, 
lymphatic vessels and blood vessels. The blood vessels in the dermis provide nourishment and 
waste removal to its own cells as well as to the stratum basale of the epidermis. The 
hypodermis lies below the dermis. Its purpose is to attach the skin to underlying bones and 
muscles as well as supplying them with blood vessels and nerves. It consists of connective 
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tissue and elastin. The main cell types are fibroblasts, macrophages and adipocytes. The 
hypodermis contains about 50% of the body fat which serves as padding and insulation for the 
body (Wajchenberg, 2000). 
 
 
Figure 11: Stem cells (SC) of the skin. A, Schematic representation of the skin epidermis with the different resident SC compartments 
and transit‑amplifying progeny identified. Bulge SCs are multipotent, residing in the permanent portion of the hair follicle (HF). 
Interfollicular epidermis SCs reside in the basal layer of the epidermis. Resident progenitors of the isthmus and sebaceous glands (SG) 
reside in the outer root sheath that is above the bulge and below the SG. It is not clear whether these two resident progenitors are 
equivalent. B, During the early stages of embryonic skin development, most cell divisions are symmetric and parallel to the basement 
membrane (BM), which ensures the growth of the surface of the developing embryo and maintains the epithelium as a single layer (top 
pannel). During epidermal stratification, ~70% of the cell divisions become asymmetric, such that the mitotic spindle is perpendicular 
to the basement membrane. This allows the development of suprabasal cells that terminally differentiate and establish the skin barrier 
(indicated by the arrow). In this mode of asymmetric cell division, different cell fate determinants are segregated unequally between 
the two daughter cells. The basal cell segregates the integrins and growth factor receptors (GFRs), which provide survival and 
proliferative cues to the SC. Polarity proteins are concentrated to the apical surface and presumably become preferentially distributed 
to the suprabasal cell (middle pannel). During epidermal homeostasis in the adult tail skin, asymmetric cell divisions occur with the 
plane of division parallel to the BM, such that only one daughter cell inherits a cell fate determinant, such as Numb, and remains a SC 
(step 1), whereas the other becomes committed to terminal differentiation, and probably undergoes delamination to reach the 
suprabasal layers (step 2; lower pannel). Adapted from: (Blanpain and Fuchs, 2009). 
 
The epidermis is a rapidly self-renewing tissue. It contains no blood vessels, and cells in the 
deepest layers are nourished by diffusion from blood capillaries extending to the upper layers 
of the dermis. The epidermis is mainly composed by keratinocytes with melanocytes, 
Langerhans cells and Merkels cells are also present. It can be further subdivided into the 
following strata (beginning with the innermost layer): stratum basale, stratum spinosum, 
stratum granulosum, stratum lucidum (present only in palms of the hands and sole of the foot) 
and stratum corneum (figure 10B).  
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Figure 12: Detailed structure of the epidermis. At the stratum granulosum/stratum corneum interface, the content of the lamellar 
bodies is extruded to the interface, thus forming continuous bilayers (Proksch et al., 2008). 
 
The epidermis maintains homeostasis by constant proliferation of rapidly dividing progeny of 
stem cells (figure 11A). Cutaneous stem cells or keratinocyte stem cells, which reside in the 
stratum basale, represent about 10% of the stratum basale population. As shown in figure 11B, 
stem cells generate daughter cells by asymmetry-division mitosis by either stem cells 
themselves or keratinocyte cells that move up from the suprabasal layers to the skin surface 
(Blanpain and Fuchs, 2009). While keratinocytes move from one stratum to the upper one, they 
mature and express different proteins (e.g. keratins; figure 12). Then the cells loose their nuclei, 
flatten and slough off from the stratum corneum in a process called desquamation. The final 
steps in keratinocyte differentiation are associated with profound changes in their structure, 
resulting in their transformation into the flat and anucleated corneocytes of the stratum 
corneum, which are loaded with keratin filaments and surrounded by a cell envelope composed 
of cross-linked proteins (cornified envelope proteins) as well as a covalently bound lipid 
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envelope (Houben et al., 2007). Extracellular non-polar lipids surround the corneocytes to form 
a hydrophobic matrix. This phenomenon, in which keratinocytes divide in the basal layer, 
produce keratins, differentiate and migrate to the upper layers as they mature, is known as 
keratinization and takes place within about 27 days. In normal epidermis, the proliferation rate 
in the basal layer is precisely balanced by desquamation of the cornified layer at the skin 
surface (Candi et al., 2005).  
Melanocytes originate in the neural crest and migrate to the stratum basale of the epidermis and 
the hair matrices. Through a process called melanogenesis, these cells produce melanin 
pigment that determines the skin color and provides protection against harmful UV (Yuji 
Yamaguchi, 2009). The major determinant of the skin color is not the number, but rather the 
activity of the melanocytes (Rees, 2003). Merkel cells are scattered in the basal layer of the 
epidermis and in the outer root sheath of hair follicles. They are located near areas of well-
vascularised, richly innervated connective tissue. Each Merkel cell is intimately associated with 
an afferent nerve terminal, forming a structure known as a Merkel cell-neuron complex, or a 
Merkel disc (Boulais and Misery, 2007). Their structure is characteristic of transducer sensory 
cells that act as intermediates between an initial stimulus and the afferent neuron impulse. 
Langerhans cells also known as dendritic cells that are potent antigen-presenting cells with 
important immunostimulatory and migratory activities also populate epidermis and dermis. 
Langerhans cells serve to fix and process cutaneous antigens. To present foreign antigens to 
naive T cells, dendritic cells must migrate from inflamed or injured peripheral tissues to the 
closest draining lymph nodes through afferent lymphatic vessels (Martin-Fontecha et al., 2009). 
Immature Langerhans cells that reside in the periphery in the steady state are highly specialized 
in antigen uptake. Langerhans cells form a dense network in the epidermis where they 
constantly scan the environment by extending and retracting their dendrites and are ideally 
positioned to detect any pathogen breaching the skin barrier. Langerhans cells transport antigen 
to skin draining lymph nodes, which is essential to ensure interaction with rare antigen-specific 
naive T cells. During this process, they undergo maturation and produce proinflammatory 
cytokines, which leads to efficient antigen presentation and activation of the innate and 
acquired immune systems. Thus, by the time Langerhans cells arrive in the lymph nodes, they 
have acquired the surface phenotype of ‘functionally’ mature dendritic cells capable of 
activating naive T cells and thereby initiating an adaptive immune response specifically 
tailored to fight off the invading cutaneous pathogen (Kaplan et al., 2008).  
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Skin wound healing 
Disruption of the skin following injury exposes the body to dehydration and infection. To avoid 
this, a number of events aim the restoration of an intact epidermal barrier through wound 
epithelialization (also called re-epithelialization). Wound healing is a complex process that 
involves 3 different phases: inflammation, proliferation and remodelling (figures 13).  
 
 
Figure 13: Summary of time sequence of the major overlapping phases of skin wound healing and expression pattern of several genes 
involved in these processes. Modified from (Michalik et al., 2001).  
 
Shortly after injury, the formation of a platelet plug and a blood clot results in a temporary 
sealing of the wound. Inflammatory cells, which are subsequently attracted to the wound site, 
are important for the defence against invading bacteria. The inflammatory cells also produce 
growth factors, cytokines and proteinases, which are required for the phase of new tissue 
formation. This phase involves migration and hyperproliferation of keratinocytes at the wound 
edge, which finally leads to coverage of the wound with a new epidermis. Concomitantly, 
repair of the injured dermis is initiated. Blood-vessel sprouting occurs at the wound edge, and 
new vasculature develops. Fibroblasts migrate into the wound, where they proliferate and 
produce large amounts of extracellular matrix (ECM).  
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Figure 14: The three classic stages of wound repair: inflammation (A), new tissue formation (B) and remodelling (C). A, Inflammation. 
This stage lasts until about 48 h after injury. Depicted is a skin wound at about 24–48 h after injury. The wound is characterized by a 
hypoxic (ischaemic) environment in which a fibrin clot has formed. Bacteria, neutrophils and platelets are abundant in the wound. 
Normal skin appendages (such as hair follicles and sweat duct glands) are still present in the skin outside the wound. B, New tissue 
formation. This stage occurs about 2–10 days after injury. Depicted is a skin wound at about 5–10 days after injury. An eschar (scab) 
has formed on the surface of the wound. Most cells from the previous stage of repair have migrated from the wound, and new blood 
vessels now populate the area. The migration of epithelial cells can be observed under the eschar. C, Remodelling. This stage lasts for a 
year or longer. Depicted is a skin wound about 1–12 months after repair. Disorganized collagen has been laid down by fibroblasts that 
have migrated into the wound. The wound has contracted near its surface, and the widest portion is now the deepest. The re-
epithelialized wound is slightly higher than the surrounding surface, and the healed region does not contain normal skin appendages 
(Gurtner et al., 2008). 
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Some fibroblasts differentiate into myofibroblasts, which are responsible for wound contraction 
and the deposition of additional matrix. The new tissue that forms at the wound site is called 
granulation tissue because of the granular appearance of the numerous capillaries. In the final 
phase, a transition from granulation tissue to mature scar tissue occurs. Matrix remodelling and 
a reduction in cellularity characterize this process. The scar tissue shows reduced mechanical 
stability and elasticity compared with uninjured skin, and it lacks appendages, including hair 
follicles, sebaceous glands and sweat glands (figure 14). 
During all these phases, various cell types and proteins are involved (Raja et al., 2007; Schafer 
and Werner, 2007). Recent studies have shown that many are essential for normal wound 
healing. Deletion of some genes such as c-Met (Chmielowiec et al., 2007), TGFβ1 (Brown et 
al., 1995), Nrf2 (Beyer et al., 2007), PPARα and PPARβ (Michalik et al., 2001) causes an 
impaired wound healing. On the other hand, the knockout of certain genes provokes an 
accelerated wound closure rate like in the case of Smad3 (Ashcroft et al., 1999) or IL-10 
(Eming et al., 2007). Interestingly, nicotine not only affects skin aging but also causes wound 
healing delay (Misery, 2004). Several key mediators of wound healing and their function are 
presented in figure 15. 
 
 
Figure 15: Soluble mediators of re-epithelialization (Gurtner et al., 2008). 
 
Role of ENaC in the skin 
The three ENaC subunits are present in the epidermis (figure 16A), hair follicles and sweat 
glands (Roudier-Pujol et al., 1996; Oda et al., 1999). The expression of ENaC increases 
following keratinocyte differentiation (Brouard et al., 1999). The application of amiloride 
blocks calcium-induced keratinocyte differentiation (Mauro et al., 1995; Mauro et al., 1997).  
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Furthermore, studies involving αENaC-deficient mice showed that their skin was hyperplasic 
(figure 16B). It was also demonstrated that ENaC modulates ionic signalling for specific 
aspects of epidermal differentiation, such as synthesis or processing of differentiation-specific 
proteins, and lipid secretion (Mauro et al., 2002). Recent studies in our laboratory have shown 
that ENaC is required for the postnatal maintenance of the epidermal barrier function (Charles 
et al., 2008).  
 
 
Figure 16: αENaC complete knockout mice exhibit a thicker epidermis. A, Detection of mRNA transcripts for α , β , and γENaC in 
ENaC wild-type (αENaC +/+), heterozygous (+/-), and homozygous mutant (-/-) mouse keratinocytes. In αENaC -/- mice, no change in 
mRNA expression of the β , and γENaC subunit was detected. The RT-PCR was controlled by detection of GAPDH message. Positive 
control (+) : αENaC cDNA; negative control (-) : PCR reaction without DNA. B, αENaC -/- mice exhibit thickening of the epidermis. 
Light microscopy of mice skin samples, taken from a-ENaC +/+, +/-, and -/- mice soon after birth and stained with hematoxylin and 
eosin. Magnification : 400x. Light microscopy demonstrated hyperplasia, nuclear atypia, and abnormal keratohyalin granules in 
αENaC -/- mice. Adapted from (Mauro et al., 2002). 
 
Injury that disrupts an epithelial layer instantaneously generates endogenous electric fields, 
which were detected at human skin wounds over 150 years ago. Recent data combining 
molecular, genetic and imaging techniques have provided significant insights into cellular and 
molecular responses to this “unconventional” signal. One unexpected finding is that the electric 
fields play an overriding guidance role in directing cell migration in epithelial wound healing. 
In experimental models where other directional cues (e.g., contact inhibition release, population 
pressure, etc.) are present, electric fields of physiological strength override them and direct cell 
migration (Zhao, 2009). The figure 17 shows the concepts concerning the directional guidance 
during wound healing. There is evidence that ENaC might play a role in creating these electric 
fields (Zhao, 2009). Unfortunately, the precise localization of this channel in the different 
epidermal layers has not been reported yet.  
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Figure 17: Directional cues that guide the epithelial cells to migrate directionally at a wound. A, The following are generally accepted 
cues: injury stimulation, chemotaxis, contact inhibition release, presence of wound void, population pressure, stress/tensile. The 
endogenous wound electric fields are a vector that constantly points to the wound center (red dashed arrows), thus could guide the 
migrating cells into the wound. B, The mechanism of generation of wound electric fields. C, Molecular basis : directional ion 
transportation generate electric potential difference. An electric potential difference, positive at the basal side relative to the apical side 
(upper part) is generated and maintained by net directional electrogenic movement of ions through pumps and channels (lower part). 
Adapted from (Zhao, 2009). 
Vascular smooth muscle cell (VSMC) migration plays a key role in tissue repair after arterial 
wall injury. VSMC migration requires integration of chemical and mechanical signaling 
mechanisms (Grifoni et al., 2006).  
 
Figure 18: ENaC inhibition reduces VSMC wound healing. A and B, Effect of benzamil (Benz) on SV40-LT VSMC viability. A, 
Metabolically active cells stained with calcein-AM and dead cells stained with ethidium homodimer-1 (EthD-1). Methanol (MeOH, 
70%) was used as a control for dead cells. B, Group data. Benzamil at 1 and 10 _M did not alter viability compared with vehicle; 100 
µM benzamil elicited a cytotoxicity effect similar to that elicited by 70% MeOH. C, VSMC wound healing 4, 8, and 24 h after ENaC 
inhibition with 1 and 10 µM benzamil. ENaC inhibition blocked healing 8 and 24 h after wound generation. Values are means ± SE (n  
= 5–8), *P < 0.05 (Grifoni et al., 2006). 
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Recently, it has been shown (figure 18) that ENaC proteins are expressed in VSMCs and that 
ENaC inhibition abolishes pressure-induced constriction in isolated artery segments (Grifoni et 
al., 2006).  
 
 
Figure 19: Epithelial Na+ channel (ENaC) participation in membrane depolarization during the course of wound healing. A–D, 
Wounded monolayers were left in the tissue culture incubator (37°C, 5% CO2) for 1 h in minimum essential medium (MEM; A and B) 
and in MEM containing 50 µM phenamil (C and D), and afterward they were loaded with Oxonol V, Sodium Green, and PI in CS and 
photographed for Sodium Green (A and C) and Oxonol V (B and D) fluorescence. Shown are pseudocolor images of the original 
monochromatic ones. Note that phenamil determined a decrease in both the Sodium Green (C) and Oxonol V (D) fluorescence 
intensities at the wound borders. E and F, Wounded monolayers were left for 6 h in the tissue culture incubator in MEM 
supplemented with 5% serum without (E) and with (F) 50 µM phenamil, and afterward they were fixed and stained for actin. Note the 
marked difference in the wound width between the two images. G and H, Wounded monolayers were left for 1 h in the tissue culture 
incubator in CS (G) and in Li+ (H), loaded with Oxonol V and PI, and photographed. Images and intensity scale are the same as in B 
and D. Note that in both cases, an increase in oxonol fluorescence occurred at the wound borders. I and J, Same as G and H, but 
labeled for actin. Note that in both images (I and J), the actin cable is present. Bar, 30 µm (Chifflet et al., 2005). 
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Membrane potential depolarization occurs at the leading edge of linear narrow wounds 
produced on cultured bovine corneal endothelial monolayers and gradually extends inward 
toward the neighboring cells. The replacement of extracellular Na+ by choline and the 
incorporation of phenamil, an inhibitor of ENaC, provokes a decrease in the actin cable and 
depolarization areas and in the lamellar activity of the wound edges. To the contrary, 
extracellular Li+ can successfully replace Na+ in the determination of the depolarization and 
cytoskeletal responses. This finding supports the idea that membrane depolarization, not the 
increase in intracellular Na+ concentration, is responsible for the formation of the actin cable, a 
result that is in agreement with previous evidence showing that nonspecific depolarization of 
the plasma membrane potential (PMP) of epithelial cells may promote characteristic 
cytoskeletal rearrangements per se (figure 19). This suggests that spontaneous depolarization of 
the PMP of the cells at the wound borders determined by a rise in the ENaC activity of these 
cells constitutes an additional factor in the intermediate cellular processes leading to wound 
healing in some epithelia (Chifflet et al., 2005). 
In collaboration with our group, the laboratory of Dr. Rivkah Isseroff (UC Davis, USA), has 
studied the process of galvanotaxis, the directional migration of cells in an electric field, in 
human keratinocytes, which are responsible for wound re-epithelialization (unpublished data). 
These cells respond to electric fields equivalent to those found in human skin wounds (50-100 
mV/mm) with persistent directional migration toward the cathode. To analyze whether ENaC is 
involved in galvanotaxis, keratinocytes from wild type  (αENaC +/+) and knockout (αENaC-/-) 
mice, in which channel activity is abolished, were  isolated. They utilized time-lapse imaging to 
record the speed and the directional route of the galvanotaxis of keratinocytes in a 100 mV/mm 
electric field. Whereas keratinocytes from αENaC knockout mice migrated at same rate as cells 
from  wild type mice, the directionality of the knockout keratinocytes was lost and cells 
 migrated randomly instead of moving toward the cathode (as did the control cells) in the 
electric field (P<0.005). A similar decrease in the directional migratory response to the electric 
field was observed when normal human  keratinocytes were treated with phenamil. Treated 
with 10mM phenamil in galvanotaxis, human keratinocyte migrated at 1mm/min as control, but 
the directionality of the cells, which is measured by the cosine value to the cathode, decreased 
by 30% from 0.86 to 0.6 (P<0.005). Since directional keratinocyte migration is required for 
wound re-epithelialization, they examined what effect ENaC inhibition by phenamil would 
have on wound re-epitheliazation of human skin wounds in an ex vivo wound healing assay. 
Application of 10mM phenamil decreased the re-epithelialization by 85%, while control 
wounds, incubated in 10%FCS-containing medium, healed completely. These results 
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demonstrate that ENaC has a potentially important function to mediate the directional 
migration and wound healing in keratinocytes (Yang et al., 2007).  
 
Figure 20: Hypothetical model for the matriptase–prostasin signaling cascade leading to epidermal barrier formation and hydration. 
This figure illustrates a suggested mechanism for the signaling cascade in which matriptase and prostasin are involved. (a) Furin auto-
activates during transport from the ER to the trans-Golgi network, where it cleaves ENaC in the extracellular loops of the a and γ  
subunits and thereby pre-activates it. (b) The pre-activated ENaC resides in the cytoplasmic membrane because the trans-Golgi 
vesicles fuse with the cytoplasmic membrane. (c) During transport towards the plasma membrane, HAI-1 associates with matriptase to 
prevent premature matriptase activation. Once inserted into the cytoplasmic membrane, matriptase, despite its association with HAI-
1, can activate (d) itself and (e) prostasin. (f) The activated prostasin cleaves the extracellular loop of the ENaC γ-subunit to fully 
activate the channel. (g) This is followed by a Na+ influx, which causes plasma membrane depolarization and increases the Ca2+ influx 
through VGCCs. (h) The increased concentration of Ca2+ activates Ca2+-dependent proteases. (i) These proteases cleave profilaggrin 
into functional filaggrin (Fg) monomers (this probably occurs in conjunction with other, non-Ca2+-dependent proteases). (j) In the SC, 
the Fg monomers are further cleaved by unknown proteases. (k) These Fg fragments can be further cleaved by Caspase-14. (l) Finally, 
the fragments are degraded by an unknown subset of proteases to generate free amino acids, some of which are hygroscopic (such as 
glutamine that is converted to pyrrolidonic carboxylic acid) and contribute to the NMFs. The increase in the concentration of Ca2+, by 
activating the Ca2+-dependent transglutaminases, is important also for the formation of the CE (not shown). The matriptase–prostasin 
signaling cascade is regulated by inhibition of matriptase and prostasin by HAI-1. LEKTImight be an inhibitor of these proteases. The 
inhibition of this signaling cascade by HAI-1, the activation of prostasin by matriptase, and the involvement of Caspase-14 in the 
degradation of Fg fragments have been genetically proven. Other steps in the cascade are more speculative (see the text for details). 
CE, cornified envelope; ENaC, epithelial sodium channel; Fg; HAI-1, hepatocyte growth factor activator inhibitor 1; LEKTI, lympho-
epithelial Kazal-type related inhibitor; NMFs, natural moisturizing factors; pro, prodomain; SC, stratum corneum; TM, 
transmembrane domain; VGCC, voltage-gated Ca2+ channel (Ovaere et al., 2009). 
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It has become clear in recent years that serine proteases have an important role in epidermal 
homeostasis, and the signaling cascades are gradually being identified. CAP3, CAP1 and furin 
are implicated in a cascade that could activate ENaC, leading to epidermal barrier formation 
and hydration, maybe in part through their involvement in filaggrin processing (Ovaere et al., 
2009). The consecutive cleavages of ENaC remove the inhibitory domains in the extracellular 
loops. Upon activation, ENaC allows Na+ influx, which could depolarize the plasma membrane 
to increase the open-probability of voltage-gated Ca2+ channels, such as the L-type voltage-
gated Ca2+ channels (Denda et al., 2006), leading to influx of Ca2+ (figure 20).  
The functional relationship between Na+ and Ca2+ channels and keratinocyte differentiation has 
been shown by treating cells with the ENaC blocker amiloride, which prevents the increase in 
intracellular Ca2+ and thereby limits other Ca2+-dependent processes such as transglutaminase 
activation and cornified envelope formation (Guitard et al., 2004).  
Profilaggrin processing in keratinocytes can be induced by treatment with Ca2+, whereas 
generation of the filaggrin monomer can be prevented by synthetic calpain inhibitors 
(Yamazaki et al., 1997). It has been proposed that, in matriptase or prostasin-deficient mice, the 
absence of prostasin-induced activation of ENaC might result only in intermediate open 
probability of the channel, and the Ca2+ influx could be sufficient for corneocyte formation but 
not for profilaggrin processing (Ovaere et al., 2009). 
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WORKING HYPOTHESIS 
ENaC is expressed in the skin and a function in keratinocyte differentiation and barrier 
formation has been demonstrated. Previous studies also suggested that it might be implicated in 
keratinocyte migration. This process is essential for remodelling of the skin following injury. 
The aim of the first part of my thesis project was to investigate the role of ENaC in skin wound 
healing. We wanted to study this process in vivo in two mouse models either deficient for 
αENaC specifically in the skin or over-expressing the αENaC subunit in the skin. By 
performing analyses of the time course and the morphology of the closing wound we may be 
able to define the role of ENaC in the skin repair. 
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MATERIAL AND METHODS 
Mouse models 
To investigate the role of ENaC during the wound healing process, we studied whether the skin 
specific deficiency or the overexpression of the channel alpha subunit can have an influence. 
Skin-specific αENaC knockout mice 
Since the constitutive αENaC knockout mice die within 48h after birth, it was not possible to 
investigate the skin development and the role of ENaC in these adult mice. αENaC knockout 
pups dehydrate due to water loss through the skin. The figure 21 illustrates the breeding 
strategy to generate conditional αENaC knockout mice. Previously, our laboratory generated 
mice with the Scnn1a (αENaC) floxed gene (Hummler et al., 2002). When this mouse is 
crossed with a mouse that expresses the Cre recombinase under the keratin 14 promoter (K14), 
the recombination should only occur in cells from the basal layer of the epidermis and other 
K14 expressing cells (Huelsken et al., 2001). Noteworthy, the K14 promoter also targets 
corneal and thymic cells, meaning that the conditional knockout mice also lack the expression 
of αENaC in these cells. 
 
 
Figure 21: Scheme of the breeding in order to obtain skin specific αENaC knockout mice. 
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Skin specific αENaC transgenic mice (Tg**) 
Simona Frateschi, in our group, developed this transgenic mouse model. The mouse αENaC 
gene is directed to the basal layer through the human K14 promoter (the basal vector was 
kindly provided by Prof. Sabine Werner, ETH Zürich). The construct furthermore contains a 
rabbit β-globin intron, the Scnn1a encoding sequence and a human growth hormone polyA. 
 
 
Figure 22: Scheme of the αENaC::K14 construct (Frateschi, 2009). 
 
Pronuclear injection was performed into FVB mouse oocytes and two strains were obtained 
that exhibit two different levels of overexpression of Scnn1a. The transgenic mice used in the 
following experiments exhibit a 20 times increased mRNA transcript expression level over 
nontransgenic mice. The αENaC protein was also increased in Tg** mice (figure 23). 
 
 
Figure 23: Molecular analysis of the skin specific αENaC overexpression model. A, αENaC mRNA transcript expression 
quantification from skin samples. B, Western blot analysis for αENaC on skin lysates of Tg** and control mice (Charles, 2007). 
 
Molecular analysis 
Following dissection, skin samples were snap frozen, lysed using the TissueLyser (Qiagen) and 
homogenized with the QIAshredder (Qiagen). RNA extraction was performed with the RNeasy 
kit (Qiagen) according to the manufacture’s instructions. Reverse transcriptase polymerase 
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chain reaction (RT-PCR) was then performed. Finally, the αENaC mRNA was quantified by 
quantitative real-time PCR (Applied Biosystems). 
Kinetic parameters of wound healing 
To study wound healing, the classical first experiment consists in following the kinetics of 
wound closure. Full-thickness wounds were performed on the back of the mice, then we 
measured the surface of the wounds regularly until closure. The results were compared the 
experimental groups (knockout or transgenic vs. control mice). 
Two days preceding the setting the wound, the back of the mice was shaved. First, mice were 
anesthetized with Ketanarkon/Rompun, then using a biopsy punch pipette (Stiefel), a full-
thickness skin wounds (2 per animal) were set on the back of the mice according to the protocol 
of the laboratory of Prof. Sabine Werner (ETHZ)(Eming et al., 2007). The wounds were 
measured every two days until complete closure. The perimeter of the wound was drawn on a 
transparent sheet, then scanned and the surface of the wound was measured with the ImageJ 
software (http://rsbweb.nih.gov/ij/). 
Morphometric analysis of healing skin 
Histology was performed to measure various parameters of an unclosed wound (day 5 post-
wounding). The same method as described above was used to perform wounds. In this protocol, 
the piece of skin that contains the unclosed wound was dissected out and put in 
paraformaldehyde for fixation prior to perform paraffin blocks and hematoxilin and eosin 
(H&E)-stained sections for further analysis. 
On the H&E-stained sections, see figure 24, following parameters can be measured (Thorey et 
al., 2004), the surface of the hyperproliferative epithelium (HE) and the wound width (WW). 
 
Figure 24: Image reconstitution of hematoxilin and eosin staining of wounded (at day 5 post-wounding) skin sections for 
morphometrical analysis. A, The purple area corresponds to the measured hyperproliferative epithelium (HE) for one side of a wound. 
B, Measurement of the wound width (black dotted line). 
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CONTRIBUTIONS 
For this project, I used the following mouse lines: αENaC::K14 ko and Tg**. I performed all 
the dissections and in vivo experiments. I also performed the molecular analyses. The sections 
were imbedded in paraffin and stained by Jean-Christophe Stehle. Dr. Samuel Rotman 
performed histopathological analyses of the skin. 
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RESULTS 
The aim of this study was to investigate the role of ENaC in wound healing. For this purpose, 
we used a conditional knockout mouse model, which lacks the expression of the αENaC 
subunit in K14 expressing cells. Thus, we expected that the channel mRNA transcript 
expression was abolished in the whole epidermis. In the αENaC transgenic mouse model, the 
transgene was targeted to the basal layer, thus specifically overexpressing the α subunit in the 
epidermis. 
Molecular analysis of the skin-specific αENaC knockout mouse model 
The K14 promoter targets Cre expression to the cells of the basal layer of the epidermis and 
hair follicles. The strategy to verify if the recombination occurred successfully was to extract 
RNA, perform reverse transcription (RT) and finally perform semi-quantitative RT-PCR and 
quantitative real-time PCR (qPCR) analyses. 
RNA extraction was performed followed by reverse transcriptase polymerase chain reaction 
(RT-PCR). Finally, the αENaC mRNA was quantified by quantitative real-time PCR 
(TaqMan® - Applied Biosystems). Figure 25A shows the localization of the primers for the 
semi-quantitative RT-PCR for Scnn1a (αENaC). In figure 25B, the product of a RT-PCR is 
shown. The qPCR result demonstrates that the recombination occurred with nearly 100% 
efficiency in knockout mice (figure 25C). 
 
 
Figure 25: Lack of αENaC gene expression in skin biopsies. A, Localization of the primers used for the semi-quantitative RT-PCR. B, 
Semi-quantitative RT-PCR of αENaC and actin. C, Quantitative real-time PCR for αENaC from 5 control (black column) and 4 
conditional knockouts (white column). Bars represent the SEM, ***P < 0.001. 
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TEWL experiments on skin conditional αENaC mutants 
To test the skin outward barrier function we performed transepidermal water loss (TEWL) 
analysis. The figure 26 presents the results obtained from two groups (figure 26A, 6-8 month-
old females and 26B, 3 month-old males). We measured the TEWL on normal and healed skin. 
There is an overall tendency for increased TEWL in the repaired skin, independently of the 
genotype. Comparison of control with conditional αENaC knockout did not show significant 
differences in all experiments. 
 
 
Figure 26: Transepidermal water loss (TEWL) analysis on αENaC skin specific knockout mice. A, Control (ctrl), heterozygous (het) 
and knockout (ko) female mice of 6-8 months of age. B, Control (ctrl) and knockout (ko) male mice of 3 months of age. C, Data of both 
experiments were pooled. Bars represent the SEM, the number of mice used is indicated in each column, n.s. = not significant, *P < 
0.05 and **P < 0.01. 
 
Analysis of the wound closure kinetics 
Skin-specific αENaC knockout mice  
We performed two 0.6 cm full-thickness excisions on the back of the mice and the closure rate 
in function of time was determined. The figure 27 presents the results for 6 individual 
experiments. None of these data showed significant differences. 
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Figure 27: Wound healing kinetics in αENaC skin conditional KO mice. A, PS1: 5.5 month-old females. B, PS2: 5 month-old males. C, 
PS3: 7 month-old females. D, PS4: 3 month-old males. E, PS5: 3 month-old females. F, PS7: 2.5 month-old males and females.  Control 
(black dots) and KO mice (white dots). Bars represent the SEM. 
 
Although the pooled data (figure 28A) revealed a tendency of delayed wound closure in 
conditional skin-specific knockout mice, it did not reach statistical significance. Figure 28B 
illustrates the wound closure from day 0 to day 12 after wounding. 
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Figure 28: Wound healing kinetics in αENaC skin-specific knockout mice. A, Control (filled circles) and knockout mice (empty 
circles), and polynomial (Poly) regression curves for control (blue dotted line) and knockout (red dotted line) mice. Bars represent the 
SEM. B, Representative images taken between day 0 and 12 showing the progression of wound healing in control (upper panel) and 
αENaC skin-specific knockout (bottom panel) mice. 
 
Skin-specific αENaC transgenic mice  
We performed the same experiment with mice from the αENaC transgenic model. In this case 
(figure 29), the wound healing process was slightly accelerated in a first phase, but the wounds 
finally closed at the same time in transgenic mice.  
 
Figure 29: Wound healing kinetics in αENaC skin specific transgenic mice. Control (black) and Tg** mice (red). Bars represent the 
SEM. 
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Morphometry of the full-thickness wound healing 
Morphometrical analyses of the hyperproliferative epithelium as well as the wound width 
(figures 30A and B, respectively) show no statistical difference between the groups in the 
αENaC skin conditional KO model. The distance between the tips of the wounds is slightly 
longer in the KO, but did not reach statistical significance (figure 30C). 
 
Figure 30: Morphometrical analysis of the skin. A, Hyperproliferative epithelium surface quantification. B, Wound width. C, Distance 
between the tips of the wound. Control (black column) and αENaC skin conditional KO (white column) mice. Bars represent the SEM. 
 
In the mouse model overexpressing αENaC in the skin, the hyperproliferative epithelium 
surface and the wound width parameters show only a small difference between transgenic and 
control (figure 31A and B, respectively), that is not statistically significant. 
 
Figure 31: Morphometrical analysis. A, Hyperproliferative epithelium surface quantification. B, Wound width. Control (black column) 
and αENaC skin specific TG** (red column) mice. Bars represent the SEM. 
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All together, theses data indicate that mice lacking the expression of the αENaC gene in the 
skin present no wound healing defect. Mice overexpressing the αENaC subunit specifically in 
the skin show slight wound healing acceleration when compared to control mice, but none of 
these data reached statistical significances. 
Corneal and skin defect in 15-month-old αENaC::K14-Cre knockout mice 
We found several old (15 months) mice presenting eye abnormalities; indeed, their cornea was 
opaque (white) and thicker. The skin was scaly. These animals are listed in table I. There were 
3 skin-specific αENaC knockout mice out of 17 mice analyzed. Five of these mice were 
females. All of them presented this phenotype. It is noteworthy, that 2 control mice also had a 
scaly skin and one animal missed one eye.  
 
Table I. Phenotypical quantification of more than 1 year old conditional αENaC knockouts 
  ctrl ko 
Phenotype mice % mice % 
Eye lost or whitened and thicker than normal 1/14 7 2/3 66 
Thicker and scaly skin 2/14 14 3/3 100 
 
At the histological level, these mice presented thicker corneal and epidermal epithelia (figure 
32). 
 
Figure 32: Histology (H&E) of the corneal epithelium (up) and the skin (bottom) of 15 month-old αENaC::K14 control and knockout 
mice.  
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DISCUSSION 
To study the role of ENaC in wound healing, we used two mouse models: one lacking (skin-
specific αENaC knockout mice) and one overexpressing (skin-specific αENaC transgenic 
mice) the Scnn1a gene specifically in the skin. Using these mice, we performed TEWL 
analysis, wound healing kinetics and morphometric experiments. The αENaC skin conditional 
knockout mice did not present altered water loss. These data confirmed preliminary 
experiments from Dr. Roch-Philippe Charles performed during his thesis work (Charles, 2007). 
In this study, the αENaC skin overexpressing mice were also analyzed and did not display a 
different TEWL than for the control littermates. However, these mice seem to have a tendency 
for a retarded wound closure and a less extended hyperproliferative epithelium, which was not 
significative in comparison with control littermates. The distance between the tips of the wound 
seemed longer in the knockout mice constant with the slight delay in wound closure observed 
with these mice. Interestingly, we found a mirrored effect in the αENaC transgenic mice with a 
slightly accelerated wound healing, at least in the early phase (until day 6 post-wounding), 
compared to nontransgenic animals. These mice showed a larger hyperproliferative epithelium 
surface, which was the opposite of knockout mice. Although, in the two models, the wound 
width measurements did not show any statistical significance between the groups.  
It might be possible that in the skin-specific αENaC knockout mice, some residual “wild-type” 
cells that did not recombine, infiltrated the epidermis during wound closure and rescued the 
wound. We analysed by qPCR the wounded skin and the skin that recovered the injury 
completely. It was arduous to obtain a clear result, since the more fibrotic tissue might have 
rendered the RNA extraction difficult. From our data (not shown), it does not seem that these 
“wild-type” cells have conquered the knockout skin. This experiment has to be repeated to 
definitely exclude this possibility. 
Our hypothesis was that ENaC might play a role in wound healing, since it is involved in 
epidermal differentiation and proliferation. As mentioned above, wound healing involves many 
complex cascades of events including a number of genes and cell types. The fact that only 
slight effects could be observed with the αENaC knockout model might be due to 
compensatory effects of other proteins like calcium channels, although we did not investigate 
this so far. Calcium has an established role in the normal homeostasis of mammalian skin and 
serves as a modulator in keratinocyte proliferation and differentiation (Lansdown, 2002). 
Overexpression of αENaC does not significantly affect the wound healing process. A possible 
reason might be that the overexpression of only one of the three subunits is not sufficient to 
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induce an increased number of active ENaC channels at the surface of the epidermal cells. An 
interesting experiment would be to cross these αENaC transgenic mice with the “Liddle” mice 
that carry a mutation at the βENaC gene locus and that is causative for increased sodium 
transport as observed in Liddle’s syndrome (or pseudoaldosteronism) patients (Pradervand et 
al., 1999).  
We observed that in several 15 month-old αENaC::K14 skin-specific knockout mice, the skin 
was scaly and the cornea was thicker and not translucent. It is possible that in these epithelia, 
this channel plays a more critical role with age.  
Changes in ion channel expression during development of cancer have been frequently 
observed (Kunzelmann, 2005). Disturbances in Na+ absorption have been observed in colonic 
cancer, and ion channels such as ether a go-go (Eag) or Ca2+-sensitive BK channels have been 
recognized for their oncogenic potential (Ousingsawat et al., 2008; Koehl et al., 2010). Colonic 
inflammation like in ulcerative colitis has been shown to reduce electrogenic Na+ transport and 
ENaC expression (Amasheh et al., 2004; Barmeyer et al., 2004). Other studies (microarray 
data) showed that in some cancers, ENaC is overexpressed (Bhoumik et al., 2008; Tripathi et 
al., 2008). Consequently, ENaC-deficient mice might be protected against cancer development. 
We have not tested this in our mice. 
To conclude, ENaC plays an important role in the keratinocyte differentiation and proliferation, 
as well as in the skin barrier function of young postnatal mice. But surprisingly, we could not 
present a clear effect of either the lack or overexpression of ENaC in the healing skin. This 
does not exclude that ENaC might play a role in this process. Nevertheless, the activity of the 
channel in the skin is not crucial for the normal physiological response to the injury. The severe 
skin phenotype (e.g, higher TEWL) observed in the constitutive knockout, might be due to 
mechanisms secondary to the lung phenotype. Nevertheless, to investigate the precise role of 
ENaC during wound healing, complementary experiments must be performed. Structural 
analysis (other morphometrical parameters e.g., the granulation tissue surface (Thorey et al., 
2004), or the orientation of keratinocytes in the hyperproliferative epithelium) of the skin of 
these mice with the help of various markers for differentiation or proliferation might help us to 
elucidate the role for ENaC in skin wound healing. In vitro experiments on primary 
keratinocytes (cell scrapping or artificial wound healing) may also help us to understand the 
function of ENaC in wound healing. The pharmacological use of ENaC inhibitors may clarify 
the role of ENaC in these processes. 
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Part II: Phenotypic analysis of mice deficient for the 
glucocorticoid-induced leucine zipper GILZ 
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INTRODUCTION 
The glucocorticoids 
Glucocorticoid effects and mechanism of action 
Glucocorticoids (GC) are a class of steroid hormones that bind to the glucocorticoid receptor 
(GR), which is present in almost every vertebrate animal cell. Cortisol (or hydrocortisone) is 
the most important human GC. In the mouse, it is mainly corticosterone that is effective. These 
hormones are essential for life, and they regulate or support a variety of important 
cardiovascular, metabolic, immunologic, and homeostatic functions.  
 
 
Figure 33: Steroidogenesis (credits : Mikael Häggström; www.wikipedia.org). 
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The name glucocorticoid (glucose + cortex + steroid) derives from their role in the regulation 
of the metabolism of glucose, their synthesis in the adrenal cortex, and their steroidal structure. 
GCs are distinguished from mineralocorticoids and sex steroids by their specific receptors, 
target cells, and effects. The precursor of all steroids is cholesterol and can be enzymatically 
processed to produce protestagens, androgens, estrogens, mineralocorticoids or glucocorticoids 
(figure 33). In technical terms, “corticosteroid” refers to both glucocorticoids and 
mineralocorticoids (as both are mimics of hormones produced by the adrenal cortex), but is 
often used as a synonym for glucocorticoid (figure 34) 
 
 
Figure 34: Chemical structures of (A) cortisol, (B) prednisolone, (C) dexamethasone and (D) RU24858 are shown. Cortisol is the major 
endogenous anti-inflammatory GC, whereas the others are synthetic. Prednisolone is widely used in the treatment of inflammation; 
dexamethasone is often used experimentally to investigate GC function; and RU24858 is a representative dissociated GC, which 
transactivates GRE-dependent reporters relatively poorly but transrepresses NFκB- and AP1-dependent reporters relatively 
efficiently (in specific cell lines), and exerts antiinflammatory effects in vivo (Clark and Lasa, 2003). 
 
GCs are part of the feedback mechanism in the immune system that turns inflammation down 
(figure 35). They have many diverse (pleiotropic) effects, including potentially harmful side 
effects. They are therefore used in medicine to treat diseases that are caused by an overactive 
immune system, such as allergies, asthma, autoimmune diseases and sepsis. They also interfere 
with some of the abnormal mechanisms in cancer cells, so they are used in high doses to treat 
cancer (Pui et al., 2004). 
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Figure 35: Schematic illustration of connections between the nervous and immune systems. Signalling between the immune system and 
the central nervous system (CNS) through systemic routes, the vagus nerve, the hypothalamic–pituitary–adrenal (HPA) axis, the 
sympathetic nervous system (SNS) and the peripheral nervous system (PNS) are shown (Sternberg, 2006). 
 
GCs cause their effects by binding to the GR, a member of the nuclear receptor family of 
ligand-dependent transcription factors. GR is present in the cells of almost all vertebrate 
tissues. Like other members of this family, GR possesses a modular structure consisting of 
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three major domains: an N-terminal, a central DNA binding domain, and a C-terminal ligand 
binding domain (Beato et al., 1995). The activated GR complex in turn up-regulates the 
expression of anti-inflammatory proteins in the nucleus (a process known as transactivation) 
and represses the expression of pro-inflammatory proteins in the cytosol by preventing the 
translocation of other transcription factors from the cytosol into the nucleus (transrepression; 
figure 36). The antagonist RU-486 (mifepristone) can inhibit the effects of the GR. This 
compound, in combination with a prostaglandin analogue, was used as abortifacient in the late 
1980s (McKinley et al., 1993). This was also used to treat Cushing’s syndrome, also known as 
hyperadrenocorticism (Johanssen and Allolio, 2007).  
 
 
Figure 36: Glucocorticoids regulate gene expression in several ways. Glucocorticoids enter the cell to bind to glucocorticoid receptors 
(GR) in the cytoplasm that translocate to the nucleus. GR homodimers bind to glucocorticoid-response elements (GRE) in the 
promoter region of steroid-sensitive genes, which may encode anti-inflammatory proteins. Less commonly, GR homodimers interact 
with negative GREs to suppress genes. Nuclear GR also interact with coactivator molecules, such as CREB-binding protein (CBP), 
which is activated by proinflammatory transcription factors, such as nuclear factor-κB (NF-κB), thus switching off the inflammatory 
genes that are activated by these transcription factors. Other abbreviations: SLPI: secretory leukoprotease inhibitor; MKP-1: 
mitogen-activated kinase phosphatase-1; IκB-α: inhibitor of NFκB; POMC: proopiomelanocortin; CRH: corticotrophin releasing 
factor (Barnes, 2010). 
 
Various synthetic GCs are available (e.g. dexamethasone); these are used either as replacement 
therapy in glucocorticoid deficiency or to suppress the immune system (figure 37). 
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Figure 37: Model of glucocorticoid modulation of the annexin A1 pathway in immune regulation. Endogenous and synthetic 
glucocorticoids can control innate and adaptive immune responses by modulating the expression and release of annexin A1. Exposure 
of innate immune cells, such as neutrophils, monocytes, macrophages and mast cells, to glucocorticoids induces the release of annexin 
A1. This, in turn, acts in a paracrine or autocrine manner to maintain the level (and duration) of cell activation. In a dynamic system 
such as the inflammatory reaction, in which spatial and temporal factors can influence the final outcome, this could promote the 
resolution of the inflammatory reaction by actively maintaining homeostatic control of innate immune cells (Perretti and D'Acquisto, 
2009). 
 
The circadian clock: regulation and effects 
Daily oscillation of physiological and behavioural processes in animals and plants has been 
reported since the fourth century BC. But it is only from the middle of the last century that the 
biology of the circadian clock started to be investigated (Pittendrigh, 1954). The first circadian 
gene, Period, was cloned from the fruitflies (Bargiello et al., 1984; Reddy et al., 1984). 
Circadian rhythms regulate hundreds of functions in the human body, including sleep and 
wakefulness, body temperature, blood pressure, hormone production, digestive secretion and 
immune activity (figure 38). Disruption of these rhythms can have a profound influence on 
health (Fu and Lee, 2003).  
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Figure 38: Circadian regulation of hormones, urine and the immune system. The circadian oscillation of hundreds of biological 
processes enables a human body to adapt to 24-hour light/dark cycles. The serum levels of cortisol and aldosterone, and urine volume, 
oscillate in circadian cycles in humans. The cortisol level peaks in healthy individuals at early morning and reach their lowest levels 
before bedtime. Disruption of cortisol circadian rhythm can result in fatigue and restlessness, weight loss, insomnia and coronary heart 
disease. Aldosterone is a steroid hormone that is secreted by the cortex of the adrenal gland and regulates the body’s electrolyte 
balance. The level of aldosterone is normally low during the day and high during sleep in humans. Disruption of aldosterone rhythms 
result in sodium and water retention, increased blood pressure and coronary heart disease. Urine volumes have inverted circadian 
oscillating patterns, compared to that of aldosterone, in healthy humans (left panel). The circadian oscillation of lymphocyte, 
monocyte, platelet and eosinophil levels in healthy young adults. The activity of the immune system, usually represented by the 
number of lymphocytes, peaks in the late evening and is lowest in the early morning. Disruption in this circadian rhythm could lead to 
immune suppression (right panel) (Fu and Lee, 2003). 
 
Several other circadian genes have been discovered. From a molecular standpoint, circadian 
rhythms are regulated by transcriptional and post-translational feedback loops generated by a 
set of interplaying clock proteins (figures 39-41).  
Circadian clocks are present in almost all mammalian tissues. The master or central clock is 
located in the hypothalamic suprachiasmatic nucleus (SCN), a small brain region containing 
10,000–15,000 neurons. The SCN clock can function autonomously, without any external 
input, but it can be reset by environmental cues such as light. Clocks outside the SCN are 
referred to as peripheral clocks and are thought to be synchronized by the master clock to 
ensure temporally coordinated physiology. The synchronization mechanisms implicate various 
humoral signals, including circulating entraining factors such as glucocorticoids. Moreover, 
peripheral clocks, such as the liver, can be synchronized by the availability of metabolites or 
feeding time. Peripheral clocks are present in almost all mammalian tissues, such as the liver, 
heart, lungs and kidneys, where they maintain circadian rhythms and modulate transcription 
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factors in a paracrine fashion to regulate tissue-specific gene expression (Sahar and Sassone-
Corsi, 2009). 
 
Figure 39: The circadian feedback loop. CLOCK and BMAL1 increase the transcription of Period (Per), Cryptochrome (Cry) and 
other clock-controlled genes (CCGs) during the day. In the classic view, the levels of Per and Cry proteins increase during the night, 
after which they dimerize and translocate to the nucleus to repress CLOCK–BMAL1-mediated transcription. Per and Cry proteins 
are then ubiquitylated and degraded to initiate a new circadian cycle. Conversely, REV-ERBα (encoded by Nr1d1) protein levels are 
high during the day and inhibit Bmal1 transcription at this time. At night, REV-ERBα protein levels are low, allowing Bmal1 
transcription to take place. P, phosphorylation; RRE, REV-ERB/ROR response elements; Ub, ubiquitylation (Sahar and Sassone-
Corsi, 2009). 
 
 
Figure 40: The suprachiasmatic nucleus (SCN) controls the activity of the autonomic nervous system through the autonomic neurons 
of the paraventricular nucleus (aPVN). These neurons project from the hypothalamus to preganglionic parasympathatic and 
sympathetic neurons in brainstem nuclei, such as the dorsal motor nucleus of the vagus (DMV) and in the intermediolateral cell 
columns (IML) of the spinal cord44. The SCN indirectly controls the secretion of adrenocorticotropic hormone (ACTH) from the 
pituitary gland, through the CRH-producing endocrine neurons in the hypothalamus. Circadian variations in the activity of the 
autonomic nervous system and in ACTH production result in rhythmic release of corticosterone from the adrenal gland into the blood. 
So, plasma levels of corticosterone undergo a 24h circadian variation in vivo (Fu and Lee, 2003). 
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Figure 41: The circadian clock controls cell proliferation and apoptosis at the systemic level. Light and other environmental cues reach 
the suprachiasmatic nuclei (SCN) through various input pathways. The SCN clock synchronizes with the environment to generate 
endogenous rhythms, which are transmitted through output pathways to peripheral tissues. Representative output pathways, such as 
the autonomic nervous system (ANS), the hypothalamic–pituitary–gonadal (HPG) and the hypothalamic–pituitary–adrenal (HPA) 
axes, are shown. The pineal gland and peripheral tissues can also feed back to SCN or HPA axes, through production of melatonin, to 
regulate homeostasis. Melatonin binds to receptors on SCN neurons to induce phase shifts. The adrenal glands produce 
glucocorticoids, which have negative feedback on the hypothalamus to terminate the release of corticotropin-releasing hormone. The 
products of immune activity, such as interferon-α and -γ, and interleukin-1, can also modulate the activity of SCN, as well as the HPA 
axis. Feedback pathways are indicated by dashed lines (Fu and Lee, 2003). 
 
The secretion of corticosterone follows the circadian criteria. There is a peak at the onset of the 
activity phase in human and rodents (figure 42A). Experiments performed on mice showed that 
this oscillation can be attenuated by chronic administration of alcohol (Kakihana and Moore, 
1976). Figure 42B shows that by knocking down the central circadian machinery, as in clock 
mutant mice, the wave is shifted but not flattened (Oishi et al., 2006).  
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Figure 42: Circadian plasma corticosterone secretion in mouse. A, Circadian variations of the plasma corticosterone in the chronically 
alcohol consuming DBA/2J male mice. Blood samples were collected after 15 weeks of alcohol consumption, 3.8 ~ (w/v) during the first 
week and 7.5 ~ for the next 14 weeks. Numbers in parentheses represent number of mice assayed for each time point. Vertical bars 
indicate SEM (Kakihana and Moore, 1976). B, Circadian variations in plasma corticosterone levels in Clock mutant mice. Open and 
filled circles indicate values from wild-type and Clock mutant mice, respectively. Open and solid bars represent lights on and off, 
respectively. Values represent means ± SEM (n = 4). Significant differences between genotypes are shown as **P < 0.01 (Oishi et al., 
2006). 
 
The glucocorticoid-induced leucine zipper (GILZ) 
GILZ cloning and role in T-cells 
The glucocorticoid-induced leucine zipper (GILZ) was originally described in as a gene 
induced by dexamethasone (DEX), a glucocorticoid receptor agonist, from a mouse thymocyte 
subtraction cDNA library (D'Adamio et al., 1997). It is expressed in various tissues and is 
rapidly induced by glucocorticoids in T lymphocytes, in which it inhibits anti-CD3-induced IL-
2 production, IL-2-receptor expression, Fas and Fas-ligand up-regulation, and cell death 
consequent to CD3-induced activation (Riccardi et al., 2000; Ayroldi et al., 2001; Smit et al., 
2005). 
In cells of the myeloid lineage, a higher basal expression of GILZ was observed, and both GCs 
and anti-inflammatory cytokines, such as IL-10, increased this expression (Cannarile et al., 
2001; Berrebi et al., 2003). Microarray experiments also demonstrated GILZ induction by GCs 
in human peripheral blood mononuclear cells and in acute lymphoblastic leukemia cells 
undergoing GC-induced apoptosis (Tonko et al., 2001; Galon et al., 2002). Direct inhibition of 
transcription through binding of GILZ to AP-1 or NFκB was suggested to block expression of 
Fas ligand, IL-2 and various markers of macrophage activation (Ayroldi et al., 2001; 
Mittelstadt and Ashwell, 2001; Berrebi et al., 2003). GILZ also inhibited ERK signaling by 
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sequestering the MAPKkinase-kinase Raf (Ayroldi et al., 2002), a mechanism that is 
presumably selective for the ERK pathway, as Raf does not activate JNK or p38. Raf has been 
shown to form a cytoplasmic complex with GR; however, the relationship of GILZ to this 
complex is not known (Widen et al., 2000). 
 
 
Figure 43: Activation of gene expression by MAPKs, and its inhibition by GILZ or MKP-1. This is an incomplete ‘circuit diagram’, 
which omits a number of important signalling molecules of the MAPK cascades. The expression of GILZ and MKP-1 is induced by 
GCs. MKP-1 dephosphorylates and inactivates the MAPKs JNK, p38 and (under some circumstances) ERK. GILZ acts by 
sequestering Raf and inhibiting the Raf–MKK1/2–ERK pathway, or by directly interfering with the function of the transcription 
factors AP-1 and NFκB. MEKK1, MAPK or ERK kinase 1; TAK1, transforming growth factor b-activated kinase-1 (Clark and Lasa, 
2003). 
 
GILZ as member of the TSC-22/DIP/BUN family 
GILZ is a member of the leucine zipper protein (Ayroldi et al., 2002) and belongs to the TGF-
β-stimulated clone-22 (TSC-22) family of transcription factors (figure 44). This family of 
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leucine zipper proteins lacks the typical canonical DNA-binding domain and has a low 
molecular weight. GILZ shares between 60-90% identity to the other members of this family at 
the protein level. A PDZ-binding domain is present at the C-terminus of some members (figure 
45). 
 
 
Figure 44: 3D model of the human GILZ. α-Helices are represented as blue cylinders, β-sheet as red ribbons, and proline residues are 
indicated in red CPK (Ayroldi et al., 2002).  
 
DIP (DSIP immunoreactive protein) shows 95% homology to GILZ from human to mouse and 
was first isolated from porcine brain (Sillard et al., 1993) and later on from human fetal brain 
(hDIP) (Vogel et al., 1996). The protein misses a large N-terminal part as compared to other 
family members and is only 77 amino-acids long. When aligning human DIP against human 
GILZ protein sequences, the proteins shows 100% homology (nucleotide alignments show 
99.1% homology, divergences might be due to sequencing errors and DIP and GILZ might be 
splice-variants of a same gene). An interesting point about this protein is that its three-
dimensional structure has been studied (Seidel et al., 1997). Its high homology to GILZ lets us 
suppose, that its tertiary structure could in a major extent serve as model for the GILZ tertiary 
structure within the conserved domains. Biological function of DIP is not yet known. 
SHS (shortsighted), alias BUN (bunched), protein was identified in Drosophila, where it acts in 
the pathway leading to photoreceptor differentiation (Treisman et al., 1995). This protein is 
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longer than the other members of the superfamily with its 224 amino-acids and has, such as 
TSC22, no PDZ-binding domain. 
Osmotic stress transcription factor 1 (OSTF1) was cloned from gills of euryhyaline tilapia 
(Oreochromis mossambicus) as a gene induced by acute hyperosmotic stress (Fiol et al., 2007). 
OSTF1 is part of the TSC22 family (figure 46). 
GILZ was also found in chicken pituitary, Ellestad et al. performed sequence alignment and 
unrooted phylogenetic tree (figure 47). 
 
Figure 45: Amino acid sequence alignment of TSC22D3 and DIP orthologs. Human, monkey (DIP), mouse, rat, dog and fish TSC22D3 
protein sequences were aligned using the T-Coffee multiple sequence alignment program (http://www.tcoffee.org). Color code for the 
identity score between residues (top). The conserved domains are indicated: the TSC-box (blue line), the leucine zipper domain (green 
line) and the PDZ (purple line). The identity score is given (bottom right). 
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TSC22 is the first isolated and the most studied member of the superfamily. It was isolated in 
1992 from TGFβ-treated mouse osteoblastic cells (MC3T3 cells) (Shibanuma et al., 1992). The 
human homologue was cloned from embryo and shown to have a widespread expression in 
adult and fetal tissue, which is in concordance with the large number of hormonal factors able 
to induce TSC22 gene. One probable function of TSC22 is the transcriptional regulation of the 
C-type natriuretic peptide (CNP) gene and the transmission of signals from cytokines to CNP 
gene expression (Ohta et al., 1996). Further results suggest that TSC22 may be a negative 
regulator of proliferation and have tumor suppressor activity (Kester et al., 1997). Given its 
apparent role as regulatory gene for cell growth, differentiation and apoptosis, TSC22 was 
proposed to be a good target for diagnosis and therapy of different cancers (Uchida et al., 
2000).  
 
 
Figure 46: Schematic structure (A) and multiple sequence alignment of the TSC22D motif (B) of tilapia osmotic stress transcription 
factor 1 (OSTF1) and mouse TSC22D family members identified by a genome-wide search. Large gray cylinders correspond to the 
conserved TSC22 ⁄ leucine zipper motif. Smaller white cylinders represent local regions of high homology. Residues shaded in darker 
tones correspond to higher level of homology in the alignment (Fiol et al., 2007). 
 
The leucine zipper domain 
Leucine zippers contain leucine-rich repeats, all of which appear to be involved in protein-
protein interaction (Kobe and Deisenhofer, 1995; Kajava and Kobe, 2002). They are made of 
coiled coils, which are structures formed by repetition of 7 residues. The amino acid chain 
forms an α-helix and the coiled coil is formed by mutual winding of these helixes around one 
another (O'Shea et al., 1989; Lupas, 1996). An important feature for these structures are the 
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hydrophobic interactions between residues located in the center of the helixes, which are 
leucines in the case of leucine zippers. 
Most identified leucine zippers are implicated in transcriptional mechanisms, however those 
proteins interact with DNA via a basic DNA binding domain, which is not present in this 
subfamily, whereas the leucine zipper motif is involved in protein-protein interactions (Moll et 
al., 2000). Several cytoplasmic membrane or membrane-bound proteins have been reported to 
contain leucine zipper structures. Examples are postsynaptic density (PSD - defined by an 
electron dense structure of postsynaptic sites) proteins, such as PSD-Zip45, in which leucine 
zippers are considered to be one of the common domains, with major importance for 
multimerization (Sun et al., 1998). Rapsyn is a leucine zipper protein of the neuromuscular 
PSD and is involved in acetylcholine receptor clustering (AchR). Deletion mutants that lack 
this motif still interact with the membrane and form clusters of rapsyn itself, but are unable to 
involve in the AchR clustering (Phillips et al., 1991). A dual leucine zipper bearing kinase 
(DLK) was reported from synaptic terminals where it was associated with both plasma 
membrane and cytosolic fractions (Mata et al., 1996). As an example of membrane proteins, a 
leucine zipper motif was identified in the C-terminus of hSK4, a calcium-activated potassium 
channel (Joiner et al., 1997). Consistent with these reports leucine zipper proteins seem to be 
involved in various molecular interactions within nuclear, cytosolic or membrane locations. 
As already mentioned, the DIP protein three-dimensional structure was extensively studied 
(Seidel et al., 1997). The synthetic protein (peptide 9-46) was shown to form dimers through 
helical structures in the leucine zipper motif. Homodimer formation depending on the coiled 
coil domain was reported for TSC-22, as well as heterodimerization with a close homologue, 
the TSC-22 homologous gene-1 (THG-1) (Kester et al., 1999). In this study a yeast two-hybrid 
screen on a mouse brain cDNA library was performed, using amino acids 38-144 as a bait. The 
only leucine zipper protein found in the screen was the THG-1, indicating probable high 
specificity of these interactions, in spite of the well-conserved helical structure. The domain 
conferring high specificity was not determined and could be located within the leucine zipper 
domain or in the family signature conserved domain or even in a C-terminal part (containing 
proline-rich domains). 
Given high homology of the leucine zipper of GILZ with the mentioned other members of the 
subfamily, it is possible that GILZ is implicated in protein-protein interactions with close 
homologs through its coiled coil structure. 
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Figure 47: Chicken glucocorticoid-induced leucine zipper (GILZ) is highly homologous with GILZ from other vertebrate species. (A) 
Predicted amino acid sequence for chicken, human, dog, mouse, zebrafish, and Xenopus GILZ were aligned, and the regions of amino 
acid sequence that are identical with the consensus derived from all species are shaded. The leucine zipper region (black underline) is 
characterized by four leucine residues at positions 76, 83, 90, and 97 and one asparagine at position 87 (double underlines). (B) 
Unrooted phylogenetic tree of GILZ amino acid sequences from the species listed in (A). The length of the lines connecting the species 
indicates the predicted evolutionary distance (Ellestad et al., 2009). 
 
The PDZ-binding domain 
Interactions between PDZ proteins and their targets are known to mediate protein localization, 
signalling and maintenance of membrane characteristics, mainly by assembling various 
function entities, including ion channels and other transmembrane receptors, at specialized 
subcellular sites such as epithelial cell tight junctions, neuromuscular junctions, and PSDs of 
neurons (Fuh et al., 2000). PDZ domains, originally described as conserved elements in the 95-
kDa post-synaptic density protein (PSD-95), the Drosophila tumor suppressor discs-large 
(DLG), and the tight junction protein zonula occludens-1 (ZO-1) (Muller et al., 1995; Craven 
and Bredt, 1998; Hata et al., 1998), have been observed in a large and diverse set of proteins. 
They are also named DLG homology region (DHG) and GLGF repeats which is the sequence 
motif contained in PDZ proteins. The structures reveal that a four-residue C-terminal stretch 
(X-Thr/Ser-X-Val-COOH or Phe/Tyr-X-Phe/Val/Ala-COOH) engages the PDZ type I and II 
domains through antiparallel main chain interactions with a β sheet of the domain. Recognition 
of the terminal carboxylate group of the peptide is conferred by main chain amides provided by 
the Gly-Leu-Gly-Phe loop as well as by an arginine side chain. Specific side chain interactions 
and a prominent hydrophobic pocket explain the selective recognition of the C-terminal 
consensus sequence (Doyle et al., 1996; Fuh et al., 2000). A third type of PDZ domain-ligand 
interaction involves the recognition of an internal peptide sequence (Fuh et al., 2000). 
Events mediated by interactions between PDZ proteins and their targets have been extensively 
studied in the past few years. These studies have demonstrated that dissociation of such 
interactions can have profound effects on the spatial distribution and stability of binding 
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partners (Fanning and Anderson, 1999). A first mutation in a gene encoding a PDZ-containing 
protein was recently reported lead to sensory disorders (Usher type 1C disease): affected 
individuals suffer both hearing loss and retinal degeneration (Montell, 2000). 
Large number of reports on PDZ interacting proteins are synaptical, where PDZ-domain-
containing proteins mainly bind cytoplasmic tails of receptors. They mostly contain several 
PDZ domains, allowing formation of large protein clusters at the plasma membrane (Garner et 
al., 2000). 
Several reports have now shown that PDZ interactions play an essential role in determining cell 
polarity (Bhat et al., 1999; Bilder and Perrimon, 2000). A study on apical or basolateral 
membrane sorting on γ-aminobutyric acid (GABA) receptors (GAT) described that two highly 
homologous isoforms, GAT-2 and GAT-3, localize to the basolateral and apical surfaces, 
respectively, when stably expressed in Madin-Darby canine kidney cells (MDCK) (Muth et al., 
1998). They showed that removal of the final three amino acids of GAT-3 disrupts its apical 
sorting. The GAT-3 C-terminal sequence is reminiscent of sequences interacting with PDZ 
domain (X-Thr-X-Phe-COOH). Similar results were shown for splice variants of the Kv3 K+ 
channel (Ponce et al., 1997). The cystic fibrosis transmembrane conductance regulator (CFTR) 
contains in its C-terminus a PDZ-interacting domain, which is required for apical polarization 
and CFTR interaction with an apical membrane protein (Moyer et al., 2000). A CFTR-
associated protein (CAP70) contains four PDZ domains, three of which are capable of binding 
to the CFTR C-terminus and might be involved in facilitated intermolecular CFTR interaction, 
which can potentiate chloride current (Wang et al., 2000). 
None of the reports treating with the GILZ/TSC/DIP/BUN family members evoke the PDZ-
interacting domains contained in the C terminus of GILZ and DIP proteins. As a consequence 
no information is available on the role and importance of this functional domain in these 
proteins. Considering the very rare reports on nuclear PDZ-interactions (Kanai et al., 2000), 
GILZ might be part of a larger cytoplasmic or membrane bound cluster. Given its probable 
direct or indirect involvement in the sodium transport machinery, it can not be excluded that 
this hypothetical cluster is implicated either in regulations of main effectors at the plasma 
membrane or in membrane trafficking in the polarized CCD cells. 
The antiapoptotic motif 
The apoptotic program is evolutionarily conserved between yeast and metazoan organisms. A 
number of mammalian cDNAs capable of suppressing the deleterious effects of Bax expression 
in yeast have been identified. Such a suppressor, named TSC22(86), represents the C-terminal 
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86 amino acids of the previously characterized leucine zipper (LZ) motif-containing 
transcriptional regulator TSC22 (Yang et al., 2006). Employing a genome-wide two-hybrid 
screen, functional genomics, and deletion mutagenesis approaches, it was shown that 
TSC22(86)-mediated antiapoptosis is independent of the LZ motif and is likely independent of 
effects on gene transcription (figure 48A). Rather, a 16-residue sequence within the conserved 
56-residue TSC22 domain is necessary for antiapoptosis (Khoury et al., 2008). This motif is 
conserved in many species and different proteins from the TSC22 family (figure 48B).  
 
 
Figure 48: A, Schematic representation of the domain organization of Tsc22(86). ‘The conserved TSC22 domain’ shown in red. The 
locations of the leucine (L) and valine (V) residues that form the LZ are shown. The domain spans residues Met1(M1)-Leu56(L56), and 
is succeeded by a variable C-terminal region spanning residues Gln57(Q57)-Ala86(A86). The predicted ‘LZ’ motif embedded within 
the TSC22 domain is present between residues V12-L40 (Khoury et al., 2008). B, Conservation of the TSC22 antiapoptotic motif across 
species. Amino acid sequence alignment of Tsc22d3 orthologs using the T-Coffee multiple sequence alignment program 
(http://www.tcoffee.org). 
 
The Tsc22d3 isoforms 
In silico analysis and functional studies revealed that gilz exhibits 4 isoforms (Soundararajan et 
al., 2007). Figure 49 represents the mouse Tsc22d3 gene, which is located on the X 
chromosome. Six exons can produce four different transcription products (of ORF lengths 414, 
606, 132, and 243 nucleotides each) with translational potential (of 137, 201, 43, and 80 amino 
acids, respectively). These isoforms are termed GILZ1, -2, -3, and -4, respectively. GILZ1 and 
-2 share exons 5 and 6, making up the TSC22/dip/bun domain, leucine zipper, and C-terminus, 
but differ in their N-terminal exon(s) and 5’-untranslated region. Although isoform 4 also 
shares exons 5 and 6 and has a unique 5’-untranslated region, only its start codon is in exon 5, 
resulting in a translational truncated variant of isoforms 1 and 2. Isoform 3 consists of exons 3 
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and 6, skipping exons 4 and 5, resulting in a frameshift and subsequent stop codon, encoding a 
43-amino acid long translation product. A CpG island and a series of Sp1 sites appear to define 
a TATAless promoter, designated as promoter 1 (P1). The large intron B, spanning almost 55 
kb, separates exons 1 and 2 from exons 3–6 and contains multiple response elements (six GREs 
and three FHREs), most of them having been reported as being functional (Asselin-Labat et al., 
2004; Asselin-Labat et al., 2005; Cartharius et al., 2005). Four GREs and three FHREs, 
combined with a TATA-box 32–25 bp 5’ from exon 3, form a transcriptionally active cluster, 
which is designated as promoter 2 (P2).  
 
 
Figure 49: Genomic structure of the mouse Tsc22d3 gene. A schematic diagram shows a region of 60,971 bp on the mouse X 
chromosome and the Tsc22d3 gene. Six exons can produce four different transcription products (of ORF lengths 414, 606, 132, and 243 
nucleotides each) with translational potential (of 137, 201, 43, and 80 amino acids, respectively). These isoforms are termed GILZ1, -2, 
-3, and -4, respectively. The black boxes represent the translated regions, and the gray boxes represent the untranslated regions of the 
Tsc22d3 gene. The CpG island locating exons 1 and 2, together with 12 potential Sp1 binding sites is designated as P1. Four GREs and 
three FHREs in the large second intron B, combined with a TATA-box 32 to 25 bp 5’ from exon 3, form a transcriptionally active 
cluster, which is designated as P2. The diamonds in intron B represent potential GREs, and the black circles represent potential 
FHREs. The numbers at the borders of the gray and black boxes indicate the nucleotide positions read from 5’ to 3’, whereas the 
numbers above the introns refer to the sizes of the respective introns. The NCBI accession numbers (in green) under the different GILZ 
isoform notations refer to previously reported mRNA transcripts available in the data base (Soundararajan et al., 2007).  
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It is interesting to note that no GREs were identified upstream of P1, suggesting that the GREs 
in intron B upstream of P2 mediate glucocorticoid and mineralocorticoid responsiveness of 
both promoters. It is also of note that there are two Elk-1 binding sites present in the CpG 
island and two more in exon 6, suggesting regulation of GILZ transcription by Elk-1. 
Sequence alignment between the 4 GILZ isoforms shows that they share homology (Figures 50 
and 51). 
 
Figure 50: Alignment of the protein sequences of all four mGILZ isoforms, GILZ1, -2, -3, and -4. (Soundararajan et al., 2007).  
 
 
Figure 51: Schematic representation of the above. The numbers represent amino acid (AA) positions on GILZ1. The regions in black 
represent regions of identityamongthe four naturally occurring mGILZ isoforms. The dotted region in GILZ3 represents the 
untranslated portion of the transcript. The region in blue (GILZ1 residues 111–125) represents the antigenic stretch recognized by our 
anti-GILZ antibody. The conserved TSC22/dip/bun signature box (TSC22) and the leucine zipper domain (LZ) are also shown 
(Soundararajan et al., 2007).  
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Implications and effects of GILZ 
GILZ in the inflammation process 
Glucocorticoids are potent modulators of the immune response and inflammatory processes. 
These hormones are the most commonly used anti-inflammatory and immunosuppressive drugs 
in the treatment of rheumatic and other inflammatory diseases. As already mentioned, cellular 
effects of GCs are mediated through the glucocorticoid receptor (GR), which regulates the 
expression of GC-responsive genes (Payvar et al., 1981; Miesfeld et al., 1984). One of the 
prominent GC-responsive genes is GILZ (D'Adamio et al., 1997; Ayroldi et al., 2001). GILZ 
controls T cell activation and development, and inhibits the activities of the key inflammatory 
signalling mediators NFκB and AP-1 (Ayroldi et al., 2001; Mittelstadt and Ashwell, 2001; 
Riccardi et al., 2001). When stimulated with GCs, macrophages synthesize significant amounts 
of GILZ, which subsequently attenuates macrophage inflammatory responses (Berrebi et al., 
2003). Moreover, gilz gene expression is downregulated in macrophages from inflammatory 
lesions of delayed type hypersensitivity reactions, and persists in tumor-infiltrating 
macrophages from Burkitt lymphoma (Berrebi et al., 2003). GILZ mediates the anti-
inflammatory effects of GCs via suppressing the activation of NF-κB in human airway 
epithelial cells (Eddleston et al., 2007) and redirects the maturation of dendritic cells, 
preventing Ag-specific T lymphocyte responses (Cohen et al., 2006). Annexin-1 (ANXA1), 
which is a mediator of the anti-inflammatory action of GCs, regulates macrophage IL-6 and 
TNF secretion via GILZ. Interestingly, GILZ induction by GCs was reduced in ANXA1 
knockout mice (Yang et al., 2009). A recent study shows that GILZ is upregulated in human 
epithelial cells upon dose-dependent alcohol exposure (Gomez et al., 2010).  
The GILZ promoter contains 6 glucocorticoid responsive elements (GRE), along with binding 
site for forkhead box class O (FOXO) family proteins, signal transducer and activator of 
transcription 6 (STAT6), nuclear factor of activated T cells (NFAT), octamer, and c-myc 
(Asselin-Labat et al., 2004; Wang et al., 2004; Asselin-Labat et al., 2005). The regulation of 
GILZ expression has been studied in a murine T lymphocyte line where FOXO3 was shown to 
activate GILZ expression independent of GCs (Asselin-Labat et al., 2004; Asselin-Labat et al., 
2005). 
These data strongly suggest that GILZ plays a key role in inflammatory inhibition and 
immunosuppression. 
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GILZ and ENaC-mediated sodium transport 
GILZ was the most significantly increased transcript induced by aldosterone in mpkCCDc14 
cells (Robert-Nicoud, 2001; Robert-Nicoud et al., 2001). Its kinetics of induction points out to 
an early-induced gene, suggesting that GILZ could participate to intracellular mechanisms 
during the first phase of the aldosterone response. 
Robert-Nicoud has shown that, in the kidney, GILZ is localised in the proximal tubules, and in 
the connecting (CNT) and collecting ducts (CD), more precisely in the principal cells (Robert-
Nicoud, 2001). GILZ is an early aldosterone-induced gene in the mpkCCDc14 cell line: its 
mRNA expression level increases significantly already 30 min after aldosterone treatment. Its 
mRNA profile expression during 24 h precedes and is similar to the transepithelial current (Isc) 
increase (figure 52), and increases in cells treated with aldosterone in a dose-dependent 
manner. These data strongly suggest that GILZ is a potential mediator of the aldosterone 
response.  
 
 
Figure 52: Time-course correlation of transepithelial current (Isc) and GILZ mRNA induction by aldosterone (1 µM) in the mpkCCDcl4 
cells. GILZ mRNA levels (black line) correspond to the quantification of the shown Northern Blotting (Robert-Nicoud, 2001). 
 
There are several evidences of a putative role for GILZ in the kidney. First, a study on teleosts 
osmotic stress adaptation showed that OSTF1 (a GILZ ortholog) was rapidly and transiently 
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induced during hyperosmotic stress after acclimatising from fresh water to seawater (Fiol and 
Kultz, 2005). Maximal increase at mRNA and protein level was detected after 2 to 4 h transfer 
to seawater, and was proportional to increasing salinity. The authors conclude that OSTF1 
represents the molecular link between the seawater-induced hormone cortisol and 
transcriptional regulation of ion transport and cell differentiation in teleost gills (Fiol and Kultz, 
2005). The gills play the role of the kidney in tilapia adaptation to changes in osmolarity. 
Cortisol is a central hormone in fish osmoregulation that promotes seawater adaptation by 
regulating gill cell differentiation, Na+/K+-ATPase, cotransporters, and ion channels, resulting 
in overall salt secretion to maintain body-water and ion homeostasis, and its levels increase 
very rapidly after transfer of tilapia to seawater (Abo Hegab and Hanke, 1984).  
 
 
Figure 53: Role of SGK1 and GILZ in hormonal regulation of ENaC activity in an epithelial cell. SGK1 and GILZ abundance is 
regulated by aldosterone (Aldo). SGK1 activity is regulated by insulin through phosphatidylinositide 3 -kinase (PI3K). GILZ acts in 
parallel to inhibit ERK signaling. Together, they coordinately block Nedd4-2 inhibition of ENaC (Bhalla et al., 2006). 
 
As shown in figure 53, GILZ seems to negatively regulate tonic inhibition of ENaC and thus 
use disinhibition to propagate the effects of aldosterone to increase sodium reabsorption in tight 
epithelia (Soundararajan et al., 2005). It appears to stimulate ENaC cell surface expression at 
least in part by the extracellular signal-related kinase 1/2 (ERK1/2). ERK1/2 appears to be 
constitutively active in distal nephron cells (Michlig et al., 2004). Its activation by progesterone 
in ENaC expressing oocytes, of by the epithelial growth factor (EGF) in MDCK cells, inhibits 
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Na+ current (Grossmann et al., 2004; Michlig et al., 2004) and a long-term (>4 h) inhibition of 
the ERK pathway stimulates it (Shen and Cotton, 2003; Falin et al., 2005), suggesting a tonic 
inhibition of Na+ transport by the ERK pathway. The fact that aldosterone induces EGF 
receptor (EGF-R) expression in renal tissue of adrenalectomized rats and in human renal 
primary cell cultures (Krug et al., 2003), and that GILZ has been shown to act as an inhibitor of 
ERK signalling pathway in T-lymphocytes by binding to Raf (Ayroldi et al., 2002) suggested 
the authors that GILZ might function as a mineralocorticoid-induced inhibitor of ERK 
signalling implicated in the early induction of ENaC-mediated transport. Indeed, 
Soundadarajan et al. showed that GILZ stimulates ENaC-mediated Na+ transport in mpkCCDcl4 
cells by inhibiting ERK, and that similarly aldosterone treatment suppressed phospho-ERK 
levels with a time course that paralleled the increase of Na+ transport (Soundararajan et al., 
2005). Nevertheless, this model has been recently revisited. Indeed, as shown in figure 9, it 
seems that GILZ associates with SGK1 to stimulate the ENaC-regulatory complex 
(Soundararajan et al., 2010). However, no functional in vivo study has been published to 
confirm this hypothesis.  
Temporal profile study of DCT/CT and CCD transcriptomes allowed identifying several genes 
involved in renal circadian rhythms (Zuber et al., 2009). GILZ and USP2 were found to follow 
a circadian expression profile. These authors further investigated the temporal profile of these 
genes in the dbp/hlf/tef (triple knockout) model (Gachon et al., 2006), and showed that the 
expression was significantly reduced in kidneys of the triple knockout mice. In clock knockout 
mice, the arterial blood pressure is lower compared to controls, indicating the physiological 
importance of the clock machinery in the renal function (Zuber et al., 2009). It is probable that 
the oscillating expression of GILZ plays also a role in this regulation. 
As in the pre-adipocytes (mentioned further), GILZ could act as an antagonist of the PPARγ 
pathway in the ASDN. PPARγ agonists induce sodium and water retention in type II diabetes 
treated patients. This effect has been shown to be due to an increase in Na+ reabsorption, 
probably in the IMCD (Guan et al., 2005; Zhang et al., 2005), either by increasing ENaCγ 
(Guan et al., 2005) or Sgk1 expression (Hong et al., 2003). More recently, data obtained with 
mice lacking specifically the expression of αENaC in the collecting duct argue against a 
primary and critical role of ENaC in thiazolidinedione-induced fluid retention (Vallon et al., 
2009). 
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Role in adipogenesis and bone regulation 
Mesenchymal stem cells (MSC) can differentiate towards myocyte, adipocyte, chondrocyte or 
osteoblast cells in a transcription factor-dependent fashion (figure 54). GILZ inhibits 
adipogenesis of MSCs. It can bind specifically to a 40-bp DNA fragment containing a unique 
tandemly repeated C/EBP-binding element present in the promoter of PPARγ2 (Shi et al., 
2003). In vitro, glucocorticoids are required for osteoblast differentiation of primary bone 
marrow stromal cells, while in vivo bone loss is induced (Clark and Lasa, 2003). Studies on 
MSC differentiation showed that overexpression of GILZ mediates the shift towards to the 
osteogenic pathway of the glucocorticoid action in this process (Shi et al., 2007; Zhang et al., 
2008).  
 
 
Figure 54: Transcriptional control of osteoblastic, chondrocytic, adipocytic and myocytic differentiation. Osteoblasts differentiate 
from mesenchymal progenitor cells that also give rise to myocytes, under the control of MRFs and MEF2, to adipocytes under the 
control of C/EBPα , β  and δ  and PPARγ , and to chondrocytes under the control of Sox5, -6 and -9 and STAT1. Runx2 is essential for 
osteoblast differentiation and is also involved in chondrocyte maturation. Osterix (Osx) acts downstream of Runx2 to induce mature 
osteoblasts that express osteoblast markers, including osteocalcin. Abbreviations: MRFs, myogenic regulatory factors (including 
MyoD, myogenin, myogenic factor 5 and myogenic regulatory factor 4); MEF2, myocyte-enhancer factor 2; C/EBP, CCAAT-
enhancer-binding protein; PPARγ , peroxisome proliferator-activated receptor γ; STAT1, signal transducers and activators of 
transcription-1; Runx2, runt-related transcription factor 2; Col-I/II/X, type I/II/X collagen; Ihh, Indian hedgehog; BSP, bone 
sialoprotein; OC, osteocalcin. Modified from (Harada and Rodan, 2003). 
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A recent study presented the estrogen receptor (ER)-mediated effects on adipogenesis (Xiao et 
al., 2010). Pseudoprotodiocsin (PPD), a steroid saponin compound found in the Dioscorea plant 
(Dinchev et al., 2008), has been reported to have an inhibitory effect on some cancer lines 
(Dong et al., 2001; Ivanova et al., 2009). Treatment with PPD at the onset of adipogenic 
differentiation resulted is decreased adipogenesis in vitro and in vivo. This was correlated with 
increased amount of ERα mRNA, protein and accumulation of ERα in the nucleus. This was 
accompanied by the decreased expression of several genes involved in adipogenesis, like 
lipoprotein lipase (LPL), C/EBPα and PPARγ. In contrast, expression of some negative factors 
of adipogenesis, including pre-adipocyte factor 1 and GILZ, was increased (Xiao et al., 2010). 
The GILZ Drosophila homolog is called bunched (bun) and is required to establish a cell fate 
boundary in the ovary (Dobens et al., 1997; Wu et al., 2008). A relationship exists between bun 
and slow boarder cells (slbo) which is the C/EBP Drosophila homolog (Levine et al., 2007), 
confirming the evolutionary conservation of this interaction. 
Peroxisome proliferator-activated receptors (PPARs) 
PPARs are ligand-activated transcription factors that belong to the nuclear hormone receptor 
superfamily. PPARα (NR1C1) was first described as a receptor that is activated by peroxisome 
proliferators, hence its name (Issemann and Green, 1990). Two additional related isotypes, 
PPARβ/δ (NR1C2) and PPARγ (NR1C3), were then found and characterized (Dreyer et al., 
1992). Each of the PPAR isotypes is encoded in a separate gene and many cellular and 
systemic roles have been attributed to these receptors, reaching far beyond the stimulation of 
peroxisome proliferation in rodents after which they were initially named (Desvergne and 
Wahli, 1999). For effective DNA binding, PPARs require heterodimerization with retinoid X 
receptors (RXR; figure 55). In line with their various developmental and physiological 
functions, PPARs exhibit broad, but isotype-specific, tissue expression patterns (Kliewer et al., 
1994; Braissant et al., 1996). PPARα is expressed at high levels in organs that carry out 
significant catabolism of fatty acids such as the brown adipose tissue, liver, heart, kidney, and 
intestine (Mandard et al., 2004). Interestingly, PPARα expression is upregulated by 
glucorticoids after skin injury (Lemberger et al., 1994). Of the three isotypes, PPARβ/δ has the 
broadest expression pattern, and the levels of expression in certain tissues depend on the extent 
of cell proliferation and differentiation.  
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Figure 55: A, Peroxisome proliferator-activated receptors (PPARs) function as heterodimers with retinoid X receptors (RXRs) and are 
activated by specific ligands; they then modulate DNA transcription by binding to defined nucleotide sequences (peroxisome 
proliferator response element, PPRE) in the promoter region of target genes. Several cofactors (coactivators or corepressors) mediate 
the ability of nuclear receptors to stimulate or repress the transcription process. B, The N-terminus A ⁄ B domain contains a ligand-
independent transcriptional activation domain (AF-1), which can be regulated by mitogen-activated protein kinase (MAPK) 
phosphorylation in a and c isotypes. The C domain contains two zinc-fingerlike motifs that specifically bind the PPRE in the 
regulatory region of PPAR-responsive genes. The D domain or hinge region allows conformational changes in the molecule. The E ⁄ F 
domain consists of the ligand-binding domain and the ligand-dependent transcriptional activation domain (AF-2). The ligand-binding 
pocket appears to be quite large in comparison with other nuclear receptors, allowing the PPARs to interact with a broad range of 
natural and synthetic ligands (Kuenzli and Saurat, 2003). 
 
Important functions have been assigned to this isotype in the skin, gut, placenta, skeletal 
muscle, adipose tissue, and brain (Braissant et al., 1996; Bastie et al., 1999; Peters et al., 2000; 
Michalik et al., 2001; Barak et al., 2002). PPARγ is expressed as two isoforms, γ1 and γ2, that 
differ at their N-terminus. PPARγ2 is found at high levels in the different adipose tissues 
(Dreyer et al., 1992; Chawla et al., 1994; Tontonoz et al., 1994a), whereas PPARγ1 has a 
broader expression pattern that extends to settings such as the gut, brain, vascular cells, and 
specific kinds of immune and inflammatory cells (Tontonoz et al., 1994b; Zhu et al., 1995). 
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Figure 56: Orthogonal views are shown in which RXRα is blue and PPARγ is red. The ligands rosiglitazone and 9-cis-retinoic acid are 
shown in green, the Zn(II) ions are white, and the coactivator LXXLL peptides are in light blue and purple (Chandra et al., 2008). 
 
Figure 56 shows the interaction between the RXRα and PPARγ with DNA. Rosiglitazone, an 
anti-diabetic compound from the thiazolidinedione class of drug, is a ligand for PPARγ. A 
ligand for RXRα is 9-cis-retinoic acid. 
The metabolic syndrome 
The metabolic syndrome is a cluster of interrelated common clinical disorders, including 
obesity, insulin resistance, glucose intolerance, hypertension, and dyslipidemia 
(hypertriglyceridemia and low HDL cholesterol levels ; figure 57)(Moller and Kaufman, 2005). 
According to recently defined criteria, the metabolic syndrome is prevalent and is associated 
with a greater risk of atherosclerotic cardiovascular disease than any of its individual 
components (Alexander et al., 2003). Primary defects in energy balance that produce obesity 
(and visceral adiposity in particular) are sufficient to drive all aspects of the syndrome (Despres 
and Lemieux, 2006). Increased free fatty acids and lipid accumulation in certain organs are 
mediators of insulin resistance (Howard and Howard, 1994). Obesity also leads to a 
proinflammatory and prothrombotic state that potentiates atherosclerosis. Pathways leading 
directly from adiposity to the genesis of dyslipidemia and hypertension have been elucidated. 
Recent knowledge implies a role for fat-derived “adipokines,” including TNFα and 
adiponectin, as pathogenic contributors or protective factors (Weisberg et al., 2003). 
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Figure 57: Potential molecular mechanisms for obesity-induced insulin resistance and glucose intolerance. Increased adiposity 
(obesity), particularly increased visceral adiposity, results from a centrally regulated imbalance in energy intake versus expenditure. 
Secondary effects of obesity include increased circulating free fatty acids (FFAs), in part resulting from a net increase in lipolysis; 
reduced adiponectin; a potential increase in insulin resistance factors (e.g., resistin); and increased proinflammatory mediators (e.g., 
TNFα). Increased lipid flux into peripheral tissues can result in accumulation of triglycerides and long-chain fatty acyl-CoA esters 
(steatosis), which mediate insulin resistance and pancreatic beta cell “lipotoxicity.” Insulin resistance in liver and muscle leads to 
hyperinsulinemia, which can, in turn, augment adipose tissue accretion and exacerbate tissue resistance to insulin (Moller and 
Kaufman, 2005). 
 
Current therapies include diet and exercise as well as agents indicated for the treatment of 
individual components of the syndrome (Moller, 2001; Katzmarzyk et al., 2003). Future 
therapies may accrue from the aggressive pursuit of newer molecular drug targets that have the 
potential to prevent or treat multiple aspects of the metabolic syndrome. 
A prevailing hypothesis for regulation of insulin sensitivity by PPARγ involves primary effects 
of PPARγ on gene transcription in adipose tissue (where it is most abundantly expressed), 
which ultimately lead to improved insulin action in muscle and liver. Direct activation of 
PPARγ leads to the induction of adipocyte genes such as those for lipoprotein lipase and fatty-
acid transporter 1, which in turn contribute to lowering triglyceride and FFA levels, 
respectively. Similarly, suppression of TNFα gene expression by PPARγ in adipose tissue has 
been reported. As FFAs and TNFα are both potential systemic mediators of insulin resistance, 
such effects are likely to contribute to the efficacy of PPARγ activation in increasing insulin 
sensitivity (Oakes et al., 1994; Moller, 2001). 
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GC excess (Cushing’s syndrome) causes visceral obesity, insulin resistance, diabetes mellitus, 
dyslipidaemia, hypertension and premature vascular mortality (Fraser et al., 1999). In 
peripheral tissues, 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) catalyses the 
conversion of cortisone to the active glucocorticoid, cortisol (figure 58). On the basis of the 
apparently insulin-sensitive phenotype of 11βHSD1-null mice, inhibition of this enzyme has 
been suggested as a potential drug target for metabolic syndrome (Seckl and Walker, 2001). 
Furthermore, in obese subjects, increased 11βHSD1 expression in subcutaneous adipose tissue, 
but not in visceral adipose tissue, is associated with the worsening of metabolic conditions. 
Higher glucocorticoid production in adipose tissue may favor the development of metabolic 
disorders through a decrease in adiponectin release (Alberti et al., 2007). 
 
 
Figure 58: Interconversion of cortisol and cortisone by enzymatic oxidation or reduction at carbon position 11 (C11), catalysed by the 
two cloned isoforms of 11β-hydroxysteroid dehydrogenase (11βHSD). By convention, bonds below the plane of the molécule (α  bonds) 
are represented by dotted lines; bonds which have no definitive orientation are represented by solid lines; and bonds above the plane 
of the molecule (β  bonds) are represented by solid triangles. Corticosterone and 11-dehydrocorticosterone have similar structures to 
cortisol and cortisone, respectively, but lack the α-hydroxyl groups at position C17 (Michael et al., 2003). 
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Several reports indicate that adipose tissue regulation depends on the circadian clock. Plasma 
concentrations of the adipose tissue hormone leptin show a clear circadian rhythm (Sinha et al., 
1996), which is not controlled by circulating glucocorticoid levels, but which disappears after 
SCN lesions (Kalsbeek et al., 2001). In addition, the circulating plasma levels of a number of 
other adipocytokines (as well as their adipose mRNA levels) show clear day/night rhythms 
(Gavrila et al., 2003; Rajala et al., 2004; Ando et al., 2005). BMAL1 knockout mice embryonic 
fibroblast cells failed to be differentiated into adipocytes, indicating a functional role for the 
circadian clock machinery in this process (Shimba et al., 2005). 
Metabolic syndrome is often associated with infertility. Obesity or overweight may result in 
hypogonadism, increased scrotal temperature, impaired spermatogenesis, decreased sperm 
concentration and motility, and increased sperm DNA damage (Pasquali et al., 2007; Kasturi et 
al., 2008). 
Sexual development and fertility 
Sexual differentiation 
The first step in the establishment of the fertility of a higher organism is the determination of its 
sexual identity, which is ultimately determined by the sex chromosomes (figure 59). 
Developmentally, male and female fetuses are essentially indistinguishable until midgestation 
in the mouse and approximately six weeks of pregnancy in humans. Thus, the formation of 
primordial germ cells (PGCs) at the base of the yolk sac, their tortuous journey along the 
hindgut to the genital ridge, and the proliferation and migration of the somatic cells and germ 
cells in the bipotential gonad are independent of which sex chromosomes the fetus harbors 
(figure 60). The gonad then differentiates along the female or male pathway, and gonadal 
development, in turn, dictates the development of the secondary sex organs (Gilbert, 2006). 
Gonad development 
Once a testis or an ovary begins to form, the developmental processes differ. In the testis cords, 
the differentiating primordial germ cells that will become spermatogonia are destined to 
undergo proliferation before entering meiosis and undergoing spermiogenesis. Germ cells arise 
and propagate in an autocrine, paracrine, juxtracrine and endocrine environment that includes 
factors within the gonads and beyond. 
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Figure 59: Sex differentiation in humans. The presence of a fetal testis that secretes both testosterone (T) and anti-Müllerian hormone 
(AMH) results in the induction of the Wolffian duct into the future vas deferens, epididymis, and seminal vesicles and the regression of 
the Müllerian duct, respectively. In females, the fetal ovary does not secrete either of these substances, so the Wolffian duct regresses, 
whereas the Müllerian duct gives rise to the fallopian tubes (oviducts), uterus and the upper portion of the vagina. Androgens 
(including testosterone) have a key role in the development of the male genital tract but are not the only signaling pathways involved. 
For a sperm and oocyte to meet in vivo, millions of spermatozoa leave the seminiferous tubules of the testis to mature in the epididymis 
before traveling through the vas deferens and urethra to enter the female, where they transverse the vagina, cervix and uterus before 
typically encountering a single oocyte in one of the fallopian tubes. Surgical contraception involves closing this pathway by removing 
segments of the two vas deferens (that is, vasectomy) in a man or both fallopian tubes (that is, tubal ligation) in a woman (Matzuk and 
Lamb, 2008). 
 
In a normal man, spermatogenesis will continue throughout his lifetime and continue to 
produce millions of sperm in each ejaculate. In contrast, in the ovary, the primordial follicles 
represent the maximum number of follicles possible in this organ, with subsequent loss 
occurring during the time between development, birth and puberty, until they are depleted at 
menopause. In addition, the processes of mitosis and meiosis vary between the ovary and testis, 
but they are highly regulated by both endocrine and paracrine factors. Epigenetic events are 
essential to germ-cell development, for example, to maintain genomic integrity in these cells 
during meiosis or for gene imprinting (figure 60)(Sasaki and Matsui, 2008). 
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Figure 60: Germ cell development and associated epigenetic events in mice. Chronology of mouse germ cell development and the main 
epigenetic events that occur. PGCs first emerge at embryonic day 7.25 (E7.25) as a cluster of about 20 cells. Subsequently, they rapidly 
proliferate with an average doubling time of approximately 16 hours. Before they stop dividing at E13.5, their number reaches up to 
about 26,000. MSCI, meiotic sex-chromosome inactivation (Sasaki and Matsui, 2008). 
 
The development of the genital tract and secondary sex organs depends upon the occurrence of 
a testis or an ovary and the presence or absence, respectively, of the sex determining region Y 
(SRY) gene carried on the Y chromosome. The oviducts, uterus and upper portion of the vagina 
of the female are derived from their embryonic precursor, the Müllerian duct, whereas the 
epididymis, vas deferens and seminal vesicles of the male differentiate from the Wolffian duct 
(figure 59)(Kobayashi and Behringer, 2003; Barsoum and Yao, 2006; Gilbert, 2006). The 
prenatal production of testicular anti-Müllerian hormone (AMH), acting through its receptor 
AMHR2, induces the regression of the Müllerian duct, whereas testosterone drives the 
development of these Wolffian duct derivatives. 5-α-reductase has a major role in the 
metabolism of testosterone to dihydrotestosterone, and this hormone is required for the 
development of the prostate and male external genitalia.  
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Figure 61: A, Major steps in male sexual differentiation. The external genitalia appear as a mesenchymal swelling between the two 
layers of the cloacal membrane at around 10.5 days post coitum (dpc) and develop further under the influence of testicular androgens. 
B, A transverse section through a mouse embryo at 11.5 dpc shows the developing urogenital ridge, which develops out of the 
intermediate mesoderm on either side of the aorta and is composed of the mesonephros and genital ridge. Within the mesonephros the 
Wolffian (male) and Müllerian (female) ducts form. At 11.5 dpc males cannot be distinguished morphologically from females. C, 
However, expression of the male-determining gene Sry induces a cascade of gene expression that results in the differentiation of the 
genital ridge and the Wolffian duct into the testis and male genital tract (rete testes, epididymis, vas deferens and seminal vesicle), 
respectively. D, At 13 dpc, the bipotential urogenital sinus develops and at 17.5 dpc the prostatic bud is formed by the urogenital sinus 
under the influence of testicular androgens. Between 14.5 and 18 dpc the testis migrates into the developing scrotum in two phases. E, 
The first phase is due to an enlargement of the gubernaculum, whereas during the second phase the gubernaculum migrates into the 
scrotum, guided by calcitonin-related peptide that is released by the genito-femoral nerve. The brain develops sexual dimorphisms, 
some of which are due to direct genetic effects, although most are caused by sex hormones (Wilhelm and Koopman, 2006). 
 
In parallel with the steps of sex determination and differentiation, key developmental and 
physiological pathways (for example, the gonadotropin and kisspeptin signaling pathways) are 
being controlled by the hypothalamus and pituitary, foreshadowing puberty and, eventually, 
reproduction, which are crucially controlled by these organs (figure 61). These developmental 
and overriding influences allow for highly regulated gene expression at every stage of ovarian 
folliculogenesis, ovulation, fertilization, implantation and early embryonic development. 
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Testis structure 
Almost healthy male vertebrates have two testes. In mammals, the testes are often contained 
within an extension of the abdomen called the scrotum. Under a tough membraneous shell, the 
tunica albuginea, the testis of amniotes, and some teleost fish, contains very fine coiled tubes 
called seminiferous tubules (figure 62A).  
 
 
Figure 62: Organization of the testis. A, Cross-section through a testis, showing the location of the seminiferous tubules, the vas 
deferens and the epididymis. B, A diagrammatic cross-section through a testicular tubule, showing the germ cells (green) at different 
stages of maturation developing embedded in somatic Sertoli cells (each Sertoli cell is outlined in red). Leydig cells (LC) — where 
testosterone is synthesized — are present in the interstitium. Maturing sperm are shown in the lumen of the tubules. PTM, peritubular 
myoid cell (Cooke and Saunders, 2002). 
 
The tubules are lined with a layer of cells (germ cells) that from puberty to old age, develop 
into sperm cells (also known as spermatozoa or male gametes). The developing sperm travel 
through the seminiferous tubules to the rete testis located in the mediastinum testis, to the 
efferent ducts, and then to the epididymis where newly-created sperm cells mature (see 
spermatogenesis). The sperm move into the vas deferens, and are eventually expelled through 
the urethra and out of the urethral orifice through muscular contractions (Marieb, 2009). Leydig 
cells (LC; also known as interstitial cells of Leydig) are located between seminiferous tubules. 
They produce testosterone in the presence of luteinizing hormone (LH). Sertoli cells (SC) have 
the important function to maintain and to nurture the developing sperm cells (figure 62B). A 
single SC extends from the basement membrane to the lumen of the seminiferous tubule. Once 
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fully differentiated, the SC is unable to proliferate. Therefore, once spermatogenesis has begun, 
no more SCs are created. The tight junctions of SCs form the blood-testis barrier, a structure 
that partitions the interstitial blood compartment of the testis from the adluminal compartment 
of the seminiferous tubules (Mruk and Cheng, 2004). These cells are also responsible for 
establishing and maintaining the spermatogonial stem cell niche, which ensures the renewal of 
stem cells and the differentiation of spermatogonia into mature germ cells that progress 
stepwise through the long process of spermatogenesis, ending in the release of spermatozoa (de 
Rooij and Grootegoed, 1998; Hess et al., 2006). SCs bind to spermatogonial cells via N-
cadherins and galactosyltransferase (via carbohydrate residues)(Akama et al., 2002). Epithelial 
cells and macrophages are also present in testis. 
Spermatogenesis 
Spermatogenesis produces mature male gametes, commonly called sperm but specifically 
known as spermatozoa, which are able to fertilize the counterpart female gamete, the oocyte, 
during conception to produce a single-celled individual known as a zygote.  
 
Figure 63: Stages of spermatogenesis. A, During the process of spermatogenesis, the mammalian germ cell undergoes mitosis, meiosis 
and structural remodelling into the mature spermatozoa (cytoplasm is indicated in green, DNA in pink). The time course shown is that 
for a human male (in mice, spermatogenesis takes 35 days). B, A single Sertoli cell with its associated germ cells. Note that tight 
juctions between Sertoli cells (arrowhead) define two compartments: the stem cells and the pre-meiotic cells (spermatogonia) are found 
on one side of the junction, whereas the meiotic (spermatocytes) and the post-meiotic (round and elongating spermatids) cells are 
found organized in strict order of maturation towards the lumen (cytoplasm is shown in dark green, DNA is shown in pink, Sertoli cell 
nucleus is shown in orange) (Cooke and Saunders, 2002). 
 
Here is the cornerstone of sexual reproduction and involves the two gametes both contributing 
half the normal set of chromosomes (haploid) to result in a chromosomally normal (diploid) 
zygote. In humans, spermatogenesis takes about 70 days (figure 63A). The spermatogonia 
development starts from the basement membrane and continues towards the lumen of 
seminiferous tubule (figure 63B). 
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To preserve the number of chromosomes in the offspring (which differs between species) each 
gamete must have half the usual number of chromosomes present in other body cells. 
Otherwise, the offspring will have twice the normal number of chromosomes, and serious 
abnormalities may result. In humans, chromosomal abnormalities arising from incorrect 
spermatogenesis can result in Down Syndrome, Klinefelter's Syndrome, and spontaneous 
abortion. 
At the beginning, each primary spermatocyte moves into the adluminal compartment (central 
region of the Sertoli cells) of the seminiferous tubules and duplicates its DNA and subsequently 
undergoes meiosis I to produce two haploid secondary spermatocytes. This division implicates 
sources of genetic variation, such as random inclusion of either parental chromosomes, and 
chromosomal crossover, to increase the genetic variability of the gamete (figure 64). 
Each cell division from a spermatogonium to a spermatid is incomplete; the cells remain 
connected to one another by bridges of cytoplasm to allow synchronous development. It should 
also be noted that not all spermatogonia divide to produce spermatocytes, otherwise the supply 
would run out. Instead, certain types of spermatogonia divide to produce copies of themselves, 
thereby ensuring a constant supply of gametogonia to fuel spermatogenesis (de Rooij and 
Mizrak, 2008). 
 
Figure 64: Stages of spermatogenesis. MI, metaphase I; MII, metaphase II (Sasaki and Matsui, 2008). 
 
Spermatidogenesis is the creation of spermatids from secondary spermatocytes. Secondary 
spermatocytes produced earlier rapidly enter meiosis II and divide to produce haploid 
spermatids. Secondary spermatocytes are rarely seen in histological preparations, meaning that 
this phase is brief. 
During spermiogenesis, the spermatids begin to grow a tail, and develop a thickened mid-piece, 
where the mitochondria gather and form an axoneme. Spermatid DNA also undergoes 
packaging, becoming highly condensed. The DNA is packaged firstly with specific nuclear 
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basic proteins, which are subsequently replaced with protamines during spermatid elongation. 
The resultant tightly packed chromatin is transcriptionally inactive. The Golgi apparatus 
surrounds the now condensed nucleus, becoming the acrosome. One of the centrioles of the cell 
elongates to become the tail of the sperm. 
Maturation then takes place under the influence of testosterone, which removes the remaining 
unnecessary cytoplasm and organelles. The excess cytoplasm, known as residual bodies, is 
phagocytosed by surrounding SCs in the testes. The resulting spermatozoa are now mature but 
lack motility, rendering them sterile. The mature spermatozoa are released from the protective 
SCs into the lumen of the seminiferous tubule in a process called spermiation. 
The non-motile spermatozoa are transported to the epididymis in testicular fluid secreted by the 
SCs with the aid of peristaltic contraction. While in the epididymis the spermatozoa gain 
motility and become capable of fertilization. However, transport of the mature spermatozoa 
through the remainder of the male reproductive system is achieved via muscle contraction 
rather than the spermatozoon's recently acquired motility (Marieb, 2009). 
Hormonal influence on spermatogenesis 
This endocrine regulation is very complex. As presented in figure 65, signals originate from the 
brain, more precisely, the hypothalamus secretes gonatotropin-releasing hormone (GnRH), 
which stimulates the release of follicle-stimulating hormone (FSH) and luteinizing hormone 
(LH) from the pituitary gland (Sharpe, 1994). They bind to their specific receptors (FSHR and 
LHR) that are expressed by SCs and LCs, respectively. The paracrine regulation of 
spermatogenesis is provided by, in one hand, testosterone and oestradiol, that are synthesized 
by LCs, and on the other hand, the activin and inhibin proteins, that are synthesized by SCs. 
The primary function of LH is to stimulate the synthesis of testosterone by LCs (Moyle and 
Ramachandran, 1973; Zhang et al., 2001). FSH acts directly on SCs to stimulate germ cell 
number and acts to increase androgen production by the LCs (O'Shaughnessy et al., 2010). 
Testosterone is necessary for normal sperm development. It activates genes in SCs, which 
promote differentiation of spermatogonia.  
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Figure 65: Hormonal regulation of spermatogenesis. Endocrine factors secreted by the pituitary gland (LH, luteinizing hormone; FSH, 
follicle-stimulating hormone) and local regulators of testis function (such as androgens, oestrogens and inhibins), as well as modulators 
of gene expression in the pituitary gland (the negative-feedback loops), are involved in the regulation of spermatogenesis. Receptors for 
LH and FSH are expressed in selected testicular cell populations. GnRH, gonadotrophin-releasing hormone; LC, Leydig cells; ST, 
Sertoli cells (Cooke and Saunders, 2002). 
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In this process, the exact role of testosterone is difficult to define. Indeed, it binds to the 
androgen receptor (AR), and when this gene is not functional (for example, individuals who 
carry loss-of-function mutations), the male gonad development is impaired and feminization 
phenotype is observed (Ghadessy et al., 1999). This is also observed with mutations in enzymes 
involved in androgen biosynthesis (Achermann et al., 2002). The aromatase (cyp19) is the 
enzyme responsible for the irreversible conversion of testosterone to estrogen (Carreau et al., 
2006). Correct androgen/estrogen balance is essential for normal sexual development and 
reproduction (Delbes et al., 2006; Carreau et al., 2007). It has been shown in the rat, that there 
is an age-related change in cellular distribution of aromatase activity being mainly in SCs of 
immature animals and then in LCs of adults (Carreau et al., 1999). But, expression in germ 
cells has also been reported (Nitta et al., 1993). The estrogen receptor (ER) mediates the effects 
and belongs to the nuclear receptor family. The two ERα and ERβ mRNAs are encoded in the 
gonad, but their spatio-temporal distribution is different (Saunders et al., 1998; Lambard et al., 
2004). Interestingly, mice deficient for ERα are infertile (secondary phenotype), whereas it is 
not the case with ERβ knockout mice (Eddy et al., 1996; Krege et al., 1998). 
GILZ and its role in reproduction 
Only few studies show the presence of GILZ in the reproductive organs or along the HPG axis. 
Cross-species expression profiling analysis of the human, mouse, and rat male meiotic 
transcriptional program, using enriched germ cell populations, whole gonads, and high-density 
oligonucleotide microarrays has been performed (Chalmel et al., 2007). From this study, it is 
possible to point out the relative expression profile of GILZ mRNA transcripts in several 
tissues and principally in the gonads (figure 66A). GILZ is widely expressed throughout the 
body. It is found in the testis and ovary as well. In the testis, it is mostly expressed in the 
spermatogonia (figure 66B) and mainly during the early phases on spermatogenesis (figure 
66C).  
GILZ is expressed in the anterior pituitary during the second half of embryonic development in 
the chick. This is consistent with in vivo regulation by circulating corticosteroids. Pituitary 
GILZ mRNA levels increase during embryogenesis to a maximum on the day of hatch, and 
decreased through the first week after hatch. GILZ expression is rapidly upregulated by 
corticosterone in embryonic pituitary cells. Exogenous GILZ overexpression increased 
prolactin mRNA above basal levels, but not as high as that in corticosterone-treated cells, 
indicating that GILZ may play a small role in lactotroph differentiation. The largest effect 
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observed was a twofold increase in FSHβ subunit in cells transfected with GILZ but not treated 
with corticosterone, suggesting that GILZ may positively regulate gonadotroph development in 
a manner not involving glucocorticoids (Ellestad et al., 2009). 
 
 
Figure 66: GILZ mRNA transcript expression (from GermOnline database website). Normalized GILZ intensity in various mouse 
organs (A), cells from testis (B) and developing spermatogonia (C) (Chalmel et al., 2007). 
 
Using microarray analysis, Tynan et al., identified 27 genes that were up-regulated and 20 that 
were down-regulated by estrogen in MCF-7 human breast cancer cells. GILZ is rapidly down-
regulated by estrogen in these cells. Estrogen antagonists block the down-regulation. The 
region of the GILZ promoter between nucleotides -104 and -69 mediates both basal activity 
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and estrogen-dependent down-regulation in MCF-7 cells. This region contains a functional 
Oct-1 binding site and a cAMP response element binding protein (CREB) binding site. The 
same DNA region mediates up-regulation by estrogen in HeLa and HEK293 cells, indicating 
that cell-specific factors are involved in estrogen regulation of this gene. The estrogen receptor 
(ER) is present in GILZ promoter protein complexes, but it does not bind directly to the 
promoter itself, as the DNA-binding domain of the estrogen receptor is not required for down-
regulation. Elimination of the CREB binding site blocks both basal activity and estrogen 
regulation (Tynan et al., 2004). Estrogen increases near the end of of murine pregnancy, it is 
plausible that estrogen down-regulates GILZ in the decidua between gestational days 16.5 and 
19.0 (Watanabe et al., 2003). Using in situ hybridization, GILZ expression has been found at 
the site of implantation in the later stages of murine pregnancy (Zhao et al., 2006). 
TSC22d1 knockout mice are subfertile (personal communication by Dr. Laurel Raftery). 
Earlier work on cell lines showed that TSC22 transcript is upregulated in response to FSH or 
progesterone stimulation (Dohrmann et al., 1999). Together, these data suggest that the TSC22 
family plays a role in reproduction. 
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WORKING HYPOTHESIS 
Glucocorticoids (GCs) are widely used as therapeutic agents (mainly as anti-inflammatory 
drugs). They function in every organ and are thus implicated in a variety of physiological 
processes such as growth development and maintenance of homeostasis. GCs regulate up to 
10% of the genes and the glucocorticoid-induced leucine zipper (GILZ, Tsc22d3) has been 
identified as one of the most expressed genes; thus, GILZ has been proposed to mimick GCs 
function. Earlier investigations strongly suggested that GILZ might be implicated in the 
regulation of the epithelial sodium channel (ENaC), consequently having a role in sodium and 
water handling. We expected that if ENaC was not properly regulated, due to GILZ-deficiency 
and that the other factors, e.g., SGK1 or Nedd4-2, being part of the described 
ENaC/GILZ/Nedd4-2/SGK1 complex, could not compensate for the lack of GILZ, we might 
observe a renal phenotype. We expect, in case of GILZ-deficiency, hypotension, lower blood 
pressure or salt loosing phenotype. GILZ was proposed to play a role in the differentiation of 
adipocytes and bone regulation, implying a possible developmental phenotype. 
The aim of my thesis project was to analyze the phenotype of GILZ knockout mice. We were 
interested to investigate the pathways or processes in which GCs play a role, for example in 
immunity or metabolism. We also wanted to analyze tissues in which less was known about 
potential GILZ functions, like in skin physiology.  
Finally, by dissecting the expression of related genes (like PPARγ2) we addressed the question 
whether GILZ mimics the effects of GCs in vivo. Other members of the same family may 
compensate the lack of GILZ. 
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MATERIAL AND METHODS 
Generation of conditional and null mutant Tsc22d3 mice 
The Tsc22d3 gene was cloned from a 129/Sv mouse genomic BAC library (Incite Genomics, 
Inc., USA). For Tsc22d3 gene information, see GenBank accession number NM_010286.3. The 
following fragments were then subcloned into a modified lox-targeting vector containing 2 
loxP and 2 Frt sites. First, a 10kb (5’ region, haboring exon 3) and a 5kb EcoRI fragments (3’ 
region, harboring exons 4 to 6), were subcloned into pBSII KS(-) and extracted using PacI and 
StuI restriction sites. The neomycin resistance gene cassette flanked by frt sites and followed by 
one loxP site (Dymecki, 1996), (Rajewsky et al., 1996) was cloned into EcoRV (3’ of the 
polyA region). The second loxP sequence was introduced in a SmaI restriction site created by 
PCR-based mutagenesis, along with a new diagnostic EcoRV restriction site 5’ of the third 
exon. Finally, the thymidine kinase cassette (HSV-tK) was inserted 3’ of the homologous 
region. Further details of cloning are available on request. The targeting vector was linearized 
with PacI, and transfected into A2 embryonic stem cells (ES cells) of the 129Sv/EV 
background (Reis et al., 1994; Hummler et al., 2002) as described previously (Hummler et al., 
1996). G418 and ganciclovir-resistant colonies were expanded and screened by PCR using the 
following primers; 5’ recombination: sense 5’-ATAGCCTGTGCTCTGGAACT-3’, antisense, 
5’-TTATGGCGCGGGGATATCTA-3’ and 3’ recombination: sense 5’-
GCCTCCGAGGTTGCAGTGTTT-3’, antisense 5’-TCGCCTTCTTGACGAGTTCTTC-3’. 
Targeted clones were confirmed by Southern blot analysis using two external probes (3’ probe: 
315 bp fragment isolated from the 3’ EcoRI clone by StuI and BglII on EcoRI-digested DNA, 
and 5’ probe: 1085 bp fragment isolated from the 5’ EcoRI clone by DraI on EcoRV-digested 
genomic DNA). PCR-amplified neomycin sequences were used as internal probe. Correctly 
targeted clones were injected into C57BL/6N blastocyts as described (Porret et al., 2006). 
Breeding of Tsc22d3loxneo mice with Flp mice (Rodriguez et al., 2000) allowed the excision of 
the neomycin cassette and with nestin-CRE (Dubois et al., 2006) mice to generate mice 
haboring the Δ allele. To obtain knockout males (Tsc22d3∆/y), heterozygous mutant Tsc22d3∆/+ 
females were crossed with wildtype males. Tsc22d3∆/+ and Tsc22d3+/+ females, as well as 
Tsc22d3+/y and Tsc22d3∆/y males were genotyped by PCR (sense (s1): 5’-
CAGGTCTGAGTAACTTGTCC-3’, antisense (as): 5’-CAGTCTGTGGTGACCGTTTC-3’, 
sense (s2): 5’-TGACAGCTGCGTTTCTCAGTG-3’). The s1, s2 and as primers were used for 
genotyping of lox and wt alleles, and s1 and as for the ∆ allele. 
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All animals were housed in a controlled environment with a 14 h light/10 h dark cycle with free 
access to water and standard laboratory diet. Males were aged from 3 to 6 months, and were 
backcrossed to C57BL/6N mice (N4-N6). The control group consisted of age-matched 
Tsc22d3+/y and Tsc22d3lox/y littermates. Mouse experiments were conducted under 
authorization of local authorities and followed Swiss guidelines. 
Histology and immunohistochemistry 
2-(n=2) and 6-(n=1) month-old mice were dissected and organs fixed with buffered formalin 
(pH 7.2) for 12 hours. Tissues were embedded in paraffin (Leica Microsystems, Wetzlar, 
Germany) and 2-3 µm sections were stained with haematoxylin and eosin (H&E). Testis 
cellular proliferation was assessed by Ki-67 antibody (monoclonal rat anti-mouse, Dako 
M7249, Carpinteria, CA, USA; dilution 1:50) with goat anti-rat HRP secondary antibody 
(Biosource ALI 3404, Camarillo, CA, USA). Apoptosis was analysed using terminal 
transferase and Biotin-16-dUTP (TUNEL Enzyme, Roche 11 767 305 001; dilution 1:250 and 
Biotin-16-dUTP, dilution 1:250; Roche 11 093 070 910, Roche Diagnostics GmbH, Mannheim, 
Germany). Sertoli cells were labelled with the rabbit anti-CTCF (#06–917; Upstate cell 
signaling, Millipore, Billerica, MA, USA; dilution 1:100); secondary antibody used was 
EnVision (DakoCytomation, Glostrup, Denmark) as previously described (Jelinic et al., 2006). 
Pancreas sections were incubated with antibodies against insulin (Linco 4011-01, Linco 
Research Inc., St. Charles, MO, USA; dilution 1:6000) and glucagon (Linco 4030-01F, Linco 
Research Inc., St. Charles, MO, USA; dilution 1:6000), and then revealed with Fuchsin (Kit 
DAKO K0625, Dako, Denmark; dilution 1:50) and DAB (Kit DAKO K3468, Dako, Denmark; 
dilution 1:50), respectively. GILZ1 and GILZ2 proteins were labelled with the polyclonal 
Tsc22d3 antibody as described (Soundararajan et al., 2007). 
Quantitative real-time PCR 
Following sacrifice, tissues were collected and quickly snap frozen in liquid nitrogen and kept 
at -80° C until used. Total RNA was extracted from tissues with the RNeasy Mini Kit or Qiazol 
(Qiagen, Valencia, CA, USA). RNA quality was verified on an agarose gel and the 
concentration was determined by a ND-1000 Spectrophotometer (NanoDrop, Wilmington, DE, 
USA). Total RNA (1 µg) was subjected to reverse transcription using the SuperScript II First-
Strand Synthesis System for RT–PCR (Invitrogen/Life Technologies Corporation, Carlsbad, 
CA, USA) following the manufacturer’s instructions. The resulting cDNA was used as a 
template for quantitative PCR (qPCR). Results were normalized using the reference genes 
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glyceraldehyde 3-phosphate dehydrogenase (GAPDH) or RNA polymerase II. Quantitative 
real-time analysis of selected genes was performed using the ABI Prism 7500 Fast Real-Time 
PCR System, SYBR Green as DNA binding dye for the detection of PCR products or the 
TaqMan probe technology (Applied Biosystems/Life Technologies Corporation, Carlsbad, CA, 
USA). Intron-spanning primers were designed (Microsynth AG, Switzerland) (see table II list 
for oligonucleotides). The cycling conditions were 95 °C for 10 min, followed by 40 cycles of 
95 °C for 15 s, and 60 °C for 1 min. To detect and eliminate possible primer–dimer artifacts, 
the dissociation curve was generated by adding a cycle of 95 °C for 15 s, 60 °C for 1 min and 
95 °C for 15 s. All primer sets produced amplicons of the expected size and their identity was 
also verified by migration of the PCR products on agarose gel. The quantification was done by 
measuring the ΔΔCt normalized to the reference gene. All measurements were done at least in 
triplicate, n = 3 mice per group, analysis performed in triplicate, data represent average ± SEM, 
in all tissues tested. 
Western blot analyses 
Mice were sacrificed according to standard procedures and various tissue samples were 
collected from dexamethasone (55 µg/100g body weight)-treated and non-treated, control and 
knockout mice. The dexamethasone was administred intraperitoneally 3-4 hours before 
euthanasia. Tissue lysis was performed in ice-cold urea (8M) using the TissueLyser (Qiagen, 
Valencia, CA, USA). Protein levels were quantified using the Pierce BCA Protein Assay 
Reagent (Thermo Fisher Scientific, Waltham, MA, USA) with BSA as a standard. Equal 
amounts of protein extracts were resolved by 12% SDS-PAGE and electro-transferred onto a 
Protran nitrocellulose membrane (Whatman/GE Healthcare, Piscataway, NJ, USA). Blots were 
blocked in tris-buffered saline containing 0.1% Tween (TBS-T) supplemented with 4% milk 
powder and immunoblotted using anti-TSC22d3 antibody, as described previously 
(Soundararajan et al., 2007). The blots were stripped and reprobed with GAPDH antibody 
(Chemicon/Millipore, Billerica, MA, USA) as a loading control; n = 2 mice per genotype.   
Hormone measurements 
For plasma aldosterone and corticosterone measurements, mice (n ≥ 7) were killed by rapid 
decapitation between 4-6 pm. Blood was collected in EDTA tubes, immediately centrifuged 
and stored at -20 oC until assayed for hormone level determination. Plasma aldosterone levels 
were measured according to standard procedure using a radioimmunoassay (RIA) using the 
Coat-A-Count RIA kit (Siemens Medical Solutions Diagnostics, Ballerup, Denmark). Mice 
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samples exhibiting values greater than 1200 pg/ml were previously diluted using a serum pool 
with a low aldosterone concentration (<50 pg/ml). Corticosterone was measured by RIA (IBL, 
Hamburg, Germany), FSH was measured by IRMA (IBL, Hamburg, Germany), and LH was 
measured by RIA (IDS, Liège, Belgium). Testosterone levels were assayed using a kit from MP 
Biomedicals (Testo DA Kit, Eschwege, Germany). The standard curves ranged between 2 and 
200 ng/ml for FSH, 0.25 and 15 ng/ml for LH, and 0.1 and 10 ng/ml for testosterone. Intra- and 
inter-assay coefficients of variation (CVs) of all three assays were less than 5% and 10%, 
respectively, n = 10 mice per genotype. 
Metabolic parameters 
Body weight was measured on a weekly basis over the whole study. Body composition was 
analyzed on individual 2.5- and 15-month-old mice under light gaz anesthesia (1-2 % 
isoflurane), by quantitative nuclear magnetic resonance using an EchoMRI Whole Body 
Composition Analyzer (EchoMedical Systems, Houston, TX, USA). Data for individual mice 
were obtained by averaging results from two consecutive measurements. Plasma glucose levels 
in the fed, 15h fasted or 6h-refed states were measured with a glucometer (Ascensia Breeze2, 
Bayer, Switzerland). Plasma insulin levels were determined from tail-tip bleedings by ELISA 
(Ultrasensitive Mouse insulin ELISA, Mercodia AB, Uppsala, Sweden).  
Glucose tolerance test; after a 15-hour overnight fast period, 6-month-old mice were injected 
i.p. with 1.5 mg/g glucose. Plasma glucose levels were measured 30 minutes before and 
punctually during 120 minutes after administration (n ≥ 6 per group). 
Insulin tolerance test; following 4 hours of food removal (9am-1pm), age-matched 7 months 
old mice were injected i.p. with 0.8 mU/g insulin by intraperitoneal injections. Blood samples 
were obtained from tail-tip bleedings, and plasma glucose levels were measured with a 
glucometer (Ascensia Breeze 2, Bayer, Switzerland).  
Adipocyte differentiation ; Mouse embryonic fibroblasts (MEFs) were generated from 13.5-
day-old embryos obtained from heterozygous mutant female Tsc22d3+/∆ mated to wild type 
malese (Yang et al., 2003). Briefly, after removal of head and visceral organs (used for 
genotyping), embryos were minced and trypsinized for 30 minutes at 37°C. Embryonic 
fibroblasts were then plated and maintained in DMEM (with 10% foetal calf serum (FCS) (Life 
Technologies), 100 U/ml penicillin and 100 µg/ml streptomycin) at 37°C in an atmosphere of 
5% CO2. All experiments were performed with Tsc22d3 wild-type and knockout MEFs after 
15-20 passages. For adipocyte differentiation, 2-day-postconfluent cells (day 0) were 
transferred to DMEM supplemented with 10% FCS, 8 µg/ml biotin, 4 µg/ml pantothenate, 0.5 
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mM 3-isobutyl-1-methylxanthine, 1 µM dexamethasone and 10 µg/ml insulin for 2 days (all 
from Sigma). Medium was renewed every 2 days with DMEM containing 10% FCS, 8 µg/ml 
biotin, 4 µg/ml pantothenate and 10 µg/ml insulin. LY294002 (Calbiochem) was prepared in 
dimethyl sulfoxide (DMSO) and added at a final concentration of 50 µM in the medium 20 
minutes before, and, every 12 hours after addition of the adipose cocktail. To visualize lipid 
accumulation, cells were stained with Oil Red O (Ramirez-Zacarias et al., 1992). Briefly, cells 
were washed with phosphate-buffered saline (PBS), fixed with 3.7% formaldehyde solution for 
1 hour and stained with Oil Red O for 1 hour using a 60:40 (v/v) dilution in water of a 0.5% 
stock solution (in isopropanol). Cells were then washed twice with PBS and twice with water. 
MEFs were pooled from n = 2 per genotype. Experiments were performed in triplicate. 
Sodium-restriction diet and water deprivation 
Mice (20–24 weeks old) were fed with a standard salt diet (0.17% sodium, Ssniff Spezialdiäten 
GmbH, Soest, Germany) followed by 12 days with a sodium-deficient diet (<0.01% sodium, 
Ssniff Spezialdiäten GmbH, GERMANY). The 23 hours water deprivation was performed 
under normal-salt diet. Body weight, food and water intake were measured during the 
experiment. Spot urine and serum/blood samples were collected before and after each 
experiment, and osmolarity as well as sodium, potassium and creatinine composition were 
analyzed at the Laboratoire Central de Chimie Clinique of the University Hospital (CHUV, 
Lausanne, Switzerland).  
Flow Cytometry and Monoclonal Antibodies 
Thymocyte, lymph node and spleen single cell suspensions were prepared by standard methods 
and stained for FACS analysis at 4°C as follows. Cells were preincubated in 50% anti-mouse 
FcR (CD16/32; clone 2.4.G.2) culture supernatant and then stained with the following 
monoclonal antibody conjugates: CD4 (RM-4.5 or GK1.5)-FITC, -PE-Cy5 or PE-Cy7; CD8α 
(53.6.7)-FITC or Alexa 647; CD11b (M1/70)-FITC, PE-Cy5 or Alexa 647; CD24 (M1/69)-PE; 
CD25 (PC61.5)-Alexa 700 or APC-Alexa 750; CD41 (MWReg30)-FITC or -PE; CD44 
(IM781)-PE-Cy7 or Pacific Blue; CD45R/B220 (RA3-6B2)-FITC, PE-Texas Red or PE-Cy7; 
CD62L (Mel14)-FITC; CD71 (R17217)-PE; CD122 (5H4)-PE; CD117 (2B8)-APC; F4/80 
(BM8)-APC Alexa750, Gr1 (RB6-8C5)-FITC, Alexa 647 or Alexa 700; Ter119-FITC or APC-
Alexa 750; TCRβ (H57)-FITC, PE-Cy5 or APC-Alexa750; TCRγδ (GL3)-FITC or PE-Cy5. 
DN1 (CD117+CD44+CD25-), DN2 (CD117+CD44+CD25+), DN3 (CD117-CD44-CD25+), DN4 
(CD117-CD44-CD25-), ISP (CD4-CD8+TCRβ-), γδT cells, DP (double positive, CD4+CD8+), 
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CD8 SP (single positive, CD4-CD8+), CD4 SP (CD4-CD8+). All FITC conjugates were purified 
and conjugated in the Ludwig Institute with the exception of CD41-FITC, which was 
purchased from BD Biosciences (San Jose, CA, USA). All Alexa 647 conjugates were prepared 
in the Ludwig Institute using the Alexa 647 conjugation kit from Invitrogen (Carlsbad, CA, 
USA). All other monoclonal antibody conjugates were purchased from eBioscience (San 
Diego, CA, USA). Intracellular staining for TCRβ was performed after first surface staining 
with all monoclonal antibodies. After fixation and permeabilization in Cytofix/Cytoperm (BD 
Biosciences, San Jose, CA, USA), the cells were incubated overnight at 4°C in 1x Permwash 
solution (BD Biosciences, San Jose, CA, USA) containing TCRβ-PE-Cy5 and then washed in 
1x Permwash and resuspended in PBS/3% FCS for FACS analysis. Samples were analyzed on 
either a FACS Canto™ or a FACS LSR II™ (both Becton Dickinson, San Jose, CA, USA) and 
the data analyzed with FlowJo™ software (TreeStar, Ashland, OR, USA). 
Cell Cycle analysis and icBcl2 staining. After surface staining, the cells were fixed and 
permeabilized (as above). Ki-67 staining and DNA content was performed as previously 
described (Wilson et al., 2008). Anti-human Ki-67-FITC (BD Biosciences, San Jose, CA, 
USA) and Hoechst 33342 at 20g/ml were added to the cells in 1x Permwash, incubated at 4°C, 
then washed and resuspended as above. The cells were analyzed on a LSR II™ Flow 
Cytometer equipped with a 355nm UV laser to detect Hoechst fluorescence. After surface 
staining, fixation and permeabilization (see above), the cells were incubated with anti-mouse 
Bcl2-FITC (BD Biosciences, San Jose, CA, USA), washed and analyzed as above. Data were 
analyzed with FlowJo™ software. 
Inflammation experiments 
Three-month-old mice were sacrificed (n = 3, each group) and bone marrow-derived dendritic 
cells (BMDC), bone marrow-derived macrophages (BMDM) and thioglycolate-elicited 
peritoneal macrophages (TEPM) were prepared and stimulated as previously described (Gross 
et al., 2006; Muruve et al., 2008; Gross et al., 2009). Briefly, LPS, MSU, ATP, Candida and 
CpG stimuli were obtained from InvivoGen (San Diego, CA, USA), ELISA kits from R&D 
Systems (Minneapolis, MN, USA). Bone marrow-derived macrophages (BMDMs) were 
obtained as previously described (Roger et al., 2009) and cultured in IMDM containing 10% 
FCS (Sigma-Aldrich), 100 UI/ml penicillin, 100 µg/ml streptomycin and 50 µM 2-
mercaptoethanol. Cells were preincubated for 1 h with dexamethasone (Sigma-Aldrich) prior to 
stimulation with 10 ng/ml of Salmonella minnesota Ultra Pure lipopolysaccharide (LPS) (List 
Biologicals Laboratories), 10 µg/ml Pam3CSK4 lipopeptide (EMC microcollections), 5x 107 
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heat-inactivated Escherichia coli (E. coli) J5 or 0.1 µM CpG oligodeoxynucleotide (CpG ODN, 
Coley Pharmaceutical Group). Cell culture supernatants were collected to measure the 
concentrations of IL-12p40 by ELISA (BD Biosciences) and the concentrations TNF and IL-6 
by bioassay (Roger et al., 2001). Splenocytes (5 x 105 cells in 200 µl) were seeded in 96-well 
plates coated with 1 µg/ml anti-CD3 and anti-CD28 antibodies (BD Biosciences) or stimulated 
with 2.5 µg/ml concanavalin A (Con A, Sigma-Aldrich) in the presence or the absence of 
dexamethasone. IL-2 in cell culture supernatants collected after 24 h was measured by ELISA 
(BD Biosciences). 
Germ cell and Sertoli cell specific knockout mice 
Gilz(lox) and Vasa-Cre (Mvh-Cre) mice were kindly provided by D.H. Castrillon, and were 
genotyped as described (Gallardo et al 2007). To achieve selective inactivation of Gilz in germ 
cells, we mated transgenic male mice expressing Cre recombinase under the control of the Mvh 
promoter with female mice carrying two floxed Gilz alleles in order to generate 50% Vasa-
Cre;Gilzfx/y and 50% Gilzfx/y male mice. These males were used to study the depletion of Gilz 
in the germline. On the other hand, Gilzfx/y males were mated with Vasa-Cre;Gilzfx/wt females in 
order to produce Vasa-Cre;Gilzfx/fx females as well as Gilzfx/fx and Vasa-Cre;Gilzfx/wt control 
littermates to assess the depletion of Gilz in the female germ cells. The genetic background of 
these mice is C57Bl/6J and SV129. 
In order to study the depletion of Gilz in the Sertoli cells, we mated Gilz lox females with Mis-
Cre (amh-cre) transgenic mice (kindly provided by F.Guillou; lecureuil et al 2002). To achieve 
selective inactivation of Gilz in Sertoli cells, we mated transgenic male mice expressing Cre 
recombinase under the control of the Amh promoter with female mice carrying two floxed Gilz 
alleles in order to generate 50% Mis-Cre;Gilzfx/y and 50% Gilzfx/y male mice. 
Sperm analysis  
Epididymal sperm count was performed with sperm extracted from the caudal epididymis and 
ductus deferens of adult (P80) male mice and was analyzed for its concentration as previously 
described (Guerif et al 2002). 
Statistical analysis 
Data were analyzed using the Student’s t test for comparison between the groups. Results are 
expressed as the mean ± SEM. A P value < 0.05 was considered as statistically significant.  
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CONTRIBUTIONS 
For this project we established many collaborations, because it would have been difficult to 
make specialized and detailed analyses in immunology, fertility or particular metabolic aspects. 
I have performed all experiments and measurements, with exception of the paraffin sections 
and the various stainings (H&E, Ki67, TUNEL, insulin, glucagon) were performed by Jean-
Christophe Stehle (Pathology Institute, UNIL). Dr. Elena Gonzalez-Rodriguez and Anne-Marie 
Mérillat developed the GILZ knockout mouse model in our group. I took care of this mouse 
line during the period of investigation. The Western blots against GILZ were performed by the 
group of Prof. David Pearce, because he had the best antibody available. I prepared and sent 
them the membranes for antibody hybridization. I prepared mouse embryonic fibroblasts from 
knockout and control animals, and Dr. Karim Nadra performed the adipogenesis differentiation 
assay. The analysis of the immune system development was performed by FACS by Dr. Anne 
Wilson. Dr. François Saller performed the blood status. Inflammasome activation and 
inflammation process analysis were performed by Dr. Virginie Pétrilli, Dr. Olaf Gross and Dr. 
Thierry Roger. The plasma glucose and insulin measurements, the high fat diet experiments 
and the echo MRI data were performed at the Mouse Metabolic Evaluation Facility (Dr. 
Frédéric Preitner). The studies involving the Sertoli and germ cell specific knockouts are done 
by Yannick Romero. Hormone measurements were done by the groups of Prof. François 
Pralong and Dr. Marc Maillard. 
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RESULTS 
Analysis of GILZ knockout mice  
In order to generate constitutive mutant mice for GILZ we performed 3 different breedings. 
The aim was to obtain y/Δ (knockout) mice, since GILZ is X-linked. In the first breeding, we 
crossed +/Δ females with y/+ males. In the second breeding, the males were y/lox and the 
females lox/Δ. In the third breeding, the males were y/+ and the females lox/Δ (figure 67). In 
all breedings, the Mendelian distribution of genotypes was observed. 
 
 
Figure 67: Offspring number values. Breeding strategy to produce control (y/+ or y/lox) and knockout (y/d) male mice. Females are 
either control (+/+, lox/+ or lox/lox) or heterozygous (d/+ or lox/d). Expected Mendelian ratio is 25%. Obtained ratio for each breeding 
is give in bold numbers. 
 
When we further bred y/Δ mice with lox/Δ or +/+ mice for a prolonged time, we never obtained 
offspring. The further analysis of these mice showed that they were sterile. Thus, it was not 
possible to obtain a Δ/Δ (knockout) female mice for the GILZ gene by standard breeding 
strategy.  
Tissue quantitative RT-PCR analysis for GILZ 
 
In order to verify whether the gene locus was inactivated, we quantified the expression of GILZ 
mRNA in kidney, heart, testis, liver, spleen, skin, brain and lung (figures 68 and 69). This 
screening confirmed that no mRNA transcript expression could be detected.  
 
 94 
 
Figure 68: GILZ quantitative real-time PCR profiles. Kidney (a), heart (b), testis (c), liver (d), spleen (e), skin (f), brain (g) and lung 
(h). Red curves correspond actin, the blue (in a) and green curves correspond to GILZ. 
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Figure 69. Knockout mice lack Tsc22d3 expression (A), Quantitative RT-PCR analysis of kidney, thymus, spleen, testis, liver, skin, 
brain, lung and heart from Tsc22d3lox/y or Tsc22d3+/y (control; gray and black columns) and Tsc22d3∆/y (ko; white columns; n = 3 per 
group; P < 0.05) determined by SYBR Green (gray) and TaqMan PCR (black columns). (B,C) Western blot analyses of kidneys from 
knockout and control mice (B) ± treated with vehicle or dexamethasone (± DEX) and (C) kidney, thymus, spleen, testis, liver, skin, 
brain, lung, heart and colon following dexamethasone stimulation. The polyclonal Tsc22d3 antibody identifies isoform 1 (15 kDa) and 
2 (30 kDa). GAPDH (35 kDa) was used as loading control; n = 2 per genotype. 
 
We have performed Western blot analysis to verify whether the GILZ protein was present in 
the knockout (figure 69B and C). We have used protein lysates from mice that were, or not, 
stimulated by dexamethasone to induce GILZ protein expression. As shown in figure 56B, in 
the controls, it was possible to detect faintly GILZ2 (30 kDa) but almost not GILZ1 (15 kDa) 
isoforms from kidney lysates from not dexamethasone-induced mice (-DEX), whereas in 
dexamethasone-stimulated mice (+DEX) the GILZ1 and GILZ2 proteins were clearly visible. 
In the knockout samples, we could not detect expression of GILZ1 nor GILZ2, even in the 
stimulated condition. Loading control was performed with anti-GAPDH (35 kDa) labelling. We 
 96 
performed this analysis on the following tissues from dexamethasone-stimulated mice: kidney, 
thymus, spleen, testis, liver, skin, brain, lung, heart and colon (figure 69C). In each tissue, we 
could observe a tissue-specific expression pattern of GILZ1 and GILZ2 isoforms. For example, 
thymus and spleen exhibited mainly GILZ1, whereas in testis, GILZ2 was detected. In 
summary, there was no detectable expression of the two GILZ isoforms in all the knockout 
samples, indicating that the GILZ protein was not present in the organs tested. 
Histopathology 
We performed histopathological analysis on kidney, thymus, spleen, testis, liver, pancreas, 
skin, lung, heart, hippocampus, cerebellum, olfactory bulb, cornea, retina, colon, bone and 
tongue in 2- and 6-month-old GILZ knockout and control mice. With exception of the testis, 
there was no major defect at the anatomical and histological levels suggesting that 
organogenesis was not disturbed in the GILZ deficient mice (figure 70).  
 
Figure 70: Histopathological analyses of control and Tsc22d3-deficient mice on hematoxylin and eosin stained paraffin sections 
(magnified 100x (scale bar = 100 µm) and 400x (scale bar = 50 µm)). Representative pictures from 6-month-old control and knockout 
mice are shown. 
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We performed more detailed heart, kidney and bone analyses. Although heart weight analyses 
indicated hypertrophy, it was not obvious from the tissue histology (figure 71). The kidneys of 
GILZ knockout mice presented no architectural or developmental defects as shown by 
histopathological analyses (performed by Dr. Samuel Rotman, Institut universitaire de 
pathologie de Lausanne; figure 72). 
 
 
Figure 71: Stereomicroscope view of heart H&E stained sections.  
 
 
Figure 72: Stereomicroscope view of kidney longitudinal (top) and midtransverse (bottom) H&E stained sections. 
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Dissections of heart and kidney were performed in mice of 6 and 12 months of age. These 
organs were subsequently weighed and the mean values are shown in figure 73. Six-month-old 
knockout mice have a significantly increased heart weight compared to controls at the same 
age. The kidney weight is not different. In 12-month-old mice, the hearts are of the same 
weight, whereas the kidneys are slightly lighter (P = 0.067) in the knockouts. 
The kidney and heart weight values were divided by the body weight or the tibia length. Using 
these ratios (indexes), no significant changes were observed. Nevertheless, these data indicate a 
tendency for heart hypertrophy (figure 73). 
 
 
Figure 73: Heart and kidney weight analysis in 6 and 12-month-old mice. Organ weight, organ weight over body weight ratio and 
organ weight over tibia length ratio for 6-month-old heart (A) and kidney (B), 12-month-old heart (C) and kidney (D). Control (black 
columns) and GILZ knockout (white columns) mice. Number of measurements is indicated. Bars represent the SEM, *P = 0.05. 
 
We also looked on the bone structure. In knockouts, the length and shape of the tibia bones 
were undistinguishable from control littermates (n = 4; figure 74). Morphology of the bone 
marrow cells is unchanged as well (cell type and number; n = 3) in the knockout mice (figure 
75). 
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Figure 74: Stereomicroscope view of the tibia bone. 
 
 
Figure 75: Microscopical pictures of H&E stained sections of bone marrow at 100x (up) and 400x (below) magnification. The 
rectangles in the top panels correspond to the location of the view at 400x magnification. 
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Metabolic parameter analyses 
Body weight measurements 
We further followed the weight gain with time in all the genotypes obtained (male y/+, y/lox 
and y/∆; and female lox/+, lox/+, lox/ and +/ mice). We have performed a body weight analysis 
where we have measured weekly the same male mice (n ≥ 8) for about ten months (figure 76). 
We could observe that the growth rate was the same from birth to the age of 6 months. From 
this moment, the knockouts were significantly lighter. 
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Figure 76. Body weight values of control (black) and knockout mice (white circles; n ≥ 8 per group; *P < 0.05; bars = SEM). 
 
We used Echo-MRI technology to measure the fat, lean and fluid body content of 2.5- and 15-
month-old mice (table II). We could observe that the values were the same for controls and 
knockouts in the younger cohort. In the 15-month-old mice, we could observe a significantly 
lower body weight and fat content in the knockouts. The other parameters (body length, lean 
and fluids) were not changed. 
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Plasma insulin and glucose concentrations 
Plasma insulin and glucose were measured under standard, fasting and refed conditions (table 
III). Under standard condition, insulin is significantly higher in the knockouts. Glucose level is 
unchanged. In fasted and refed conditions, there were no significant differences. 
 
 
 
We performed glucose (GTT) and insulin tolerance tests (ITT; figure 77A and B). In these 
experiments, plasma glucose is measured following intraperitoneal administration of glucose or 
insulin. Both groups responded equally to these tests, suggesting no major dysfunction of 
glucose or insulin regulation, despite that the plasma insulin concentration is elevated in 
knockout mice under normal feeding condition (table III). 
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Figure 77. Glucose and insulin sensitivity. (A), glucose and (B) insulin tolerance tests; plasma glucose concentration was measured 30 
min. before and during 120 min. following intraperitoneal administration of 1.5 mg/g glucose (A)  or 0.8 mU/g insulin (B; n ≥ 6 per 
group; bars = SEM).  
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Since insulin is linked to glucagon, we decided to stain pancreas sections for insulin and 
glucagon (figure 78A). We quantified the number of α cells (secreting glucagon) in Langerhans 
islets. The ratio of α cells/total cells is elevated in knockouts compared to controls (figure 
78B). The plasma levels of glucagon under standard conditions are not changed (figure 78C).  
 
 
Figure 78. Glucagon secretion. (A), Glucagon (brown, α  cells) and insulin (rose, β  cells) expression in pancreatic islets of Langerhans 
from control (left) and knockout (right) mice. (n = 3 mice per group; scale bar = 50 µm). (B), Ratio of glucagon-positive Langerhans 
cells (N = 15-18 images, n = 3 mice per group) in control (black) and knockout mice (white columns; **P < 0.001; bar = SEM). (C), 
Plasma glucagon by ELISA was measured under standard condition in 4-month-old mice (n ≥ 8 mice per group; bar = SEM). 
 
Adipogenesis and high fat diet experiment 
We investigated adipogenesis by differentiating mouse embryonic fibroblasts (MEFs) into 
adipocytes. As shown in figure 79A and B, in both groups, adipocytes developed when 
differentiation medium was applied, as revealed by the Oil red O staining. The number and the 
shape of the adipocytes were not changed. In parallel, at the mRNA level, we measured by 
qRT-PCR the expression of GILZ, PPARγ2 and fatty acid binding protein 4 (FABP4) from 
cells that were ± stimulated with differentiation medium (figure 79C). 
 
Figure 79. Adipocyte differentiation. (A, B) Two days after confluence, MEF cells were ± induced to differentiate into adipocytes (ND, 
not differentiated; D, differentiated MEFs). Cells from control (ctrl) and knockout (ko) mice were stained with Oil-Red O at 8 days 
post-induction. (A), Overview and (B), higher magnification on Oil-Red O-stained cells from control (ctrl) and knockout (ko) mice 
exposed (D, differentiated) and not exposed to adipogenic medium (ND, not differentiated). Note that there is no obvious difference 
between the two groups. (C), Quantitative RT-PCR of GILZ, PPARγ2 and FABP4 from non-differentiated (ND) and differentiated (D) 
MEF cells from control and knockout mice. Experiments were performed in triplicate; *P < 0.05, ***P < 0.001).  
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Figure 80. Body weight analysis, plasma insulin measurements and liver histology from chow and high fat diet fed (HFD) mice. (A), 
Body weight values following chow and high fat diets. (B), Plasma insulin (ng/ml) measurements in chow and HFD mice under fed, 
fasted and refed conditions. Control mice (Chow in black; HFD in blue) and knockout mice (chow in white; HFD in red; n ≥ 11 per 
group; bars = SEM). (C), Liver H&E stained sections following 18 weeks of chow and HFD fed control and knockout mice (n = 3; scale 
bar = 100 µm). 
 
We challenged our mice by feeding them with high fat diet for 18 weeks (starting at 6 weeks of 
age). We also compared the results with control and knockout groups fed with chow (standard 
diet). The figure 80A shows the results obtained. Under chow diet the knockout and control 
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mice had the same growth rate, whereas under high fat diet, the knockout group gained less 
weight than the control (about 8% less body weight, P = 0.11 at week 17 of the experiment). 
We measured plasma insulin levels in fed, fasted and refed conditions (figure 80B). As 
expected, insulin concentration is higher in knockouts under normal feeding conditions. In the 
fasting situation, knockout mice had lower (but not significant) insulin levels. When the mice 
were refed, the levels were not different between the groups, in chow and HFD. 
Sodium and water handling  
Under standard, sodium- or water-deprived conditions, we have analyzed the blood and urine 
concentrations of Na+ and K+, osmolarity and plasma aldosterone (table V). In general, no 
major changes could be measured. Plasma K+ is significantly higher in the knockout mice 
under standard condition. Following 10-day sodium-deprived diet, the GILZ-deficient mice had 
significantly increased plasma Na+ and decreased K+ concentrations. The plasma aldosterone 
levels are not different between the genotypes under standard and sodium-deprived diets. The 
knockout mice responded like controls to the sodium-deprived diet, the body weight, food and 
water intakes were the same (figure 81). The 23-hour water deprivation had no effect on our 
measurements. The urinary data are not modified under any condition. 
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Figure 81. Physiological parameters upon salt-deprived diet. Six-month-old control and knockout mice were analyzed with respect for 
body weight (A), food (B) and water (C) intake before and following 12 consecutive days of sodium-deprived diet (n ≥  7). 
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Molecular analysis of potentially GILZ target-dependent genes 
We investigated by real-time qPCR the levels of mRNA transcripts expressed of several genes 
that might regulate or be regulated by GILZ in various tissues. 
 
Figure 82: Real-time qPCR results for PPARγ2, PPARγ , KLF5, KLF15, αENaC, TSC22D1, adiponectin, aP2, GR and AR. Data 
correspond to the mean of relative mRNA transcript expression (in %). Control (black columns) and GILZ knockout (white columns) 
mice. For each group n ≥ 3 animals. Bars represent the SEM, *P < 0.05 and **P < 0.01. 
 
The results of these analyses are given by gene (figure 82) or by tissue (figure 83). The figure 
82 shows the results by genes and figure 83 by tissues analysed. Testis of knockout mice was 
the organ that shows the majority of unbalanced gene expression. Indeed, PPARγ, PPARγ2, GR 
and KLF5 mRNA transcripts were less abundant, whereas AR and KLF15 were more 
expressed in knockout male gonads. In the liver, less expression of PPARγ2 was measured. 
 
Figure 83: Real-time qPCR results for testis, kidney and fat tissues. Data corresponds to the mean of relative mRNA transcript 
expression (in %). Control (black columns) and GILZ knockout (white columns) mice. For each group n ≥ 3 animals. Bars represent 
the SEM, *P < 0.05 and **P < 0.01. 
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At the protein level, we tested the expression of the glucocorticoid receptor (GR) in testis 
lysates from mice ± stimulated (or not) by dexamethasone (n = 2). These results indicated that 
dexamethasone treatment induced an increase of GR that was not different in the knockout 
mice. Quantification of the protein expression did not confirm that GR protein was less 
abundant in the knockout testis than in the controls, as expected from the qPCR experiments 
(figure 84). 
 
 
Figure 84: Western blot analysis for GR in testis protein lysates. GR antibody (GRα  95 kDa; GRβ  90 kDa) used against control (ctrl) 
and knockout (ko) testis lysates from dexamethasone-stimulated (+dex) or not (-dex) mice. Actin (42 kDa) antibody is used as loading 
control. 
 
Immune development and inflammation 
Thymus structure and immune cell development 
The architecture of the thymus was analyzed in 3-month-old mice by histology (figure 85). At 
100x magnification (upper pictures), it is possible to distinguish clearly the border between the 
cortex and the medulla regions in both genotypes. The cell population does not seem altered or 
changed. At higher magnification (400x, lower pictures), no obvious phenotype could be 
detected. 
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Figure 85. Thymus histology. H&E staining of thymic paraffin sections from 3-month-old mice. Control (ctrl) and knockout (ko) 
samples at 10x (up; scale bar = 100 µm) and 40x (down; scale bar = 50 µm). 
 
We have measured the weight of the thymus at different ages: 10, 20 days and between 2 and 
4.5 months (figure 86A). At the age of 10 and 20 days, no differences could be observed, 
whereas the thymus from knockout mice between 2 and 4.5 months was significantly lighter. 
We then measured the amount of cells that compose the thymus, spleen and lymph node by 
flow cytometry (figure 86B to D). For the thymus, we examined the following subsets: DN1 to 
4, ISP, γδT, DP, CD8 and CD4 cells. There were no significant differences between the groups 
excepted for the DN3 (less cells) and DN4 (more cells) subsets (figure 86B). In the spleen, the 
subsets analyzed were: B, CD8, CD4, RBC, Ebs, Mega, Gran and Mac cells. Only the amount 
of erythroblast was significantly increased in the knockouts (figure 86C). In the lymph node, 
we measured the number of CD8, CD4 and B cells, and no changes could be observed (figure 
86D). Together, these data indicated no major impairment of the immune system development.  
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Figure 86. Thymus size and flow cytometric analyses of thymus, spleen and lymph nodes from 10-week-old male control (black) and 
knockout (white columns) mice. (A), The size of the thymus in 10-, 20-day-old and 2-4.5-month-old mice (n ≥  7). (B), Absolute cell 
numbers (x106) for the following thymocyte subsets: DN1 (CD117+CD44+CD25-), DN2 (CD117+CD44+CD25+), DN3 (CD117-CD44-
CD25+), DN4 (CD117-CD44-CD25-), ISP (CD4-CD8+TCRβ -), γδT cells, DP (double positive, CD4+CD8+), CD8 SP (single positive, CD4-
CD8+), CD4 SP (CD4-CD8+). (C), Absolute cell numbers (x106) for the following splenocyte subsets: B cells, CD8 SP, CD4 SP, RBC 
(erythrocytes) and EBs (Erythroblasts, Ter119+CD71+), Mega (Megakaryocytes), Gran (Granulocytes), Mac (Macrophages). (D), 
Absolute cell numbers (x106) for the following lymph node subsets: CD8 SP and CD4 SP cells, B cells. Black bars: control; white bars: 
knockout mice, data represent average ± SEM. At least 3 mice per group were analyzed. *P < 0.05 when compared to control. 
 
We have analyzed the cell cycle, the Bcl2 and TCRβ+ cells in various thymus subsets (figure 
87). We could not observe any significant changes in all the subsets tested. 
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Figure 87. Thymus cell cycle, Bcl2 and TCRβ+ analysis. (A) Percentage of cells in the S+G2/M. (B) Cell count for Bcl2 in the various 
thymus subsets. (C) TCRβ+ cells analyzed in DN3 and DN4 subsets. Black lines or bars: control; dotted lines or white bars: knockout 
mice, data represent average ± SEM. At least 3 mice per group were analyzed. 
 
Inflammatory response experiments 
To test functionally the immune system, we have put cells (macrophages or splenocytes) in 
culture and stimulated them with inflammatory agents and measured the cytokine secretion. We 
also applied dexamethasone, as anti-inflammatory agent, in the medium and observed if there 
were genotype-dependent effects. 
In the first experiment, we analyzed the role of GILZ in peritoneal macrophages. In all 
stimulatory conditions tested, we found a tendency for increased RANTES secretion in 
knockouts, although the overall response was not strikingly different (figure 88).  
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Figure 88 Analysis of peritoneal and bone marrow-derived macrophages cytokine secretion. (A-C), ELISA for TNF, RANTES, MIP-2 
and IL-6 following (A), stimulation of peritoneal macrophages for 6 hours with LPS supplemented by MSU, Nig, ATP, R837 or with 
Pam3, zymo, pIC, TNF or PGN alone. (B), stimulation of peritoneal macrophages for 24 hours with LPS, zymo, R837, pIC, TNF or 
Pam3 and (C), stimulation of bone marrow-derived macrophages with zymo, R837, PGN and LPS with or without dexamethsasone 
(0.2 µM). Data is shown as mean values of duplicated stimulations ± SEM from 3 mice per group. 
 
In a second series of experiments performed on bone marrow-derived dendritic cells (BMDCs) 
upon treatment with various stimuli (LPS, MSU, ATP, Candida and CpG), we tested the 
inflammasome activation and found overall no difference in the secretion of IL-1β, TNF or 
RANTES between the knockout and the control littermates. Dexamethasone treatment led to an 
equally reduced cytokine production that was not altered in the absence of Tsc22d3 (figure 89). 
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Figure 89. Normal cytokine production by Tsc22d3-deficient bone marrow-derived cells. (A), To test inflammasome activation, cells 
were primed with 10 ng/ml of ultra-pure LPS for the indicated periods prior to inflammasome activation by 100 ng/ml of MSU (for 5h) 
or 5 mM of ATP (for 1h). Inflammasome activation was quantified by measuring the amount of IL-1β  in cell-free supernatants. An 
influence of dexamethasone on inflammasome activation was addressed by adding dexamethasone to the cells at three different time 
points prior to ATP or MSU stimulation as indicated. (B, C) cells as in (A) were pretreated for the indicated periods with 
dexamethasone and stimulated for 6h with 5x106 heat inactivated Candida cells per ml or 1µM CpG. TNF and RANTES secretion into 
the medium was measured by ELISA. Data is shown as mean values of triplet stimulations ± SEM and representative for three 
independent experiments with a total of 6 control and 6 knockout mice. 
 
Furthermore, we tested whether Tsc22d3 was implicated in a sepsis model and analysed 
cytokine secretion of IL-6, IL-12, TNF- and IL-2 in bone marrow-derived macrophages upon 
various stimuli (figure 89). No significant difference could be observed in knockout mice, that 
responded equally in a dose-dependent manner to dexamethasone administration (figure 89). In 
addition, experiments performed on splenocytes stimulated by anti-CD3 plus anti-CD28 or 
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concanavalin A, exibited a dexamethasone dose-dependent response independent on the 
absence of presence of Tsc22d3 (figure 90). Altogether, our experiments did not reveal a 
crucial involvement of Tsc22d3 in immunology or inflammatory responses upon various 
stimuli. 
 
 
Figure 90. Tsc22d3-deficient bone marrow-derived macrophages (BMDMs) are not particularly susceptible to the immunosuppressive 
effects of dexamethasone. Control and knockout (A-C) and splenocytes (D-E) were incubated with or without (med) increasing 
concentrations of dexamethasone (DEX, 10-10-10-7 M) and stimulated with LPS, Pam3CSK4 (Pam3), Escherichia coli (J5), CpG 
oligodeoxynucleotide (CpG), anti-CD3 plus anti-CD28 or concanavalin A., IL-6 (A), IL-12p40 (B), TNF (C) and IL-2 concentrations 
were quantified in cell-culture supernatants collected 4 h (TNF) or 18 h (IL-6, IL-12p40, IL-2) after stimulation. Cytokine 
concentrations in cells stimulated without dexamethasone were set at 1 for normalization. Data are means ± SD of triplicates samples 
from one experiment comprising two mice per experimental condition and are representative of two experiments. 
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Blood parameters 
Mice were given to Dr. François Saller (Service and Central Laboratory of Hematology, Centre 
Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland) to perform blood 
composition analysis. We could observe a significant decrease in the number of neutrophils and 
platelets, whereas the lymphocyte number was increased (figure 91). Leukocytes and red blood 
cells remain unchanged. The monocytes number was decreased, but this difference did not 
reach statistical significance. 
 
 
Figure 91: Blood cell count. Values for leukocytes, neutrophils, lymphocytes, monocytes, platelets and red blood cells (erythroblasts). 
Control (black column) and GILZ knockout (white column) mice (n = 9). Bars represent the SEM, *P < 0.05. 
 
Gonad development and fertility 
The structure on the testis is effected in the GILZ-deficient mice 
As mentioned before, male knockout mice were unfertile. In adult animals, testes were 
drastically reduced in size and they were about 80% lighter (figure 92A). Histology revealed 
important structural changes (figure 92B). Indeed, the seminiferous tubules of knockout mice 
were disrupted and there was an augmented proportion of interstitial Leydig cells (arrow). 
Figure 92C, shows a view from immunostained seminiferous tubules using a CCCTC-binding 
factor (CTCF) antibody, counterstained with hematoxylin for nuclei (blue). This CTCF 
antibody labelled Sertoli cells (figure 92C, black-filled arrowhead). We could observe the 
presence of elongated spermatids in the controls (figure 92C, white arrowhead), whereas the 
knockout tubules lacked developing germ cells, where only few residual Sertoli cells remained.  
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Figure 92. Tsc22d3 knockout males are sterile. (A), Representative pictures from control (left) and knockout (right) adult testes. Note 
the significant decrease in testicular mass in adult knockout. (B, C), H&E-stained paraffin sections from control (ctrl) and knockout 
(ko) testes reveal increased spermatogenic cell apoptosis, absence of mature sperms and hyperproliferation of Leydig cells (black 
arrow). (C), Immunohistochemistry of Sertoli cells (rabbit anti-CTCF antibody; black arrowhead) and counterstaining with 
hematoxylin reveals blue nuclei. Note the presence of elongated spermatids (white arrowhead) in the control testis, which is absent in 
the knockout. 
 
We quantified the number of cells per tubule. The knockout tubules have a lower cell 
population; the ratio is given in figure 93 (left graph). To discriminate whether this difference 
originated from a lower cell proliferation or an increased cell death, we stained sections with 
Ki-67 and TUNEL labelling, respectively. We counted positive cells (for Ki-67 and TUNEL 
markers) and normalized this value to the total number of cell per tubule for each genotype. 
The ratio of proliferative cells (Ki-67) was the same in both groups, whereas the in the 
knockout tubules the proportional number of apoptotic cells (TUNEL) was significantly 
increased (figure 93, right graph). These data were consistent with the anti-apoptotic role 
proposed for GILZ. 
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Figure 93. Total number of cells per seminiferous tubule (N ≥  20 tubules per group) in control and knockout mice (left). Ratio of Ki-67 
positive cells divided by total cell number, middle) and ratio of TUNEL positive cells divided by total cell number per seminiferous 
tubule, N = 18 tubules, right). 
 
Hormonal measurements and GILZ-target genes analyses 
We analysed the plasma levels of several hormones, which are crucial for sexual development 
and its maintenance (figure 94). Corticosterone levels were significantly lower in the 
knockouts. FSH and testosterone concentrations were significantly increased. LH levels were 
not changed. 
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Figure 94. Corticosterone (cort), follicle stimulating (FSH), luteinizing hormone (LH) and testosterone (testo) hormone levels in plasma 
[ng/mL] from control and knockout males (n ≥  10 animals per group). 
 
Several mRNA transcripts were abnormally expressed in testis: PPARγ2, PPARγ, Tsc22d1, 
GR, AR, KLF5 and KLF15. The mRNA level of PPARγ2 was significantly lower in knockouts 
as shown by RT-PCR and qRT-PCR (figure 95A and B). We also analyzed the protein level in 
testis lysates (figure 95C). In this experiment, it was only possible to detect the 56 kDa 
PPARγ2 band in the control samples. This was not surprising, because the expression of 
mRNA transcripts was low in the knockout testes. 
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Figure 95. Analysis of PPARγ2 expression in testis. (A) Semi-quantitative RT-PCR for PPARγ2. As control, GAPDH mRNA was used. 
(B) Quantitative RT-PCR for PPARγ2 normalized to GAPDH expression. (C) Western blot analysis using a PPARγ2 antibody on testis 
lysates. The arrow indicates the PPARγ2 protein (56 kDa). As loading control β−actin was used. Black bars: control; white bars: 
knockout mice. Data represent average ± SEM. Statistical analysis was performed using the unpaired Student's t-test, where **P < 
0.01 when compared to control. 
 
Sertoli cell and germ cell-specific GILZ knockout mice 
In collaboration with Yannick Romero (Department of Genetic Medicine and Development, 
University of Geneva, Medical School, Switzerland), we generated mice bearing the gilz 
deletion specifically in Sertoli cells or in germ cells. 
 
 
Figure 96: Sertoli cell specific knockout. A, Pictures of a whole testis (upper panel) and histological sections (lower panel) from control 
and GILZ::Mis-Cre knockout littermates (80 days-old mice). The mouse body (B), epididymis (C) and testis (D) weights are given. E, 
Epididymal sperm count. Control (black column, n = 9) and GILZ::Mis-Cre knockout (white column, n = 4) mice. Bars represent the 
SEM. 
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Sertoli cell-specific GILZ knockout (Mis-Cre ko (Lecureuil et al., 2002)) mice displayed 
normal testis size and histology at 80 days of age (figure 96A). The mouse body weight, 
epididymis and testis weights were comparable to the control mice (figure 96B-D). The sperm 
count was also similar to the controls (figure 96E). 
Germ cell-specific GILZ knockout (Vasa-Cre ko (Gallardo et al., 2007)) mice displayed 
reduced testis size and the overall organization of seminiferous tubules was similar to the 
constitutive knockout at 80 days of age (figure 97A). The mouse body weight was unchanged, 
whereas epididymis and testis weights were significantly lower than the controls (figure 97B-
D). The sperm count was near zero in the Vasa-Cre ko mice (figure 97E). 
 
 
Figure 97: Germ cell specific knockout. A, Pictures of a whole testis (upper panel) and histological sections (lower panel) from control 
and GILZ::Vasa-Cre knockout littermates (80 days-old mice). The mouse body (B), epididymis (C) and testis (D) weights are given. E, 
Epididymal sperm count. Control (black column, n = 4) and GILZ::Vasa-Cre knockout (white column, n = 3) mice. Bars represent the 
SEM, ***P < 0.001. 
 
Skin analysis 
To investigate whether GILZ played a role in the skin we performed barrier function and 
wound healing experiments. Histologically, the GILZ knockout skin presented no defect (figure 
98). The overall structure was preserved (width of the epidermis, no sign of inflammation 
detected). Obviously, the amount of hair follicles was normal. 
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Figure 98: H&E stained skin sections at 100x magnification. 
 
Transepidermal water loss (TEWL) measurements show significantly (P < 0.001) increased 
outwards water loss through the knockout skin compared to controls (figure 99). 
 
 
Figure 99: Transepidermal water loss (TEWL) measurements. Control (black columns) and GILZ knockout (white columns) mice. For 
each group n ≥ 5 animals (with at least 3 measurements per mouse). Bars represent the SEM, ***P < 0.001. 
 
To investigate further this skin barrier phenotype, I performed the toluidine blue skin 
permeation assay with newborn mice (P0). This allowed to control whether there was an 
inwards barrier defect as well. Figure 100 showed staining of the head and forelimb of several 
mice after the toluidine blue treatment. The staining with toluidine of the knockout skin was 
not stronger than for the control littermates. This suggested, that at P0, there was no apparent 
barrier defect. 
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Figure 100: Toluidine blue skin permeability assay. Picture of head and forelimb of P0 mice after immersion in toluidine blue solution. 
 
We analyzed the wound closure rate in control and GILZ-deficient mice. The knockout mice 
presented no delay nor accelerated wound healing (figure 101). 
 
 
Figure 101: Wound healing kinetics in GILZ-deficient mice. Control (black dots) and knockout (grey dots) mice closure rate after 
wounding. For each group n ≥ 5 animals (means of 2 wounds per mouse). Bars represent the SEM. 
 
The architecture of the healing skin, and here more specifically, the hyperproliferative 
epithelium, was similar in both groups as seen in figure 102. The analysis of the 
morphometrical parameters (the hyperproliferative epithelium surface and the wound width) 
indicated no defects (figure 103). 
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Figure 102: H&E stained skin sections at 100x magnification five days after wounding. Representative pictures of the 
hyperproliferative epithelium of control (ctrl) and GILZ knockout (ko) mice. 
 
 
Figure 103: Morphometrical analysis of the skin. A, Quantification of hyperproliferative epithelium surface. B, Wound width. Control 
(black column) and GILZ knockout (white column) mice. Bars represent the SEM. 
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DISCUSSION 
The GILZ knockout mouse model 
GILZ and its homolog genes have been studied for more than ten years in different species and 
cell types. These in vitro investigations showed that GILZ played a role in immunological and 
inflammation processes, but also in bone or adipose tissue formation. It has also been suggested 
that GILZ was a regulator of the ENaC-mediated renal sodium reabsorption via the ERK 
pathway. 
Our group generated the first constitutive knockout mice for the gilz gene. These mutant mice 
were viable. Molecular analysis of this mouse model revealed that the Cre-mediated 
recombination was 100% in the knockout mice. Our qPCR analysis data revealed only residual 
GILZ mRNA expression in heart, lung and skin tissue. We performed also Western blot 
analysis to detect the levels of GILZ protein in several tissues (antibody from kindly provided 
by Dr. David Pearce, UCSF, USA). This allowed to confirm the absence of GILZ protein in all 
the tissues tested. 
Water and sodium handling 
Several genes, like Sgk1 and Nedd4-2, were known to regulate the degradation of ENaC 
(Soundararajan et al., 2010). As already mentioned in the first part of this thesis, mutations in 
ENaC or its regulator can result in more or less severe renal phenotypes. We have performed 
electrolyte and aldosterone analysis in GILZ-deficient mice. We found small changes in plasma 
electrolyte concentration without dramatic physiological effects. These mice adapted normally 
to 10-day low sodium diet or 23-hour water deprivation. In conclusion, the expected function 
on the renal salt and water homeostasis is still under debate, or at least, GILZ is not limiting for 
this regulation. 
Immunity in GILZ knockout mice 
The activation of cytokine expression and secretion by cells of the innate immune system is 
essential for early host defence against infections and for subsequent development of adaptive 
immunity, as well as for the expression of many inflammatory diseases. Endogenous 
glucocorticoids can modulate the expression of pro- and anti-inflammatory genes, and 
therefore, they are widely used as anti-inflammatory and immunosuppressive agents (Baschant 
and Tuckermann; Herold et al., 2006). Following dexamethasone administration, Gilz 
expression was highly up-regulated, suggesting a potential role of GILZ in the immune system 
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and inflammation processes (D'Adamio et al., 1997). GILZ has been extensively studied in 
vitro, thus we investigated the immune system development and the inflammatory response 
upon various stimulations. 
Immune development and function were also assessed in our GILZ-deficient mice. There, no 
dramatic abnormalities were found. After puberty, the thymus weight was decreased in the 
knockouts, but the general architecture was preserved. This suggests that this effect might be 
due to the high concentration of plasma testosterone. Indeed, androgens influence considerably 
the size and composition of the thymus. Chemical or surgical castration results in thymic 
enlargement, whereas androgen replacement reverses these effects (Olsen et al., 1998; Hince et 
al., 2008; Lynch et al., 2009). The majority of the subsets analyzed from the thymus, spleen 
and lymph node were not affected in cell number. Exception was found in the thymus with 
significantly less double-negative (DN)3 and more DN4 thymocytes. Here again, this could be 
an indirect effect due to the unbalanced testosterone concentration. Castrated rats presented an 
increased proliferation of DN3 cells (Leposavic and Perisic, 2008). In the spleen, we found 
more erythroblasts in knockouts. Erythropoiesis has been found to be increased by testosterone 
treatment in human (Coviello et al., 2008). Thus, we propose that the increased spleen 
erythroblast value in GILZ knockout mice may be due to the high testosterone concentration. 
Of interest, the DP thymocyte population, which is known to be glucocorticoid-senstitive, is the 
same in the two groups (Ashwell et al., 2000). 
Functionally, cytokine secretion from macrophages or splenocytes was normal and anti-
inflammatory response to dexamethasone treatment was preserved. We found significantly 
lower number of neutrophils and platelets, but higher number lymphocytes in the blood (figure 
72). This indicates an unbalanced haematopoietic stem cell development or regulation in the 
knockout. 
In summary and unexpectedly, in immunity, less difference as expected could be observed 
between the mutant mice and the control littermates. Together, these data indicate that solely 
GILZ was not required for normal immune development and response. Indeed, there was 
probably functional redundancy; there were probably other partners that could compensate the 
lack of GILZ. 
Fat metabolism is mildly altered in GILZ-deficient mice 
It has been demonstrated that GILZ could inhibit adipogenesis of mesenchymal stem cells by 
binding to a tandem repeat of C/EBP binding sites in the PPARγ2 promoter (Shi et al., 2003). 
This suggests that GILZ might play a developmental role. Under standard conditions, GILZ-
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deficient mice did not gain weight like control mice, this difference was significant from 6 
months onwards. The body fat composition is significantly lower in 15-month-old knockout 
mice. This indicates that this metabolic defect is linked to aging, or at least evidenced with 
time. In 3 to 4-month-old mice, the expression of several adipogenic markers was unchanged at 
the mRNA level. GILZ deficiency influenced the levels of plasma insulin, thus knockout mice 
had increased concentrations under standard conditions. Glucose levels were less affected, but 
were generally decreased (not significantly) in all our experiments. Glucose and insulin 
tolerance tests did not reveal differences. To uncover the mechanisms by which the GILZ-
deficient mice are protected against weight intake, we have put them under a high fat diet 
(HFD) for about 15 weeks. Echo MRI body composition analysis indicated that the fat content 
is lower in knockout mice. Liver histology showed that GILZ-deficient mice do not develop 
hepatic steatosis. Although the analysis is not complete yet, it is clear that knockout mice are 
protected against HFD-induced obesity. 
GILZ knockout males are sterile 
The first and most striking phenotype observed was the sterility of y/Δ males. This was 
observed while the knockout males were used for breeding. Whole body histology has been 
performed to uncover developmental or pathophysiological defects. All tissues analyzed 
presented normal histology with the exception of testis characterized by severe dysplasia 
evident as early as 20 days after birth. We expected that higher corticosterone levels would 
compensate the lack of GILZ, but this opposite result might be due an inappropriate feedback 
loop mechanism. Or in the testis, the action of GCs is mediated via GILZ. Circulating 
testosterone and FSH levels are higher, whereas LH is not significantly modified. Histology of 
knockout testes revealed incorrect maintenance and development of germ cells. FSH and 
androgen act to stimulate and maintain spermatogenesis. In order to characterize the specific 
effects of FSH, hypogonadal (hpg) mice crossed with either Sertoli cell-specific 
(hpg.SCARKO) or total androgen receptor knockout mice (hpg.ARKO), then supplemented 
with recombinant FSH. This study revealed that FSH, independently of androgens, stimulated 
spermatogenesis during the initial stages to optimise germ cell number. FSH also indirectly 
stimulated androgen production by the Leydig cells, that induces proliferation and/or 
differentiation from precursor stem cells (O'Shaughnessy et al.). This could partly explain the 
increased Leydig cell population and higher plasma testosterone level. It was also found that 
the androgen receptor mRNA level in the testis was higher. These data suggested androgen 
insensitivity. It is not well established whether glucocorticoids could affect AR expression or if 
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GILZ is involved in its regulation, but crosstalk between hormone receptors cannot be excluded 
(Yen et al., 1997).  
Interestingly, we found significantly lower expression of Pparγ2 mRNA and protein. It has 
been reported that PPARγ is expressed in Sertoli cells and in spermatocytes (Froment et al., 
2006). PPARs might play a role in reproductive tissues, but their exact function is still under 
debate (Froment et al., 2006; Huang, 2008).  
It is not known, whether the mutation also affects the origin of the hypothalamic-pituitary-
gonadal (HPG) axis. GILZ is present in the chicken pituitary and regulates several hormones 
(Ellestad et al., 2009); this may also explain the increased levels of FSH in knockout mice. 
Stress effects on reproduction result from abnormal regulation of the hypothalamic-pituitary-
adrenal (HPA) and the HPG axes (Kirby et al., 2009). After immobilisation stress in the rat, 
there is an increase in circulating GCs followed by a drop of the testosterone level. This is 
further associated with an enhanced testicular germ cell apoptosis (Yazawa et al., 1999). In our 
GILZ knockout mice, we measured a 20% decrease of plasma corticosterone concentration, but 
we also find an increased apoptosis rate. It has been reported that a potent GR agonist 
(mifepristone or RU486) could inhibit the dexamethasone-induced germ cell apoptosis 
(Yazawa et al., 2000; Sasagawa et al., 2001). Several studies involving bunched, the drosophila 
TSC22 homolog, showed that this gene is important for cellular growth, proliferation and 
survival (Dobens et al., 1997; Gupta et al., 2003; Levine et al., 2007; Wu et al., 2008). In yeast, 
an antiapoptotic motif has been described for this gene (Khoury et al., 2008). This sequence is 
present in the GILZ nucleotide sequence. Hence, the lack of GILZ protein could promote 
apoptosis. In this study, we only investigated the male phenotype. In collaboration with Dr. 
Serge Nef, in Geneva, we are currently generating female knockout mice using the Vasa-Cre 
mice (Gallardo et al., 2007). This germ cell-specific promoter is leaky in the females, meaning 
that the expression of the targeted gene is partial during a certain time. This allows the 
generation of knockout females. There are strong indications that the female fertility might be 
impaired as well. It has been shown that GILZ contains an estrogen response element in the 
promoter region (Tynan et al., 2004). It is regulated during pregnancy and might play a role in 
facilitating the detachment of the fetus and the placenta from the implantation site (Zhao et al., 
2006). 
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Summary of the findings 
Field of interest Phenotype / observations 
Whole body histopathology No obvious phenotype at birth until two weeks of age, progressive testis 
atrophy. The development and morphology of all other organs tested is 
not different from controls. Heart index increased in adults, kidney index 
unchanged. 
Sodium and water handling Upon normal salt diet, plasma potassium concentration increased, 
sodium concentration unchanged. Upon sodium-deprived diet, plasma 
potassium concentration decreased, sodium concentration increased. 
Aldosterone concentrations are unchanged upon each condition. 
Adaptation to 23h water deprivation preserved.  
Immunity Adult thymus decreased in size. With exception of the increased number 
of erythroblast, the spleen size and cell subsets not different from 
control. The inflammatory responses in macrophages and splenocytes 
(cytokine secretion and sepsis +/- dexamethasone treatment) were not 
different from controls. Blood neutrophils and platelets were decreased, 
and lymphocytes increased. 
Fat metabolism From 6 months onwards, lower body weight and fat content. Plasma 
insulin level was elevated under standard diet conditions. Glucagon 
secreting cells were increased in Langerhans islets despite normal 
plasma glucagon levels. MEF differentiation into adipocytes was not 
different from controls. Knockout mice were protected against high fat 
diet-induced obesity. 
Fertility Knockout males were sterile. Testes were smaller and presented a severe 
dysplasia most likely due to increased apoptosis. Spermatogenesis was 
impaired and mature spermatozoa absent. Leydig cell hyperproliferation. 
Plasma corticosterone levels were lower, whereas FSH and testosterone 
were higher. Testis from Sertoli cell-specific GILZ knockout mice were 
not different from controls, whereas testis from germ cell specific GILZ 
knockout were like in the complete knockout.  
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Skin Transepidermal water loss was increased when compared to controls. 
The inwards barrier function of the newborn skin was intact as 
evidenced by toluidine blue permeation assay. 
Molecular analysis (mRNA) PPARγ2 decreased in testis and liver. 
PPARγ decreased in testis. 
KLF5 decreased in testis. 
KLF15 increased in testis. 
TSC22D1 increased in testis. 
Glucocorticoid receptor decreased in testis. 
Androgen receptor increased in testis. 
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PERSPECTIVES AND FUTURE EXPERIMENTS 
To unveil the pathophysiology related to the male sterility phenotype, it would be necessary to 
study the mechanisms in a spatio-temporal way; this can be done by cellular and molecular 
means. We will have to determine the onset of the phenotype and characterize the pathways or 
molecules that are deregulated causing sterility. This could be achieved mainly by 
immunohistochemistry and qRT-PCR analyses. Also further investigations of the Vasa-Cre 
(germ cell-specific) GILZ knockout mice would help to understand those apoptotic processes, 
induced by GILZ-deficiency in spermatogonia, that might be responsible for the sterility. By 
crossing Vasa-Cre female mice (GILZlox/+; Cre+) with Vasa-Cre negative males (GILZlox/y; 
Cre-), it is possible to obtain female GILZ knockout mice (GILZlox/lox; Cre+). It will be 
interesting to analyze the phenotype of these female knockout mice. 
 
Protection against high fat diet-induced obesity must be studied more in details. Fat and liver 
tissue analysis (mRNA expression levels of specific markers and histology). ITT and GTT 
must be performed under high fat diet. Energy expenditure analyses should also help to 
uncover certain mechanisms causing this metabolic phenotype. 
 
Since GILZ is part of the same complex with ENaC/SGK1/Nedd4-2, it would be of great 
interest to cross the GILZ knockout mice with the SGK1 mutant mice (Wulff et al., 2002) to 
observe an eventual renal phenotype.  
 
It would be interesting to make a double knockout Tsc22d3/Tsc22d1 (L. Raftery laboratory). 
This would help us to verify whether redundancy occurs in GILZ knockout mice. 
 
GILZ is expressed in neurons of the central nervous system as shown by in situ hybridization 
analyses (Yachi et al., 2007). In this study, Yachi and colleagues established a link between 
stress and GILZ. Glucocorticoids are released in response to stress stimuli (Muller et al., 2004), 
therefore cognitive experiments would allow to establish the functional activity of GILZ in the 
central nervous system and, for example concerning the stress sensibility. 
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ANNEXES 
Manuscript in preparation 
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Protocols 
Extraction of tail DNA 
 
First part: digestion 
1. Cut 3 to 5 mm of tail (at least 2 weeks old mice) 
2. Add 750 µL of a mix of Tail Buffer and Proteinase K 
3. Incubate overnight at 56°C 
During digestion, the plasma membrane and the nuclear membrane of the cells get 
disrupted. 
Second part: extraction 
4. Spin down 1 min. at Room Temperature (RT), full speed (13'000 rpm on Mirko 
20 Hettisch Zentrifugen) 
5. Mix 5 min. at RT, full speed (on eppendorf mixer 5432) 
6. Add 250 µL NaCl saturated (about 6M - The role of NaCl is to precipitate DNA and get rid 
of proteins.) 
7. Mix 5 min. at RT, full speed. The solution has to become opaque; otherwise 
more NaCl has to be added. 
8. Spin down 10 min. at RT, full speed 
9. Take 750 µL of the liquid phase, without top and pellet, and transfer it into a 
new tube 
10. Add 500 µL isopropanol (Isopropanol is used to crystallize DNA.) 
11. Mix 2 min. at RT, full speed 
12. Spin down 1 min. at RT, full speed 
13. Discard the supernatant 
14. Wash the pellet with 1.5 mL EtOH 70% (EtOH crystallizes and precipitates DNA.) 
15. Spin down 1 min. at RT, full speed 
16. Discard the supernatant taking great care of the pellet 
17. Let dry the tubes upside down for 5 min. at RT 
18. Add 120 µL TE (see annex) to re-suspend DNA 
19. Incubate 2 hours at 37°C with shaking (eppendorf mixer, 400 rpm) 
 
Genomic DNA can be stored at -20°C. 
 
Tail Buffer + Proteinase K Mix (per tail): 
712.5 µL Tail Buffer 
37.5 µL Proteinase K 
 
Proteinase K (10 mg/mL) is a serine protease that digests proteins and removes contamination 
from preparations of nucleic acids. Addition of proteinase K to these preparations rapidly 
inactivates nucleases that might  otherwise degrade the DNA during purification. The enzyme 
is active in the presence of chemicals that denature proteins (SDS), chelating agents (EDTA), 
and other reagents and inhibitors. 
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Tail Buffer 
Compounds: Role(s) of compounds: 
1/20 Tris-HCl (Tris hydrochloride) 1M pH8 pH regulator 
1/50 NaCl 5M 
1/5 EDTA (ethylenediaminetetraacetic 
acid) 0.5M 
Limitation of proteins hydrolysis in cell extracts and inhibition of polymerases activity, thus 
purifying nucleic acids. 
1/20 SDS (sodium dodecyl sulfate) 20% Denaturation of proteins by deleting non-covalent 
bindings. Conferring a negative global charge on the proteins. 
17/25 ddH2O 
 
TE Buffer 
Compounds: Role(s) of compounds: 
Tris-HCl See Tail Buffer 
EDTA See Tail Buffer 
TE buffer protects DNA from degradation, used for storage of nucleic acids. 
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Isolation of DNA via NaOH digestion 
 
1. Cut a 2-3 mm piece of tail 
2. Add 600 µL NaOH 50mM (sodium hydroxide breaks chemical bonds keeping the tissues 
intact - digestion). 
3. Incubate at 95°C for 30 min. agitating (500 rpm). Shake well once or twice 
during this time. 
4. Let cool down and neutralize with 100 µL Tris-HCl 1M pH8 (Tris-HCl keeps pH stable). 
5. Spin down 5 min. at RT, full speed 
 
DNA can be stored at 4°C for a short time (otherwise store it at -20°C). 
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RNA extraction protocol 
 
The tissues or organs isolated from the organism have to be stored at -80°C or in 
liquid nitrogen for short storage. 
1. Put a steal bead into the tube containing the tissue 
2. Under the hood, add 400 µL of Trizol (Invitrogen) 
3. Put the tubes into the TissueLyser machine (Qiagen) and homogenize for 30 
sec. 
4. Under the hood, add 600 µL more of Trizol 
5. Re-homogenize for 30 sec. 
6. Spin down at 1000 g for 1 min. 
7. Collect the supernatant an transfer it into a new tube 
8. Incubate 5 min. at RT 
9. Under the hood, add 200 µL of chloroform (1/5 volume of Trizol) 
10. Shake the tubes for 15 sec. and incubate 3 min. at RT 
11. Spin down at 4°C at 12’000 g for 15 min. 
12. Transfer the colorless aqueous upper phase into a new tube 
13. Add 250 µL of isopropanol (1/4 volume of Trizol) 
14. Incubate 10 min. at RT 
15. Spin down at 4°C at 12’000 g for 10 min. 
16. Discard the supernatant 
17. Wash the pellet with 500 µL of EtOH 75% DEPC and vortex 
18. Spin down at 4°C at 7500 g for 5 min. 
19. Discard the supernatant 
20. Air-dry the pellet for 1 hour 
21. Re-suspend RNA into H2O DEPC 
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Reverse transcription protocol 
 
After RNA extraction, the concentration has to be measured with the NanoDrop. 
1. Calculate the volume of extraction to take, in order to have 1 ng of RNA: 
 
if [RNA] = x[ng / µL]⇒V = 1000/x [µL] 
 
2. Calculate the volume of H2O DEPC to add to have a volume of 10 µL 
3. Mix 1: 
Oligo(dT): 1 µL * number of samples (+ error margin) 
dNTP mix: 1 µL * number of samples (+ error margin) 
4. In new tubes, put: 
H2O DEPC according to calculation 
RNA according to calculation 
2 µL of Mix 1 
5. Incubate at 65°C for 5 min. 
6. Mix 2: 
5X First-Strand Buffer: 4 µL * number of samples (+ error margin) 
0.1M DTT: 2 µL * number of samples (+ error margin) 
at very last time: SuperScript II RT: 1 µL * # of samples (+ margin) 
7. Cool down the tubes in ice and spin down 
8. Add 7 µL of Mix 2 and mix by pipetting 
9. Incubate at 42°C for 50 min. 
10. Incubate at 70°C for 15 min. 
11. Dilute into 80 µL of H2O DEPC 
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Protein extraction for Western blot analysis 
 
Thiocyanate extraction: for keratins removal, extraction in thiocyanate buffer (1M NaSCN, 
50mM Hepes, 10mM EDTA, 0.3M orthophenantolin, 0.1% isopropanol, 20µg/ml PMSF, 
pH=6.8). 
1. Homogenate the samples in buffer, 
2. Spin @ 27000g, 30’, 0°C 
3. Take the supernatant, dilute 10 times with 4°C water, 
4. Spin @ 27000g, 1h, 0°C (rotor SS34, 15000 rpm) 
5. Dissolve the pellet directly in laemmli buffer 1.5x 
6. Heat 5’ 95°C 
7. Cool on ice. 
 
Urea extraction: extraction of all the proteins of the skin. (8M Urea, 10mM EDTA, 50mM Tris-
Hcl pH=8.0). 
1. Homogenate the samples in buffer, 
2. Incubate 30 on ice (4°C) 
3. Spin @ 15000g, 30’, 0°C 
4. Take the supernatant 
5. Add 5x laemmli buffer (final 1x) 
6. Heat 5’ 95°C 
7. Cool on ice. 
 
Homogenization with the TissueLyser (Qiagen): 
1. In 2ml “safe-lock” Eppendorf tubes on a cold block 
2. Add 2cm2 of skin sample, 600µl of buffer, one 5mm iron bead, 
3. Shake 30’’ at 30Hz, 
4. Turn the tube holder upside-down 
5. Shake 30’’ at 30Hz, 
6. Proceed with the extraction 
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Western blot analysis  
 
Protein quantification using the BCA Protein Assay kit (Pierce): 
o in a 50ml Falcon tube: 
 98 µl from bottle A x (number of samples + 2)  
 2 µl from bottle B x (number of samples + 2)  
o on a transparent plate, put 2 lines of BSA (10 µl) as a ladder (from 0 to 10mg of 
protein), then put the samples (10 µl). Quickly add 100 µl of the BCA mix over 
every protein well. 
o Measure proteins a 540 nm wave length, the BSA scale must be between 0.1 and 
1. If necessary, wait and repeat the measurement. 
Plot the data as follows in excel: 
 
 
 
The data obtained is then treated as shown below : 
 
 
The data obtained is then plotted as shown below : 
 
 
 
The slope allows to calculate the values for the protein concentration of the samples of interest. 
 
in duplicate 
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This is an example of the data obtained of testis protein lysates. 
 
Gels : 
Separating gel : (20 ml) Stacking gel : (10 ml) 
• 5 ml Tris-HCl 1.5 M, pH 8.8. 2.5 ml Tris-HCl 0.5 M, pH 6.8. 
• 0.2 ml SDS 10%. 100 µl SDS 10%. 
• 6.5 ml acrylamide 30%. 1.3 ml acrylamide 30%. 
• 8.3 ml ddH2O. 6.1 ml dcH2O. 
• 150 µl APS 10%. 50 µl APS 10%. 
• 15 µl Temed. 20 µl Temed. 
 
Calculate and prepare samples that manner : 
 
What we look for is the initial volume:  
Cf = 2 µg/µl     Vf = 100 µl 
The initial concentration is divided by 1000. 
Example : 
Vi = (2*100)/14.025 = 14.260 µl of proteins 
Water to add : 100 - Vi = 85.74 µl 
 
Once the protein volume has been taken and put in an Eppendorf tube we must add: 
• 20 µl de Laemmli buffer 5x 
• Vortex and put 5 min at 95 °C 
• Thermic shock bye putting on ice 
• Centrifuge briefly 
 
Migrate the proteins on the acrylamide gel, in an SDS-Page Gel box with the migration buffer 
1x at 80 V for 15 min, then at 120 V until the lightest proteins join the bottom of the gel. 
 
Initial concentration (Ci) x Initial Volume (Vi) = Final Concentration (Cf) x Final Volume (Vf) 
Vi = CfVf 
Ci 
 180 
 
 
The stacking gel is used to compact proteins before entering the separating gel. The latter is 
used to separate the proteins in function of their size. 
 
After the migration, transfer the proteins on a nitrocellulose membrane. Transfer buffer 1x is 
used and a transfer box. The gel has to be placed as shown is the following image: 
 
 
A potential must be applied, either 100 V for 1 h or 40 V for 24 h, both at 4 °C. This electrical 
potential drives proteins from the negative to the positive side of the membrane. 
 
Proteins can be revealed by Ponceau S red 1% staining (2 min). Wash the membrane with 
distilled water.  
 
Bloc the membrane with TBS tween + milk for 30 min (RT). This step is used to avoid 
unspecific binding of the primary antibody.  
 
Incubate the membrane with the primary antibody for 1 h, then wash 3x with TBS tween and 
apply the secondary antibody for 1 h. The antibodies must be diluted in 2% milk. The 
concentration depends on the affinity of the antibody itself. 
 
The secondary antibody is normally conjugated so to be reacting chemically or physically. The 
ECL kit is used to react with HRP-conjugated antibodies by bioluminescence. 
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The proteins of interest on the membrane can then be revealed on a negative film in a dark 
room. 
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Cell culture of mouse embryonic fiboblasts (MEFs) 
 
Breed 2 females with 1 male the evening and the morning after (early) separate the male and 
check the plug on the females. 
 
14 days after, dissect the mother to take out the embryos: 
• From the embryos, take out the head and liver (decidua). 
• Perform PCR from unwanted part for genotyping. Each embryo is kept separately until 
genotype is known. 
• The embryo is digested into trypsin. 
• Once genotyped, pool cells form 3 animals together (by genotype!!), filter and put into 
75 cm2 flasks with 12 ml of medium. 
• 2 days after, pass the cells into 175 cm2 flasks with 45 ml medium. 
• 2 days after, pass 1 flask into 3 of the same size. 
 
To freeze the cells, take out the medium and rinse with PBS. Trypsinize few minutes and 
resuspend with 10 ml of medium in a 50 ml Falcon tube. Centrifuge at 1500 rpm and take out 
the supernatant. Resuspend the pellet with 12 ml of  “freezing medium” (=10% DMSO, 40% 
FBS et 50% complete medium). Put the cells into cryovials (1 ml per tube) and store at -70 °C 
for one week and then store into liquid N2 for longer periods. 
 
To use the frozen cells, thaw cryovials at 37 °C. Pool 2 tubes per genotype into a 15 ml Falcon 
tube and gently add 8 ml of medium. Centrifuge at 1200 rpm for 5 min. Take out the 
supernatant and keep the pellet. Resuspend the cells into 4 ml of medium. Put the suspension 
into a 75 cm2 flask and add 11 ml of medium. Store in the incubation oven (37 °C, 5 % CO2).  
• After 2 days, pass into 175 cm2 flask. 
• After 2 days, pass into 3x175 cm2 flasks. 
• After 2 days, pass the cells into: 
o 6x 100mm petri dishes (15 ml) 
o 6x 6-well dishes (4 ml) 
o 2x 175 cm2 flasks (45 ml) 
• After 2 days, change the medium. 
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MEF differentiation into adipocytes 
 
Once cells are subconfluent (2 days after confluence), put the “differentiation medium”. 
 
For 500 ml of  “differentiation medium” mix these reagents to DMEM: 
• 50 ml FBS. 
• 5.5 ml Sodium Pyruvate. 
• 5.5 ml L-glutamine. 
• 500 µl Dexamethasone 1 µM ; prepared like this : 6.8 mg in 1 ml mQ water. 
• 150 µl IBMX 0.5 mM ; prepared like this : 57.5 mg in 150 µl NaOH 2M. 
• 500 µl Insulin 5 mg/ml ; prepared like this : 5 mg in 1 ml HCl 50 mM. 
• 500 µl Roziglitazone 2 µM ; prepared like this : 0.25 mg in 500 µl DMSO/PBS 
(proportion 1:3). Prepare at the last moment (can not be kept once in solution). 
 
Once differentiated, cells must be kept into the “maintaining medium”. 
 
For 300 ml of  “maintaining medium” mix these reagents to DMEM: 
• 300 ml of DMEM. 
• 30 ml FBS. 
• 1/1000 Gentanamicin. 
• 300 µl Insulin (same concentration as for the differentiation medium). 
• 0.3 mg Roziglitazone in 200 µl DMSO. 
After 2 days, change this maintaining medium, and after 2 days again. 
When the cells are ready for further experiments, rinse them with PBS : 
1. For Oil red O staining, put formaldehyde on the cells for 15 min (caution, do not breath 
or touch !) Put Oil red O stain for 4 h on the dried/fixed cells. After, rinse with distilled 
water and take the picture with an inverted microscope. 
2. For RNA analysis, use 600 µl of RLT buffer (RNeasy kit - Qiagen) for the lysis of the 
cells. Scrap the cells and put them into a Qiashredder column (Qiagen) for better lysis. 
Then extract the RNA following standard protocols. 
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Primary keratinocytes cell culture 
 
• Take pups because in adult skin there is too many fibroblasts that would invade the 
culture dish instead of keratinocytes. 
• Decapitation of the animal. 
• Cut and keep the tail for genotyping.  
• Cut the fore and hind legs at the half-length. 
• Incision of the back with a scalpel. 
• Peel a bit the skin away from both sides. 
• Take away the skin from the legs. 
• Spread out the skin with dermal side in contact with a dispase (5 mg/mL in Dubelco 
minimal essential medium (DMEM) ie: without Ca++ nor Mg++) solution. 
• Let incubate O/N at 4 °C or at 37 °C for 1-2 h. 
• Put the skin on the epidermal side on a dish and take away the dermis that should go 
easily due to the dispase treatment. 
 
• To put the skins in the dishes, forceps, funnel, gauzes (tissue) to filtrate… Put 
everything under UV light for 10 min to disinfect, heat the coating solution and the 
complete culture medium at 37 °C. 
• In the hood, the flux comes from upside, so avoid to pass over objects or dishes. 
Bacteria don’t fly! 
• Put the coating solution (2 mL per medium culture dish), which is used as a protein 
matrix for cells to adhere.  
 
• To separate dermis and epidermis, stick the skin epidermal side on the dish. Pull softly 
to get rid of the dermis, which is larger. Then pool the epidermises that are thinner and 
whiter than the dermis, by genotype. Then add 4mL of medium. 
• Then slice thinly the skins with scissors avoiding putting the hand over the dish. 
• Homogenize with a pipette, then take the cells from the medium and put them on the 
funnel with the gauze (filtration process to get rid of “everything” else than cells). 
Repeat this step with new medium 10 mL. 
• Centrifuge 2 min (don’t touch the speed control if using the machine in the culture room 
of the DPT) to collect cells at the bottom of the tube. 
• Recover the coating solution on the side of the dish without making traces with the 
pipette, because cells wouldn’t grow there. 
• Take the supernatant after centrifugation of the Falcon tubes. Then suspend the base 
(culot) with medium 2 mL (for 1 dish) on the dishes for sedimentation. Check with the 
microscope that there are enough cells. 
• Isolated cells that are clear have more chance to grow. 
• Let incubate without EGF during 2-4 h at 37 °C then change the medium with one 
containing EGF when cells have well adhered (when it is the case, there is less contrast 
viewing with the microscope, meaning that they are well alive). 
• Flame a glass pipette then aspire particles (dead cells). 
• To do this change of medium it is necessary to rinse first with PBS or old culture 
medium that is still sterile and isotonic. Avoid the contact of the pipette and the dish. 
• Put the new medium 4 mL per mid sized dish. 
• Add EGF 1 µL/mL, or even 2 µL/mL to boost the reaction at the start of the culture. 
• Add Ca++ (about 40-80 µM) as defined by R.-P. Charles. 
• Incubate at 37 °C until the next passage (when the medium in the dishes changes color. 
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